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Abstract 
Background: A wealth of studies has demonstrated the detrimental effects of exposure to 
maternal stress in utero on emotional psychopathology in childhood. Many of these effects have 
been attributed to foetal programming of offspring brain development during gestation. 
Research has also demonstrated an association between exposure to prenatal maternal 
depression and offspring childhood maltreatment. The main aim of this thesis is to investigate 
the long-term effects of offspring exposure to prenatal maternal depression on depressive 
psychopathology in young adulthood, and whether exposure to childhood maltreatment 
contributes to this association. Secondary aims are to characterise the biological characteristics 
of young adult offspring who were exposed to prenatal maternal depression, in terms of 
hypothalamic-pituitary-adrenal (HPA) axis function, inflammation and metabolic function. 
Previous research has shown that abnormalities in all three systems are associated with 
exposure to prenatal maternal depression, childhood maltreatment and depressive 
psychopathology. 
 
Methods: The sample comprised 103 offspring from the South London Child Development Study 
(SLCDS), a prospective longitudinal birth cohort study setup in 1986 that had followed mothers 
and their offspring from pregnancy to 16 years. This PhD thesis continued the SLCDS by 
assessing the offspring at age 25. Data on offspring exposure to depression in utero (20 and 36 
weeks gestation), childhood maltreatment (birth to 17 years) and young adulthood DSM-IV 
depressive disorders (18 to 25 years) were obtained through one-to-one clinical interviews. 
Biological measures of offspring HPA axis function, inflammation and metabolic function were 
obtained at 25 years. 
 
Results: Offspring exposed to prenatal maternal depression were significantly more likely to 
have a DSM-IV depressive disorder in young adulthood (18 to 25 years) compared to offspring 
not so exposed. Offspring exposure to childhood maltreatment and further maternal depression 
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during childhood were found individually to mediate this association. Offspring exposed to 
prenatal maternal depression also exhibited significantly greater systemic inflammation at 25 
years compared to non-exposed offspring, whilst offspring exposed to childhood maltreatment 
demonstrated HPA axis abnormalities compared to non-exposed offspring. No effect of early life 
adversity on metabolic function was observed. 
 
Conclusions: Exposure to prenatal maternal depression results in persistent psychological and 
biological changes in the offspring that are observable during young adulthood. Childhood 
maltreatment contributes to these pathologies. These findings have direct implications for policy 
development and clinical practice: identification and treatment of maternal depression during 
pregnancy could have a direct impact on reducing levels of child maltreatment as well as 
depression in the young adult population. 
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Dante Cicchetti, in his influential editorial “The Emergence of Developmental Psychopathology” 
(1984), articulates a case for the strength and appeal of developmental psychopathology, as a 
distinct discipline, as resting upon its integrative and explanatory qualities. Indeed, the 
developmental psychopathologist of the twenty-first century routinely investigates both 
abnormal and normal human pathology within a developmental framework and at multiple 
levels of analysis (Cicchetti & Cohen, 2006). Armed with these methodological techniques, 
psychological and medical theory can be webbed together in an attempt to provide a 
comprehensive account of human adjustment across the lifespan (Sroufe & Rutter, 1984).  
 
It is with such a perspective in mind, that this thesis aims to investigate foetal programming of 
depression and neurobiological and metabolic dysfunction in young adulthood. This 
investigation is operationalized in the context of exploring the impact of foetal exposure to 
maternal depression during pregnancy on young adulthood depressive disorders and on 
neuroendocrinological, inflammatory and metabolic function at twenty-five years of age.  
 
The purpose of the introductory background that follows is to provide an overview of the 
pertinent literature on each of these topics, with a focus on the relationship of these biological 
systems to depression and early life stress (prenatal maternal stress and child maltreatment). 
First, a brief overview of depression, foetal programming and child maltreatment is provided. 
Next, I review the literature linking these three adversities. In the second section, I examine 
alterations in the three biological systems in the context of depression, and as function of 
exposure to early life stress. Research is drawn from a mixture of high-quality review articles and 
contemporary empirical papers.  
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1.2. Major depressive disorder  
 
1.2.1. Phenomenology 
Major depressive disorder (MDD) is a highly prevalent mental disorder characterised by a broad 
symptomatology, with a multifactorial aetiology. According to the Diagnostic and Statistical 
Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR; American Psychiatric 
Association, 2000), a diagnosis of MDD is rated if an individual has suffered from at least one 
core symptom of (i) depressed mood or (ii) diminished interest or pleasure in activities, and at 
least three of the following symptoms: (iii) significant weight change or change in appetite; (iv) 
insomnia or hypersomnia; (v) psychomotor agitation or retardation; (vi) fatigue or loss of energy; 
(vii) feelings of worthlessness or excessive or inappropriate guilt; (viii) diminished ability to think 
or concentrate or indecisiveness; (ix) recurrent thoughts of death, recurrent suicidal ideation or 
plans for committing suicide. These symptoms must be present for most of the day, nearly every 
day, for at least two weeks. Furthermore, the symptoms must cause significant distress or 
impairment in normal functioning, and should not be attributable to the death of a loved one, a 
general medical condition or substance use (American Psychiatric Association, 2000).  
 
MDD is one of the main contributors to the burden of disease worldwide (Kessler, Zhao, Blazer, 
& Swartz, 1997). It has a lifetime prevalence of 16.5% (Kessler, Berglund, et al., 2005) and a 12-
month prevalence of 6.7% (Kessler, Chiu, Demler, & Walters, 2005). Mean age of onset is 
estimated at 32 years of age, with 18-29 year olds estimated to be 70% more likely to experience 
lifetime depression than 60+ years olds (Kessler, Berglund, et al., 2005) and for 12-month 
prevalence depression, they are 200% more likely to experience a depressive episode than are 
60+ years olds (Kessler, Chiu, et al., 2005). One of the most consistent sociodemographic 




MDD has a multifactorial aetiology that is characterised by interplay between environmental 
and genetic risks. Research has identified numerous psychosocial and biological vulnerability 
factors that increase the emergence of the disorder, but with no single risk factor being found to 
be wholly accountable for its emergence. Rather, multiple biopsychosocial pathways have been 
identified in the pathogenesis of depression. Key biological mechanisms argued to be involved in 
the pathogenesis of depression include dysregulation in neuroendocrinological systems 
(Pariante & Lightman, 2008; Pariante, Nesse, Nutt, & Wolpert, 2009), inflammation (Raison, 
Capuron, & Miller, 2006), dysregulation in neurotransmission (Hirschfeld, 2000; von Wolff, 
Hölzel, Westphal, Härter, & Kriston, 2013), the genetic transmission of temperament (Sullivan, 
Neale, & Kendler, 2000), and abnormalities in brain structure (Jacobs, Van Praag, & Gage, 2000) 
and function (Leppänen, 2006). Key psychosocial theories include the stress/vulnerability model 
for depression (G. W. Brown & Harris, 1986; G. W. Brown & Prudo, 1981), including the impact 
of stressful life events (Kendler, Karkowski, & Prescott, 1999) and childhood maltreatment 
(Bifulco & Moran, 1998; Widom, DuMont, & Czaja, 2007). 
 
 
1.2.3. Depression during pregnancy  
A meta-analysis was conducted in 2004 into the prevalence of prenatal depression (Bennett, 
Einarson, Taddio, Koren, & Einarson, 2004).  The meta-analysis included studies published since 
1980. Twenty-one studies were identified, seven of which were based on clinical diagnoses of 
depression rated through structured clinical interviews (Schedule for Affective Disorders and 
Schizophrenia; SADS), whilst the remaining studies were based on ratings of depression 
captured through self-report measures such as the Edinburgh Postnatal Depression Scale (EPDS) 
and the Beck Depression Inventory (BDI). The authors report the point prevalence of depression 
by trimester, with rates of 7.4%, 12.8% and 12.0% in the first, second and third trimesters, 
respectively. Prevalence estimated through structured interviews did not differ significantly 
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from rates attained through the EPDS, but were significantly lower that rates attained through 
the BDI. 
 
In a further meta-analysis, Gavin and colleagues (2005), reviewed studies where depression 
during pregnancy had been rated through only structured clinical interviews. The authors report 
a period prevalence rate (conception to birth) for MDD of 12.7%, with this rising to 18.4%  when 
ratings of minor depression (akin to the DSM-IV diagnosis of major depressive disorder not 
otherwise specified [MDD NOS] ; American Psychiatric Association, 2000)  were included. In both 
studies there were noteworthy methodological flaws, such as the exclusion of women with 
previous psychiatric histories and of low socioeconomic status. Given that both of these factors 
are well-known risk factors for depression (Gotlib & Hammen, 2009), it is likely that these 




1.3. Foetal programming 
The foetal origins of adult disease (FOAD) hypothesis is the notion that exposure to intrauterine 
insults during gestation affects foetal brain development, leading to vulnerabilities for a variety 
of neuropsychiatric and chronic physical health diseases in adult life. This concept was initially 
termed the “Barker Hypothesis”, in acknowledgement of the late David Barker, who, in his 
seminal 1995 paper presented the argument for an association between poor foetal growth and 
elevated cardiovascular disease (CVD) in adulthood. Barker and colleagues’ research was 
predominantly drawn from a series of studies on a British cohort of men and women that 
demonstrated an inverse relationship between low birth weight and death from CVD, and 
elevated markers of the metabolic syndrome (D Barker, Gluckman, et al., 1993; D Barker, Hales, 
et al., 1993).  
 
Barker’s original hypothesis (D Barker & Clark, 1997; D Barker, 1995) postulates that offspring 
exposure to adverse conditions during gestation, especially malnutrition, ultimately leads to 
“programming” of insulin resistance and glucose intolerance. This phenomenon resonates with 
an evolutionary adaptation, functioning to enhance the foetus’ ability to retain as much 
nutritional energy as possible, resulting in the development of the “thrifty phenotype”. It is 
argued that this physiological reprogramming translates into a risk for metabolic diseases in later 
life in scenarios where high-energy food becomes readily available. This concept of “mismatch” 
between the foetal environment and post birth environment in predicting pathological 
conditions has been replicated in animal studies. It is worth noting that “mismatch” is argued to 
be a U-shaped phenomenon in which both overabundance and scarcity in gestational 
environmental conditions can result in the foetus making short-term adaptations that are non-
beneficiary in the long run. For example, studies in rodents have shown that maternal high fat 
diet during pregnancy leads to the greatest obesity in pups fed a normal diet after birth, whilst a 
maternal low calorie diet leads to obesity in offspring that go on to be fed a high fat diet 
postnatally (Howie, Sloboda, Kamal, & Vickers, 2009; Thompson et al., 2007).  
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Since its inception into the wider research field, the Barker Hypothesis has been applied to a 
variety of offspring in utero risk exposures, as well as to a variety of later neuropsychiatric 
conditions, including emotional and behavioural psychopathology. Specifically, prenatal 
exposures that cause distress to the mother have been studied. These have included maternal 
experience of severe stressful life events during the antenatal period, such as suffering 
bereavement or witnessing a terrorist attack, as well as maternal experience of depression and 
anxiety. In these latter instances (maternal experience of depression and anxiety during 
pregnancy), it has been argued that such symptomatology is the consequence of being stressed, 
and that such psychological distress experienced by the mother may be a risk factor for her 
developing foetus. The term “prenatal stress” has become the widest and most generic term 
used to characterise such maternal experiences of distress during pregnancy (Glover, 2011). In 
detailing the available literature, I use the term “prenatal maternal stress” to conceptualise 
maternal experience of distress during pregnancy, including both severe stressful life events and 
depression and anxiety. 
 
This keen interest and widespread application of foetal programming models to a multitude of 
prenatal risks and pathological conditions, led to the expansion of the term from the Barker 
Hypothesis to the FOAD hypothesis. Accordingly, research in the last decade has primarily 
focused on identifying biological mechanisms responsible for the translation of in utero adversity 
into vulnerability for adulthood disease (Charil, Laplante, Vaillancourt, & King, 2010; Reynolds, 
2013; Seckl & Holmes, 2007), with a large body of research focusing specifically on the effects of 
prenatal maternal stress (Glover, 2011; Huizink, Mulder, & Buitelaar, 2004; Van Den Bergh, 
Mulder, Mennes, & Glover, 2005). The literature presented in this chapter will centre around the 
effects of prenatal maternal stress, in particular mood disturbances, on offspring 
psychopathology and reactivity in neuroendocrine, inflammatory and metabolic systems. This 
PhD thesis also refers directly to this model, as it will specifically look at the impact of exposure 
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to prenatal maternal depression on depressive psychopathology in young adulthood, as well as 
dysfunction in neuroendocrine, inflammatory and metabolic systems.  
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1.4. Prenatal maternal stress and offspring psychopathology 
Over the past two decades a wealth of research has been conducted into the effects of offspring 
exposure to prenatal maternal stress on emotional and behavioural adjustment. The earliest 
observations for this link come from retrospective cohort studies that involved mothers who 
were pregnant during periods of natural adversities. For example, Brown and colleagues (2000) 
reported that offspring of mothers who experienced famine during the Dutch Hunger Winter of 
1944-1945, showed elevated rates of MDD in their own adult lives in comparison with offspring 
of mothers who were pregnant during the same years but did not experience famine. In another 
study, Meijer (1985) found that children of mothers who were pregnant during the Israeli Six-
Day War in 1967 showed behavioural problems in comparison with offspring of mothers who 
were pregnant in 1969. Whilst these findings suggest an association between maternal 
emotional state during pregnancy and offspring affective and behavioural psychopathology, they 
are limited by methodological weaknesses that are an artefact of their retrospective nature. A 
major caveat is the inability to control for unmeasured confounders, such as other maternal 
characteristics that could account for the observed associations (Thapar & Rutter, 2009). Thus, 
one cannot be confident from retrospective studies alone that these links are not in fact 
spurious.  
 
In contrast, prospective longitudinal studies, many of which have been setup in the past couple 
of decades, are better able to control for the influence of potential confounders, thus offering 
more robust tests of foetal programming effects by maternal experience of stress during 
pregnancy. Indeed, the prospective design is one of the core strengths of this thesis. Prospective 
studies have demonstrated an association between numerous types of maternal prenatal stress, 
such as daily hassles, life events and mood disturbances, on a variety of offspring 
neurodevelopmental outcomes, including behavioural, emotional and cognitive problems 
(Glover, 2011; Huizink et al., 2004; Talge, Neal, & Glover, 2007; Van Den Bergh et al., 2005). A 
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common feature of these prospective studies is their exploration of offspring outcomes during 
childhood (infancy into adolescence).   
 
In a study of 22 mother-infant dyads, maternal prenatal anxiety and depression were 
significantly associated with infant negative behavioural reactivity to novelty (Davis et al., 2004). 
No associations were observed for maternal postnatal depression and anxiety. In another study 
of 170 mothers and their 8 month old infants, high levels of pregnancy-specific anxiety was 
found to predict lower mental and motor developmental in the offspring (Huizink, Robles de 
Medina, Mulder, Visser, & Buitelaar, 2003). Additionally, high amounts of self-reported daily 
hassles during pregnancy were also associated with lower mental developmental scores at 8 
months. In a study of 71 Dutch mothers and their eight year old children, Van den Bergh and 
colleagues (2004) found that maternal prenatal anxiety during pregnancy explained, 
respectively, 15%, and 9% of the variance in cross-situational offspring externalizing problems, 
and self-report anxiety, even after controlling for child’s gender, parents’ educational level, birth 
weight, and postnatal maternal anxiety. At 15 years, maternal prenatal anxiety was found to 
predict depressive symptomology in the offspring (Van den Bergh, Van Calster, Smits, Van 
Huffel, & Lagae, 2008). Similarly, all effects remained after controlling for maternal prenatal 
smoking, birth weight, obstetrical outcomes, maternal postnatal anxiety and offspring puberty 
development. 
 
Further strong evidence for an association between maternal prenatal mood and offspring 
outcome comes from the Avon Longitudinal Study of Parents and Children (ALSPAC). The 
ALSPAC is a unique British birth cohort comprising detailed prospectively collected information 
on over 14,000 mothers and their offspring. In a study including over 7,000 mother-child dyads, 
O’Connor and colleagues (O’Connor, Heron, et al., 2002; O’Connor, Heron, Golding, et al., 2002) 
showed that offspring of mothers who were prenatally anxious were twice as likely to exhibit 
behavioural depressive and anxious psychopathology at four years, compared to offspring of 
27 
non-prenatally anxious mothers These effects persisted into middle childhood (O’Connor, Heron, 
Golding, & Glover, 2003). Furthermore, when the offspring reached adolescence (13 years) 
maternal prenatal anxiety continued to predict disruptive behaviour symptomatology (E Barker 
& Maughan, 2009; O’Donnell, 2010) and emotional symptomatology (O’Donnell, 2010). 
Importantly, the aforementioned effects of maternal prenatal anxiety were found to be 
independent to the effects of prenatal smoking and drinking, obstetric outcomes, psychosocial 
disadvantage, maternal age and maternal postnatal anxiety and depression.  
 
Turning more specifically to the influence of prenatal maternal depression, neonates born to 
mothers who were depressed during pregnancy have been shown to be less reactive to auditory 
stimulation in comparison to neonates born to non-depressed mothers. In our South London 
Child Development Study (SLCDS), a prospective longitudinal birth cohort study of over 150 
mother-offspring pairs, offspring of mothers who suffered clinical depression during pregnancy 
were found to have greater depression and conduct problems in adolescence compared to 
offspring of mothers who were not clinically depressed in pregnancy (Hay, Pawlby, Waters, 
Perra, & Sharp, 2010; Hay, Pawlby, Waters, & Sharp, 2008; Pawlby, Hay, Sharp, Waters, & 
O’Keane, 2009; Waters, 2008). Notably, prenatal maternal depression significantly predicted 
offspring psychopathology after controlling for the family environment, the mother’s smoking 
and drinking during pregnancy, and parents’ antisocial behaviour. The effects on offspring 
conduct disorder were independent of maternal postnatal depression, whilst the effects on 
offspring depression were partially mediated by maternal postnatal depression. Findings from 
the ALSPAC have also provided evidence for the influence of prenatal maternal depression. 
O’Donnell (2010) showed that in over 9,000 mother-offspring pairs, prenatal maternal 
depression was associated with offspring emotional and behavioural problems at 13 years, 
independent of the effects of prenatal maternal anxiety and other potential confounders. 
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Finally, findings from animal studies of the effects of prenatal maternal stress on the offspring 
are comparable to those found in the human study literature. For example, studies in rodents 
show that pups of prenatally stressed dams showed greater depressive-like behaviour, such as 
decreased exploratory behaviour and reduced feeding behaviour, compared to pups of non-
stressed dams (Weinstock, 2008).  
 
Collectively, these findings provide robust evidence for an association between prenatal 
maternal stress and offspring psychopathology. Moreover, there is keen evidence that prenatal 
maternal depression specifically, is associated with detrimental offspring emotional and 
behavioural problems in childhood and adolescence. The fact that wide varieties of stressors in 
pregnancy are shown to affect a wide variety of psychopathologies in the offspring, suggests 
that prenatal maternal stress generates general, non-specific neurobehavioural vulnerability in 
the offspring, that has the potential to manifest in an array of emotional, behavioural and 
developmental problems. This observation suggests an important point. It advocates the notion 
that the hormonal environment afforded by the mother may programme underlying 
neurobiological systems that are component facets of emotional and behavioural development. 
Further studies are needed to investigate the persistence of these effects into adulthood, with 
particular attention to the development of depression. Levels of depression tend to increase 
through the transition period from childhood, adolescence and young adulthood (Costello, 
Copeland, & Angold, 2011). Also, depression in adolescence is commonly preceded by disruptive 
behavioural disorders (Hipwell et al., 2011). These data would suggest that programming effects 




1.5. Child maltreatment 
Child maltreatment is a major public health issue. The National Society for Prevention of Cruelty 
to Children (NSPCC) identifies child maltreatment as any exposure to physical abuse, sexual 
abuse, emotional abuse, neglect or domestic violence. In the wider research literature, the 
terms "adverse childhood experiences" (ACEs), "victimization" and "trauma" have been applied 
in a more generic manner to refer to the aforementioned forms of abuse and neglect, as well as 
to other negative childhood experiences such as peer bullying, exposure to major traumatic life 
events and parental loss (Preer, Sorrentino, Ryznar, & Newton, 2013). However, the most widely 
accepted definition of child maltreatment comprises child sexual abuse (CSA), child physical 
abuse (CPA), child emotional abuse (sometimes referred to as psychological abuse) and child 
neglect. Table 1 provides definitions for these forms of abuse and neglect (Norman et al., 2012).  
 
Currently, over 40,000 children in England are on the child protection register (Department for 
Education, 2012). Over 18,000 children are registered for being exposed to neglect, over 4,000 
are registered for being exposed to CPA, over 2,000 are registered for exposure to CSA and over 
12,000 are registered for exposure to emotional abuse. Global prevalence rates for child 
maltreatment remain uncertain, with estimates varying between 2% and 67% (Norman et al., 
2012). These discrepancies are likely because much violence against children remains hidden 
and unreported due to fear and stigma, as well as due to a general societal acceptance of this 




Table 1. Common definitions of child maltreatment 
Type of maltreatment Description 
Child physical abuse Physical abuse of a child is defined as the intentional use of physical 
force against a child that results in, or has a high likelihood of 
resulting in, harm for the child’s health, survival, development, or 
dignity. This includes hitting, beating, kicking, shaking, biting, 
strangling, scalding, burning, poisoning, and suffocating. Much 
physical violence against children in the home is inflicted with the 
object of punishing. 
Child sexual abuse Sexual abuse is defined as the involvement of a child in sexual activity 
that he or she does not fully comprehend, is unable to give informed 
consent to, or for which the child is not developmentally prepared or 
else that violates the laws or social taboos of society. Sexual abuse 
can be perpetrated by adults and other children who are, by virtue of 
their age or stage of development, in a position of responsibility, 
trust, or power over the victim. 
Child emotional abuse Emotional and psychological abuse involves both isolated incidents, as 
well as a pattern of failure over time on the part of a parent or 
caregiver to provide a developmentally appropriate and supportive 
environment. Acts in this category may have a high probability of 
damaging the child’s physical or mental health, or his/her physical, 
mental, spiritual, moral, or social development. Abuse of this type 
includes the following: the restriction of movement; patterns of 
belittling; blaming; threatening; frightening; discriminating against, or 
ridiculing; antipathy; and other non-physical forms of rejection or 
hostile treatment. 
Child neglect Neglect includes both isolated incidents, as well as a pattern of failure 
over time on the part of a parent or other family member to provide 
for the development and well-being of the child, where the parent is 
in a position to do so, in one or more of the following areas: health; 
education; emotional development; nutrition; shelter; safe living 
conditions. The parents of neglected children are not necessarily 
poor. 
Note. Adapted from Norman et al., 2012.   
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1.6. Child maltreatment and affective disorders 
Child maltreatment has repeatedly been shown to predict a variety of psychiatric disorders in 
adulthood, including mood disorders, substance use disorders and psychotic disorders (Green et 
al., 2010; Keyes et al., 2012; Norman et al., 2012). Furthermore, in regards to risk specifically for 
depression, studies have shown that a range of abuse types (e.g. sexual, physical, emotional) 
and forms of neglect (e.g. physical, emotional) are associated with elevated risk for depression 
(Antonia Bifulco, Moran, Baines, Bunn, & Stanford, 2002; Fergusson, Boden, & Horwood, 2008; 
Green et al., 2010; Keyes et al., 2012; Lieberman, Chu, Van Horn, & Harris, 2011; Nanni, Uher, & 
Danese, 2012; Nemeroff, 2004; Norman et al., 2012; Widom et al., 2007). Some studies have 
suggested a  ‘dose-response’ relationship between severity of maltreatment and depression 
(Antonia Bifulco et al., 2002; Wise, Zierler, Krieger, & Harlow, 2001), whilst a recent meta-
analysis revealed an association with unfavourable (i.e. recurrent or chronic) courses of MDD 
(Nanni et al., 2012). Preclinical studies in rodents and non-human primates have also shown that 
prolonged separation during the early sensitive period of development leads to behavioural 
changes in the offspring, that persist into adult life, and resemble depressive and anxious human 
symptomatology (Nemeroff, 2004).  
 
These cumulative findings also support the notion that childhood maltreatment may exert its 
effects through generalised risk vulnerabilities for psychopathology, such as dysfunction in 
neuroregulatory mechanisms, rather than through individual pathways to specific disorders. 
Indeed, Keyes and colleagues (2012) conducted a specific test of this hypothesis. They 
demonstrated in a nationally representative sample of 34,653 American adults, that the effects 
of child abuse (physical, sexual, emotional abuse) on affective and substance use disorders were 
fully mediated by dysregulation in latent generalised internalising and externalising dimensions, 




1.7. Prenatal maternal stress and offspring child maltreatment 
 
1.7.1. Predictors of child maltreatment 
It has been observed that child maltreatment potential is highest amongst families that 
experience cumulative environmental adversities (Begle, Dumas, & Hanson, 2010). Key risk 
markers for child maltreatment potential include parental mental health problems, parental 
antisocial traits, low socioeconomic status (SES), parental experience of maltreatment in their 
own childhood, parental financial, housing and relationship difficulties, and offspring disruptive 
behaviour problems (Appleyard, Berlin, Rosanbalm, & Dodge, 2011; Berlin, Appleyard, & Dodge, 
2011; Jaffee et al., 2004; Lereya & Wolke, 2013; Plant, Barker, Waters, Pawlby, & Pariante, 2013; 
Sidebotham & Golding, 2001; Sidebotham & Heron, 2003, 2006; Thornberry, Knight, & 
Lovegrove, 2012). These findings suggest that risk for child maltreatment potential can be 




1.7.2. Prenatal maternal stress as a risk factor for offspring child maltreatment 
In accordance with a child-driven effects model, the literature reviewed in section 1.4 that 
demonstrates a robust link between maternal prenatal stress and offspring disruptive behaviour, 
supports the idea that prenatal maternal stress is a key risk factor for child maltreatment 
potential. That is, the argument follows that prenatal maternal stress can indirectly increase the 
risk of child maltreatment potential through increasing the child’s propensity for elevated 
disruptive behaviour, which in turn may elicit detrimental parenting practices. Indeed, in an 
adoption study of adolescents and their adoptive and biological parents, Ge and colleagues 
(1996) found (i) that adolescents’ hostile and antisocial behaviour was correlated with their 
biological parents’ antisocial behaviour, and (ii) adoptive parents of adolescents who showed 
disruptive behaviours exhibited harsher parenting practices which were positively correlated 
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with the child’s biological parents’ behavioural problems. This data provides support for 
offspring-elicited harsher parenting as a function of the offspring’s disruptive characteristics. 
However, a limitation to this premise is that it may not be as applicable to neglect, as it is to 
abuse. Also, parents are not always the perpetrators of child abuse. 
 
A parent-driven model can be argued to have greater power in accounting for risk for child 
maltreatment. Whilst research has illustrated that maternal experience of mental health 
difficulties increases the risk of offspring childhood maltreatment (see 1.7.1), less research has 
focused on whether maternal mood disturbances specifically during pregnancy are associated 
with greater levels of childhood maltreatment. A meta-analysis was conducted in 2008 into the 
relationship between maternal mental health problems and maternal-foetal attachment 
(Alhusen, 2008). Overall findings, from a review of 22 studies, revealed that maternal depression 
and anxiety during pregnancy was associated with lower maternal-foetal attachment. 
Furthermore, rates of child-mother secure attachment were shown to be lower amongst 
maltreated preschool children, whilst rates of disorganized attachment were found to be higher, 
in comparison with non-maltreated children (Stronach et al., 2011). Together, these data give 
support to the notion that mothers who suffer depression and anxiety during pregnancy may go 
on to have poorer parent-child relationships with their offspring, putting the offspring at risk for 
greater exposure to neglect and abuse. 
 
In support of this premise, data from our SLCDS revealed that offspring of mothers who 
experienced prenatal depression were 4 times more likely to experience child maltreatment 
between birth and age 11, in comparison with offspring of mothers who were not depressed 
during pregnancy (Pawlby, Hay, Sharp, Waters, & Pariante, 2011). This association was 
independent of the effects of maternal postnatal depression and other prenatal risks. Notably, in 
all instances of CSA, the perpetrator was not a parent. These data suggest several important 
points. First, they provide a clear association between maternal depression specifically during 
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the antenatal period and offspring exposure to maltreatment. Second, they illustrate that it is 
not necessarily the case that mothers who are depressed in pregnancy go on to abuse their 
offspring; rather, such mothers appear less able to protect their young, indirectly exposing them 
to elevated risks of abuse.  
 
Moreover, in a recent study conducted using data from the ALSPAC (n = 8,829), Lereya and 
Wolke (2013) found that prenatal maternal depression and anxiety predicted offspring peer 
victimisation at age 8. This effect was observed after controlling for gender, partner conflict, 
offspring temperament, postnatal family adversity and other stressors during pregnancy. In tests 
for indirect effects, prenatal maternal depression and anxiety were found to lead indirectly to 
peer victimisation through maladaptive parenting styles (hitting, shouting, parent hostility etc.). 
These data complement the findings from our South London Child Development Study, and 
provide novel information on the potential mechanisms (parental-driven effects) of the 
association between prenatal maternal affective psychopathology and offspring experiences of 
abuse and neglect. 
 
Animal models have also been used to test whether maternal stress during pregnancy alters 
maternal behaviour after birth. One of the best models in which this has been examined is 
through assessing licking and grooming (LG) behaviour in rodents, as an index of maternal care. 
Champagne and colleagues (2006) have conducted some of the clearest investigations into this 
phenomenon. In a series of studies, they demonstrated that dams that naturally expressed high 
LG under normal circumstances, exhibited low LG at six days post-birth after being subjected to 
seven days of restraint stress during pregnancy. Furthermore, dams that were subjected to 
prenatal stress also exhibited decreased oxytocin levels in the postnatal period. Higher human 
maternal oxytocin levels during pregnancy have been found to be positively associated with 
maternal bonding behaviour, attachment-related thoughts and frequency of checking of the 
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infant (Feldman, Weller, Zagoory-Sharon, & Levine, 2007), as well as protective of the 
occurrence of postnatal depression (Skrundz, Bolten, Nast, Hellhammer, & Meinlschmidt, 2011).  
 
There is also evidence supporting the notion that environmental experiences after birth can 
modulate the effects of prenatal maternal stress. In our South London Child Development Study, 
we found that offspring exposure to child maltreatment increased the risk of adolescent 
depression by four fold (Pawlby et al., 2011). In a sample (n = 271) of mother-child pairs drawn 
from the Wirral Child Health and Development Study, prenatal maternal depression was found 
to predict increased infant (10 months) negative emotionality and poorer physiological 
adaptability (measured via response to vagal withdrawal from a stressor) in only offspring whose 
mothers showed low stroking behaviour (H Sharp et al., 2012). These studies suggest that 
adversity during foetal life and after birth affect similar underlying physiological and 
psychological domains.  
 
These research findings show prenatal maternal stress to be a distinct risk factor for child 
maltreatment potential. Mechanisms appear to be indirect through two non-mutually exclusive 
pathways: (i) elevation of offspring disruptive behaviour which may in turn elicit harsher 
parenting practices (child-driven effects); (ii) down-regulation of maternal care, thereby 




1.8. Interim summary 
From the research reviewed in this section, we have seen that offspring exposure to maternal 
stress during gestation can have long lasting detrimental effects on behavioural and emotional 
adjustment across the childhood years. Much of this impairment manifests as stress-related 
psychopathology such as depression. Furthermore, gross environmental adversity during 
childhood, specifically experience of child abuse and neglect (collectively termed child 
maltreatment), is also strongly associated with affective psychopathology, which manifests 
predominantly during adulthood. The effects of exposure to early life stress (prenatal maternal 
stress and child maltreatment) are argued to be mediated by generalised vulnerability to stress 
reactivity. This notion suggests that dysregulation in biological stress systems may be one 
putative mechanism for the biological embedding of adversity into vulnerability for stress-
related disorders such as depression. Furthermore, the similarity in psychological outcomes 
between individuals exposed to gross adversity during childhood (i.e. child maltreatment) and 
during gestation (i.e. intrauterine exposure to maternal stress during pregnancy) resonates 
equifinality, further alluding to a shared underlying mechanism for the translation of 
psychosocial adversity into risk for affective psychopathology. 
 
The initial literature on foetal programming effects, as indexed by poor obstetric outcomes, 
demonstrated negative consequences on cardio-metabolic parameters. These findings support 
the notion of programming of biological systems relevant to chronic health conditions.  Thus, the 
next section will review the literature on the effects of early life stress on neuroendocrine, 
inflammatory and metabolic systems. It will conceptualise these systems both as outcomes per 
se and as potential mediators for the biological embedding of adversity on risk for depression.  
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1.9. Biological reactivity 
 
The hypothalamus-pituitary-adrenal (HPA) axis, the inflammatory response, and abnormalities in 
metabolic function have all been found to be influenced by early life stress. In addition each of 
these systems has been associated independently with depression. This section will explore the 
link between abnormalities in each of these systems and depression, as well as the impact of 
early life stress upon them. Thus, they will be treated both as outcomes in their own right, as 
well as potential mechanisms for the pathogenesis of depression within the context of the 
influence of early life stress. 
 
 
1.9.1. HPA axis 
A primary function of the HPA axis is modulating the response to stress, which comprises an 
individual’s reaction to external and internal (psychological) stimuli and challenge. HPA axis 
activity begins with stimulatory input to the hypothalamus, which stimulates secretion of 
corticotropin-releasing-hormone (CRH) and vasopressin. CRH and vasopressin stimulate the 
secretion of adrenocorticotrophic hormone (ACTH) from the anterior pituitary into the blood 
stream, which thereby stimulates the secretion of glucocorticoids (GCs; cortisol in humans, 
corticosterone in rodents) from the adrenal cortex. Once released, GCs exert their action 
primarily by binding to glucocorticoid receptors (GRs) found in many body tissues. GCs exert 
inhibitory effects on the HPA axis through activation of GRs in the hypothalamus, thereby 
executing negative feedback as a self-regulatory mechanism. The HPA axis is also involved in the 
modulation of a range of other physiological processes such as metabolism and immunity, as 




1.9.1.1. Diurnal rhythm  
Cortisol production follows a diurnal rhythm, with levels decreasing through the afternoon, 
reaching a nadir late at night. Levels then increase towards the end of the sleep cycle and peak 
around 30 minutes after awakening (Pruessner et al., 1997).  
 
 
1.9.1.2. Cortisol awakening response 
The cortisol awakening response (CAR) is the observation that cortisol levels start to increase 
after awakening, reaching a peak at around 30 minutes post awakening and tailing off 
thereafter. Pruessner and colleagues (1997) were amongst the first researchers to characterise 
the CAR, demonstrating moderate intra-individual reliability across days. The CAR has since 
become considered a reliable marker of HPA axis activity that appears to be independent to the 
diurnal profile (Clow, Thorn, Evans, & Hucklebridge, 2004). However, the precise function of the 
CAR is not clear (Fries, Dettenborn, & Kirschbaum, 2009). Initial theories posited that its purpose 
was to promote physiological processes, such as metabolic activity, upon awakening (Pruessner 
et al., 1997). However, studies have since demonstrated awakening cortisol levels to be 
unrelated to awakening blood glucose levels (Hucklebridge, Clow, Abeyguneratne, Huezo-Diaz, & 
Evans, 1999). As awakening is akin to a small stressor, the CAR has been interpreted as an index 
of stress reactivity (Clow, Hucklebridge, Stalder, Evans, & Thorn, 2010). Indeed, in a systematic 
review of 147 studies, a higher CAR, with respect to a greater increase in cortisol since 
awakening, was found to be positively associated with work and general life stress, and 
negatively correlated with fatigue, burnout and exhaustion (Gonzalez, Jenkins, Steiner, & 






1.9.2. HPA axis in depression 
A common biological characteristic of depression is dysregulation in the HPA axis (Holsboer, 
2000). Hyperactivity of the HPA axis has been observed in many studies of depressed individuals, 
who show increased levels of plasma, salivary and urinary cortisol, as well as larger pituitary and 
adrenal glands (Nemeroff & Vale, 2005). Impaired function of the GR is thought to result in 
impaired GC-mediated negative feedback, which it is argued underlies the dysfunction in the 
HPA axis that is commonly observed in depressed patents. This concept of impairment in GR 
signalling as a key molecular mechanism of HPA axis dysregulation has been referred to as “GC 
resistance” (Pariante & Lightman, 2008). Support for the notion of GC resistance in depressed 
patients comes from a multitude of studies demonstrating that the synthetic administration of 
the GC dexamethasone, does not lead to suppression of the HPA axis, as measured by GC 
output, whilst GC suppression is observed amongst healthy individuals (Pariante & Lightman, 
2008).  Support also comes from animal studies using transgenic mouse strains that under- or 
overexpress GRs. Such studies have demonstrated that mice with decreased GR expression 
exhibit greater depressive-like behaviours (Chourbaji, Vogt, & Gass, 2008). Furthermore, in vitro 
studies have consistently shown that antidepressants modulate GR function (Anacker, Zunszain, 
Carvalho, & Pariante, 2011), further suggesting that the receptor may play a pivotal role in 
neurobiological disturbances that contribute to depressive psychopathology. 
 
 
1.9.2.1. Diurnal cortisol and CAR in depression 
Whilst it is clearly evident that dysregulation of the HPA axis is a key feature of depression, the 
exact nature of this dysfunction is not fully understood. Studies investigating atypical diurnal 
HPA patterns in depressed individuals have produced mixed results, with a wealth of studies 
reporting hypercortisolemia (Bhagwagar, Hafizi, & Cowen, 2003, 2005; Vreeburg et al., 2009), 
but others reporting hypoactivity (Jarcho, Slavich, Tylova-Stein, Wolkowitz, & Burke, 2013).  
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For example, in a study of 20 non-medicated depressed patients and 40 healthy controls, 
depressed patients were found to secrete approximately 25% more cortisol than controls at 30 
minutes post-awakening, but had similar cortisol levels 60 minutes after waking (Bhagwagar et 
al., 2005). In another study of 1,588 Dutch adults, depressed and remitted individuals showed an 
elevated CAR compared to healthy controls. Evening cortisol levels were also found to be higher 
amongst depressed individuals at 10pm, but not 11pm, in comparison with controls (Vreeburg et 
al., 2009). In contrast, Jarcho and colleagues (2013) found in sample of 23 depressed women and 
26 matched controls, that depressed women exhibited lower cortisol at 30 minutes post 
awaking, as well as in the evening, in comparison with controls. Depressed patients also showed 
less suppression of cortisol following dexamethasone administration than non-depressed 
women, suggesting GC resistance in these women. One potential explanation for these 
seemingly paradoxical findings could be that GC output may not be a linear correlate to all 
functional activity of the HPA axis. That is, whilst impairment in GR-mediated feedback may 
indeed be present, this could manifest differently depending on the chronicity and severity of 
disturbance, with a blunted CAR perhaps being indicative of fatigue and exhaustion. These 
discrepancies could also be explained by methodological differences such as sampling, type of 
depression, co-morbid conditions, age and early life experiences. What is clear, however, from 







1.9.3. HPA axis and early life stress 
Much research has also focused on investigating alterations in the HPA axis in relation to early 
life stress. HPA axis dysfunction is both a detrimental outcome in its own right, as well as a 
potential mechanism for the transmission of disease pathology. That is, given the strong 
association between early life adversities, such as child maltreatment and exposure to 
depression in utero and risk for depression (see 1.4 and 1.6), and the posited involvement of 
HPA axis dysfunction in the pathogenesis of depression, much investigation has been motivated 
by the proposition that dysregulation in the HPA axis system may be a key biological mechanism 
for the translation of psychosocial adversities into biological vulnerabilities for later 
psychopathology. This section will review the pertinent literature on changes in HPA axis 
function as a consequence of (i) exposure to depression in utero and (ii) exposure to childhood 
maltreatment, which is the focus of this thesis. 
 
 
1.9.3.1. Prenatal maternal stress and programming of the offspring HPA axis 
Pathophysiological explanations for the reliable association between foetal exposure to prenatal 
maternal stress and later pathological conditions (see 1.3 and 1.4) have focused primarily on (i) 
foetal malnutrition and (ii) programming of the HPA axis through excessive exposure to GCs 
(Seckl & Holmes, 2007). This section will focus on the latter theme.  
 
Much of the initial research into foetal programming of the HPA axis was conducted in animals, 
yet in the past decade, several studies have involved humans. Findings from early animal studies 
(primarily rodents and nonhuman primates) revealed that offspring of mothers who were 
injected with artificial GCs (i.e. dexamethasone, betamethasone) show hyperactivity of the HPA 
axis, in addition to depressive- and anxiety-like behaviour (Charil et al., 2010; Glover, O’Connor, 
& O’Donnell, 2010; Reynolds, 2013; Seckl & Holmes, 2007; Weinstock, 2008).   
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Human evidence for foetal programming of the HPA axis comes from a mixture of studies, some 
of which have investigated offspring HPA axis function in relation to maternal reports of 
psychological distress during pregnancy, whilst others have included measurements of maternal 
cortisol levels during pregnancy in addition to reports of psychological report of stress. In a 
prospective Dutch sample of 15 year old offspring and their mothers (n = 58), prenatal maternal 
anxiety predicted a lower diurnal cortisol profile, characterised by lower awakening cortisol but 
higher evening cortisol, in offspring of mothers who were prenatally anxious during pregnancy 
and in comparison to offspring of non-prenatally anxious mothers (Van den Bergh et al., 2008). 
Notably, these effects remained after controlling for maternal smoking, birth weight, obstetric 
outcomes, postnatal anxiety and puberty phase. Furthermore, using data from the ALSPAC, 
O’Donnell and colleagues (2013) also showed that in a sample of 889 15 year-olds, both 
maternal prenatal depression and anxiety predicted a blunted CAR (at 30 minutes post-
awakening), and an overall flatter diurnal profile, indexed by lower awakening but higher 
evening cortisol levels. These effects were also independent of the effects of postnatal 
psychosocial factors.  
 
In terms of studies which directly measured maternal cortisol levels during pregnancy, Davis and 
colleagues (2011) found that in a sample of 116 mother-infant dyads, higher maternal prenatal 
cortisol levels positively predicted a larger cortisol response to the heel-stick procedure in their 1 
day old infants. Furthermore, poorer infant behavioural recovery from the procedure was 
observed amongst infants whose mothers reported high distress levels and who exhibited 
elevated cortisol during pregnancy. In a recent prospective study involving 125 mother-infant 
pairs, higher levels of amniotic cortisol predicted increased cortisol response to separation-
reunion stress at 17 months; infants who were exposed to higher levels of amniotic cortisol 
showed higher baseline cortisol levels and a blunted cortisol response to the stressor (O’Connor, 
Bergman, Sarkar, & Glover, 2013). This effect was independent of prenatal, obstetric, SES and 
attachment factors. 
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These studies support the premise that foetal exposure to maternal prenatal stress can lead to 
persistent changes in the HPA axis that are observable up to 15 years later. However, in all of 
these studies, GC output has been the main measure of HPA axis function. To characterise fully 
these alterations, examination of further dimensions of the HPA axis are required. Animal 
studies have demonstrated that excessive prenatal GCs can down-regulate GR density, as 
indexed by reduced messenger RNA (mRNA) expression in the hypothalamic paraventricular 
nucleus, with the implication of programming GC resistance in the offspring after birth, and thus 
stress reactivity (Welberg, Seckl, & Holmes, 2000). In a human study (n = 82), Oberlander and 
colleagues (2008) showed that 3-month-old offspring whose mothers had been depressed 
during pregnancy exhibited increased methylation at the 1F promoter region of the GR gene, 
NR3C1, as found in peripheral blood mononuclear cells (PBMCs),  in comparison with offspring 
of non-prenatally depressed mothers. Increased methylation status was further positively 
associated with elevated offspring cortisol output in response to a stress challenge. In a more 
recent study, prenatal exposure to maternal stress (severe intimate partner violence) also 
predicted increased methylation at the 1F region of NR3C1 in their offspring at 10 years of age 
(Radtke et al., 2011). Although gene expression or DNA methylation status will not be examined 
in this PhD thesis, DNA and mRNA samples will be collected for biobanking for future analysis. 
 
Finally, research has demonstrated that women’s HPA axes are hyperactive during pregnancy, as 
indexed by elevated circulating cortisol levels (Jung et al., 2011) and increased secretion of 
placental CRH (Petraglia et al., 1993). Notably, HPA axis activity regulates parturition, with 
greater activation associated with shorter gestation terms, thus the use of gestational birth 
weight and gestational age as an indirect measure of an adverse intrauterine environment 
(Duthie & Reynolds, 2013). In a recent study (n = 65), pregnant depressed women were found to 
have higher CRH concentrations at the second trimester point, and had higher mean evening 
salivary cortisol concentrations in comparison to healthy controls (O’Keane et al., 2011). 
Depressed women also had a shorter pregnancy length. Furthermore, Katz and colleagues 
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(2012) demonstrated that GR functional sensitivity, assessed in PBMCs from a group of 29 
pregnant women, was negatively correlated with depressive symptomatology.  
 
Overall, these studies point to a the putative role of foetal exposure to excessive maternal GCs, 
brought about through excessive distress and mood disturbances during pregnancy, in 
programming alterations to the offspring’s HPA axis. Albeit that many of these studies have 
notable methodological limitations, such as small sample sizes and potential confounding 
influence from co-occurring psychosocial and medical factors, yet, collective evidence supports 
current programming theory and warrants continued investigation into the role of the HPA axis 
as a putative biological mechanism for the intergenerational transmission of stress reactivity.  
 
 
1.9.3.2. Child maltreatment and alterations to the HPA axis 
A multitude of studies have also characterised childhood maltreatment though its 
neurobiological sequelae in terms of alterations to the HPA axis (Heim, Newport, Mletzko, 
Miller, & Nemeroff, 2008; Nemeroff, 2004). There is a high degree of similarity between the 
effects of offspring exposure to intrauterine-environmental stress (i.e. prenatal maternal stress) 
and adverse experiences during childhood, such as exposure to child maltreatment, alluding to 
the notion that these insults differ primarily by timing, rather than by the nature of their effects 
on the HPA axis (Gluckman, Hanson, Spencer, & Bateson, 2005). 
 
Indeed, rodent studies have demonstrated that maternal separation results in persistent 
alterations to the HPA axis (hyperactivity and attenuation), indexed through increased GC 
response to stressors, increased plasma ACTH, and decreased GR densities in the hippocampus 
(de Kloet & Oitzl, 2003; Francis, Caldji, Champagne, Plotsky, & Meaney, 1999; Sánchez, Ladd, & 
Plotsky, 2001). Moreover, pups of dams exhibiting low LG behaviour showed decreased GR 
expression accompanied by increased methylation of the promoter region of NR3C1, suggesting 
45 
epigenetic modulation (Weaver et al., 2004). In contrast, enhanced maternal care, as expressed 
through greater LG behaviour, results in a reduced pup GC response to acute stress, increased 
hippocampal GR mRNA expression, decreased hypothalamic CRH mRNA and enhanced GC 
feedback sensitivity (D Liu et al., 1997).  
 
In studies of humans, findings have been more mixed. For example, De Bellis and colleagues ( 
1994) reported a blunted ACTH response to CRH challenge in sexually abused girls in comparison 
with controls. In contrast, Hart and colleagues (1996) found cortisol hypersecretion in response 
to stress challenge in a group of maltreated preschool children. Other studies have found 
alterations in HPA axis parameters to be modulated by the presence of psychopathology 
(McCrory, De Brito, & Viding, 2010), whereby some studies have reported hypoactivity in the 
context of maltreated and depressed children (Tarullo & Gunnar, 2006).  
 
Amongst adults, Heim and colleagues (2002) found that in a sample of 49 women, a history of 
childhood maltreatment was associated with an increased ACTH and response to psychosocial 
challenge, whilst adulthood life events further amplified these effects. Further studies have 
observed hypoactivity in maltreated individuals in the context of posttraumatic stress disorder 
(PTSD). Inconsistencies across these studies may reflect differences in the severity, timing and 
chronicity of maltreatment, as well as the influence of confounds including the frequently 
observed comorbidity of depression, PTSD and trauma. In a unique study, McGowan and 
colleagues (2009) observed increased methylation of GR NR3C1 promoter region and decreased 





Inflammation is the process of activation of the immune system in the interest of self-
preservation. The inflammatory response can occur over a short period of time (acute) or can 
persist with long course (chronic). Key aspects involved in the inflammatory response are the 
production of cytokines (e.g. interleukin- [IL] 1, 6, 4, 10, tumor necrosis factor-alpha [TNF-α]) 
acute phase proteins (e.g. C-reactive protein [CRP]) chemokines and adhesion molecules (Maes, 
1995; G. E. Miller, Stetler, Carney, Freedland, & Banks, 2002; Musselman, Miller, et al., 2001). 
Activation of the immune response leads to the production of cytokines, pro- and anti-
inflammatory, which in turn influence pathophysiological domains such as neuroendocrine 
function, neurotransmitter metabolism and regional brain activity (Dantzer, O’Connor, Freund, 




1.9.5. Inflammation and the HPA axis 
Inflammation and the HPA axis have bidirectional modulatory effects. Under normal 
circumstances, activation of the HPA axis has potent inhibitory effects on inflammation. 
However, in cases of dysfunctional HPA axis activity, it has been argued that this usual inhibitory 
control is no longer effected, thus enabling the activity of inflammatory pathways (G Miller et 
al., 2008). Inflammation is believed to modulate the neuroendocrine system through two broad 
mechanisms: (i) activation of the HPA axis and (ii) through direct effects on the GR (Horowitz, 
Zunszain, Anacker, Musaelyan, & Pariante, 2013). Evidence for the activating effects of cytokines 
on the HPA axis comes from the paradigm of therapeutic chronic administration of 
proinflammatory cytokine interferon alpha (IFN-α), which is routinely used for medical illness 
such as hepatitis C. IFN-α has been observed to active the HPA axis, indexed through elevated 
ACTH and GCs, within hours of administration (Capuron et al., 2003). The second mechanism 
involves cytokine mediated negative effects on GR function. Cytokines have been observed to 
induce a state of GC resistance through the down-regulation of GR function (A Miller, 2009). 
Under normal circumstances, crosstalk between cytokines and the GR involves the activation of 
signalling proteins that have been identified as targets for the anti-inflammatory actions of GCs 
(Zunszain, Anacker, Cattaneo, Carvalho, & Pariante, 2011). Cytokine activated signalling has 
been shown to impair GR function, through processes such as reducing GR translocation to the 






1.9.6. Inflammation and depression 
There is a substantial amount of clinical evidence that supports the notion that the immune 
system is activated in depressed patients, and that this activation plays a role in disease 
progression as well as the ameliorating effects of antidepressant therapy (A Miller, Maletic, & 
Raison, 2009; Raison et al., 2006). Recent meta-analyses revealed that patients with MDD 
exhibit elevated peripheral blood inflammatory biomarkers, most commonly, proinflammatory 
cytokines IL-1, IL-6 and TNF-α, and CRP (Dowlati et al., 2010; Y Liu, Ho, & Mak, 2012). Levels of 
numerous other cytokines, such as IL-1 and monocyte chemoattractant protein 1 (MCP-1), have 
also been shown to be raised (Zorrilla et al., 2001). Furthermore, studies have demonstrated 
that such elevated levels of inflammatory biomarkers can be reversed by effective 
antidepressant treatment (Lanquillon, Krieg, Bening-Abu-Shach, & Vedder, 2000). Work from 
animal studies has also demonstrated that treatment with proinflammatory cytokines induces 
depressive-like behaviours in rodents (Anisman, 2009). 
 
More direct evidence that inflammation is involved in the pathogenesis of depression comes 
from studies examining the effects of IFN-α treatment. It has been observed that within 3 
months, up to 50% of patients undergoing such treatment acquire depression symptoms which 
meet criteria for a diagnosis of MDD (Musselman, Lawson, et al., 2001; Raison et al., 2005). 
These studies form the foundation for the theory of cytokine-mediated inflammatory processes 
in the pathogenesis of depression. Accordingly, inflammation is argued to contribute to a state 
of HPA axis dysfunction by promoting GC resistance (A Miller, 2009; Pace et al., 2007; Zunszain 
et al., 2011), through a process of cytokine-induced functional impairment of the GR (. Miller & 
Raison, 2006; Wang, Wu, & Miller, 2004).  
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1.9.7. Inflammation and early life stress 
 
1.9.7.1. Prenatal maternal stress and offspring inflammatory response 
As discussed in section 1.9.3.1, a large body of research has investigated the developmental 
plasticity effects of prenatal maternal stress on the foetus’ neuroendocrine system. Given the 
observed integration between the HPA axis and the inflammatory response, as well as their 
mutual contribution to the risk of depression, interest has turned to the potential role of 
maternal-foetal inflammatory pathways as an associated candidate mechanism for the biological 
embedding of intrauterine stress (Entringer et al., 2012). Indeed, studies have demonstrated 
that stressed pregnant women not only show hyperactivity of the HPA axis (O’Keane et al., 
2011), but also increased inflammation, indexed by higher levels of proinflammatory cytokines 
IL-6 and TNF- α (Coussons-Read, Okun, & Nettles, 2007; Coussons-Read, Okun, Schmitt, & Giese, 
2005). 
 
Studies investigating foetal programming of the immune response by maternal stress are few 
and far between. Currently, most work has been conducted in animals. In one study, pregnant 
mice were stressed, followed by an examination of cytokine levels in the brains of the pups who 
were sacrificed 24 hours after administration of lipopolysaccharide (LPS). Compared to pups of 
non-prenatally stressed damns, pups of prenatally stressed mothers exhibited elevated levels of 
IL-1β and TNF-α in the hippocampus (Diz-Chaves, Astiz, Bellini, & Garcia-Segura, 2013). In a study 
using non-human primates, the immune and GC response in offspring of prenatally stressed 
rhesus monkeys was compared to that of offspring of non-prenatally stressed mothers. 
Offspring of mothers who were prenatally stressed show elevated HPA axis activity, but a 
reduced inflammatory response (reduced levels of IL-6 and TNF-α) to LPS challenge. The authors 
argue that the reduced inflammatory response may be accounted for by the elevated HPA axis 
activity, given its suppressive effects on inflammation (Coe, 2002).  
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In a recent human study (n = 76), O’Connor and colleagues (O’Connor, Winter, et al., 2013) 
found that prenatal maternal anxiety predicted reduced adaptive immunity in the infant at 6 
months. These effects were independent of obstetric and maternal factors. In a retrospective 
study (n = 34) into the effects of prenatal maternal stress on the offspring’s inflammatory 
response, women who reported that their mother experienced emotional stress (major life 
events) during pregnancy, showed elevated levels of PBMC proinflammatory cytokines IL-4, IL-6 
and IL-10 in response to phytohemagglutinin challenge, in comparison with women whose 
mothers were not prenatally stressed (Entringer, Kumsta, et al., 2008).  
 
These studies suggest that HPA axis function and the inflammatory response are highly 
interlinked in both mother and the growing foetus. One potential mechanism for the effects of 
prenatal maternal stress on offspring inflammation could be through HPA axis-mediated effects. 
Indeed, if this were the case, it could be argued that hyperactivity of the HPA axis in the 
offspring could lead to GC induced immune-suppressive effects, which some of the 
aforementioned studies may have indeed indexed (Marques, O’Connor, Roth, Susser, & Bjørke-
Monsen, 2013). Another non-mutually exclusive candidate mechanism could be the direct effect 
of elevated maternal-foetal inflammation during pregnancy, which may programme offspring 
immune reactivity. At present, there is limited evidence that directly supports this hypothesis. 
 
 
1.9.7.2. Child maltreatment and inflammation 
The link between child maltreatment and inflammation was first demonstrated in the Dunedin 
Multidisciplinary Health and Development Study (DMHDS). The DMHDS is a prospective 
longitudinal birth cohort study based in New Zealand that has followed over 1,000 individuals 
from early childhood to age 32. Danese and colleagues, including my second supervisor Prof 
Pariante (2007), showed that maltreatment in childhood predicted high inflammation, as 
indexed by plasma CRP levels at 32 years. This effect was independent of stress in adulthood, 
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health and lifestyle factors and co-occurring early life risks. Furthermore, CRP levels were 
observed to be highest amongst individuals who experienced current depression and had a 
history of child maltreatment (Danese et al., 2008).  
 
More recently, in a retrospective study involving 1,000 US adults, cumulative early life stress, 
which included childhood experiences of abuse and neglect, was found to be positively 
associated with elevated CRP, IL-6 and adhesion molecules (Slopen et al., 2010). In a study (n = 
69) involving depression free adults, individuals with a history of childhood maltreatment 
exhibited an elevated IL-6 response to a psychosocial stress challenge (Trier Social Stress Test), 
in comparison to non-maltreated individuals (Carpenter et al., 2010). These findings, it has been 
argued, reflect the biological embedding of early life stress through the inflammation processes, 
putting the individual at risk for inflammatory related psychiatric and cardio-metabolic diseases 






1.9.8. Metabolic syndrome 
The metabolic syndrome is a clustering of metabolic risk factors, which predispose an individual 
to developing type II diabetes and CVD, in particular, coronary heart disease (CHD). CHD is one 
of the most common types of CVD. It is a condition characterised by plaque formation in the 
arterial walls through the pathological process of atherosclerosis. Atherosclerosis is an 
inflammatory condition in which the walls of the arterial blood vessels thicken as a result of 
accumulation of fatty deposits on the interior wall linings, specifically cholesterol (CHOL) and 
triglycerides (TGs; Maton, 1997). It constitutes a chronic inflammatory response in the walls of 
arteries whereby macrophages and white blood cells accumulate in the formation of plaques. 
This process is promoted by the amassing of low-density lipoproteins, responsible for the 
transport of CHOL and TGs, in the arteries. In contrast, high-density lipoproteins provide 
protective functional benefits, particularly by reducing arterial inflammation and plaque 
formation and ultimately protecting against atherosclerosis and subsequent CHD (Toth, 2005) 
There are various conceptualisations of the metabolic syndrome, as defined by various medical 
bodies, which differ in minor dimensions. Yet, there is a general consensus amongst all 
organizations that the primary components of metabolic syndrome comprise insulin resistance 
(IR), visceral obesity, high blood pressure and dyslipidaemia. IR is the condition whereby 
peripheral tissue cells fail to respond to insulin, produced by the pancreas. Insulin continues to 
be produced, yet the cells (muscle, fat and red blood cells) become resistant and are unable to 
use it effectively to absorb circulating glucose from blood plasma, leading to a state of 
hyperglycaemia. Beta cells in the pancreas subsequently increase their production of insulin to 
compensate, further contributing to hyperinsulinaemia. This condition of dysregulated glucose 
levels contributes to the development of type II diabetes (Beck-Nielsen, 2013) 
 
Table 2 summarises the definitions according to the International Diabetes Federation (IDF; 
International Diabetes Federation, 2006), the World Health Organization  (WHO; World Health 
Organization, 1999) and the European Group for the Study of Insulin Resistance (EGIR; Beck-
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Nielsen, 1999). According to the WHO and the EGIR, IR is a crucial criterion for the diagnosis of 
metabolic syndrome, whilst more recent criteria from the IDF allow for diagnosis through the 
presence of central obesity, as an index of IR. The prevalence of metabolic syndrome is 6.7% 
among individuals aged 20 – 29 years, and rises to more than 40% in those 60 years or older 
(Ford, 2005). Although the metabolic syndrome is frequently referred to as a discrete entity, it is 
worth noting that, without a common aetiology, this grouping of metabolic abnormalities could 
reflect clustering of unrelated factors through to a constellation of indices for a shared 
















European Group for 




Central obesity (large 
WC or high BMI), plus 
at least two of the 
following: high FPG, 
high TGs, low HDL-C, 
high blood pressure. 
Impaired glucose 
tolerance, impaired FPG 
or insulin resistance, 
plus at least two of the 
following : central 
obesity (large WHR or 
high BMI); dyslipidaemia 
(high TGs and low HDL-
C); high blood pressure. 
Insulin resistance plus 
at least two of the 
following: high FPG, 
dyslipidaemia (high 
TGs or low HDL-C); 




> 5.6 – > 6.1 
WC (cm) > 94 (males) 
> 90  (females) 
– > 94 (males) 
> 80  (females) 
WHR – > .90 (males) 




> 30 > 30 – 
TGs  
(nmol/L) 
> 1.7 nmol/L > 1.7 > 2.0 
HDL-C  
(nmol/L) 
< 1.03 (males) 
<1.29 (females) 
< .9 (males) 
< 1.0 (females) 
< 1.0 
Blood pressure  
 (mmHg) 
>130/85 > 140/90 > 140/90 
Note. Adapted from (Beck-Nielsen, 1999; International Diabetes Federation, 2006; World Health 
Organization, 1999). FPG = fasting plasma glucose; WC = waist circumference; WHR = waist to 
hip ratio; TGs = triglycerides; BMI = body mass index; HDL-C = high density lipoprotein 
cholesterol. Blood pressure limits are systolic/diastolic. 
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1.9.9. Metabolic syndrome and the HPA axis and inflammation 
The HPA axis, inflammation and metabolic function are intimately linked. In a study of 205 men, 
HPA axis activity (enhanced responsiveness to ACTH) was positively associated with raised blood 
pressure, glucose intolerance, and hypertriglyceridemia (Reynolds et al., 2001). Notably, low 
birth weight was also observed to be a correlate of enhanced HPA axis activity, alluding to the 
notion that HPA hyperactivity may be a mediating mechanism between an adverse intrauterine 
environment and later metabolic abnormalities. Elevated GCs are thought to increase plasma 
glucose indirectly through their antagonising effects on insulin action. They have also been 
observed to promote the action of lipoprotein lipase, which modulates the storage of fat (TGs 
and CHOLs) in adipocytes (fat cells), and thus visceral fat deposition (Dinan, 2004).  
 
One argument for the link between metabolic syndrome and inflammation is derived from the 
finding that proinflammatory cytokines are overexpressed in obese individuals by adipose tissue 
(Hotamisligil, Shargill, & Spiegelman, 1993). The phenomenon is argued to originate in saturated 
adipocytes that respond to overfeeding by the release of proinflammatory cytokines, specifically 
TNF-α and IL-6. This localised inflammation can trigger systemic inflammation which is 
associated with elevated parameters of the metabolic syndrome such as hypertension, 
dyslipidaemia and IR (Emanuela et al., 2012). Furthermore, the energy demand of the activated 
immune response has been causally related to the metabolic syndrome (Straub, 2011). Also, 
elevated CRP has become a widely acknowledged risk marker for CVD (Ridker, Cushman, 
Stampfer, Tracy, & Hennekens, 1997; Ridker, Hennekens, Buring, & Rifai, 2000; Ridker, Rifai, 
Rose, Buring, & Cook, 2002), with a strongly evidenced association with atherosclerosis. It has 
also been posited that poor metabolic function, such as IR, could indirectly elevate systemic 
inflammation through resistance to the anti-inflammatory actions of insulin (Esposito & 
Giugliano, 2004). Thus, it is conceivable that once in a state of persistent inflammation, HPA axis 
activation or metabolic dysfunction, any of these conditions could have positive feedback on one 
another, leading to a state of cumulative activation across systems (Leonard, 2013).  
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1.9.10. Metabolic syndrome and depression 
Research into the association between metabolic syndrome and depression is rooted in the 
established finding of high comorbidity between CVD and depression (Barth, Schumacher, & 
Herrmann-Lingen, 2004; Fielding, 1991). This association is believed to be bidirectional, with 
cohort studies demonstrating a positive association between depressive symptomatology and 
CVD mortality (Wulsin et al., 2005), as well as the elevated prevalence of depression in CVD 
patients (Fielding, 1991; Whooley & Wong, 2013). Metabolic syndrome, amongst other 
processes, such as inflammation, HPA axis hyperactivity, health behaviours, and platelet 
hyperactivity, is argued to be a key pathophysiological factor linking depression to adverse 
cardio-metabolic outcomes (Celano & Huffman, 2011; Halaris, 2013; Whooley & Wong, 2013).  
 
Indeed, in a cross-sectional study in Australia involving 1,690 participants, Dunbar and 
colleagues (2008) observed that individuals diagnosed with metabolic syndrome had 
significantly greater depressive psychopathology. Moreover, in a subgroup of diabetes-free 
individuals, this association remained. Furthermore, low HDL-C levels and large waist 
circumferences (WCs) showed significant independent associations with depression. In a US 
sample of over 6,000 CVD and diabetes-free adult men and women, the prevalence of metabolic 
syndrome was significantly elevated amongst women with a history of depression. This effect 
remained when controlling for age, education, smoking, physical inactivity, carbohydrate 
consumption, and alcohol use. No effect was observed in men, however (Kinder, Carnethon, 
Palaniappan, King, & Fortmann, 2004). In a recent systematic review involving over 40 cross-
sectional and cohort studies, support for bi-directional effects between the metabolic syndrome 
and depression were observed, with the majority of studies reporting depression as the 
outcome, whereby effect sizes ranged between 1.07 - 1.91 odds ratio (Pan et al., 2012). 
Furthermore, a meta-analysis into the relationship specifically between obesity and depression 
revealed reciprocal links (Luppino et al., 2010). 
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1.9.11. Metabolic syndrome and early life stress 
 
1.9.11.1. Metabolic syndrome and exposure to prenatal maternal stress 
As discussed in section 1.3, the in utero environment presents a unique developmental time 
period in which the offspring’s developing organs are particularly susceptible to plasticity effects 
in response to intrauterine adversity – the FOAD hypothesis. Exposure to suboptimal maternal 
hormonal states and under-nutrition during pregnancy are the most commonly researched 
forms of prenatal adversity.  
 
The link between prenatal maternal adversity and offspring metabolic syndrome, research has 
focused primarily on the association between under-nutrition, often indexed through low birth 
weight, and components of the metabolic syndrome, such as hypertension, dyslipidaemia and 
IR, given their centrality to the development of CVD and type II diabetes. As mentioned, some of 
the earliest investigations into this link were the work of Barker and colleagues (D Barker, 
Gluckman, et al., 1993; D Barker, Hales, et al., 1993), who demonstrated in a cohort of British 
adults, that low birth weight significantly predicts hypertension, impaired glucose tolerance and 
dyslipidaemia. Research has also indicated elevated adulthood BMI in offspring born to mothers 
who experienced famine during pregnancy (Ravelli et al., 1998).  
 
Such associations are argued to be a consequence of alterations to physiological responsiveness 
and morphological changes as a function of a varying gestational environment during sensitive 
periods of development. Plasticity in peripheral targets, such as adipose tissue, the pancreas and 
liver, in addition to the brain and component neurobiological systems (e.g. HPA axis 
programming, inflammation programming), have been proposed as candidate mechanisms by 
which programming of metabolic dysfunction occurs, given their collective role in metabolic 
regulation after birth (Entringer et al., 2012), see Figure 1. Metabolic related diseases are 
believed to arise through a series of interactions between a vulnerable predisposition, as 
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programmed during foetal life, and environmental influences after birth (D Barker, 2008; 
Rinaudo & Wang, 2012). Indeed, metabolic diseases are most common in low- and middle-
income countries where the combination of foetal under-nutrition and adulthood over-nutrition 
are most common (Symonds, Sebert, Hyatt, & Budge, 2009).  
 
Less research has explored specifically the association between prenatal maternal psychosocial 
stress and offspring metabolic syndrome and its components. One reason for this may be due to 
the fact that many prospective studies into the effects of prenatal emotional stress have only 
been set up in the past two decades, and as clinical abnormalities in metabolic parameters are 
most prevalent in older adults, a lack of observations may reflect prematurity in the potential 
manifestation of effects, rather than non-existence of such effects. Nevertheless, in a 
prospective Dutch cohort study involving over 2,000 mother-child pairs, higher prenatal 
maternal cumulative stress (depressive symptoms, anxiety, daily hassles, job strain) was 
positively associated with systolic and diastolic blood pressure and mean arterial pressure, in the 
offspring at age eight (van Dijk, van Eijsden, Stronks, Gemke, & Vrijkotte, 2012).  
 
In a retrospective study involving 58 young adult offspring, reports of maternal severe life events 
during pregnancy (death of someone close, severe illness of someone close, relationship 
conflicts, severe financial problems, car accidents, becoming political refugees) were significantly 
associated with elevated two-hour insulin following an oral glucose tolerance test, suggesting 
glucose-insulin metabolism irregularities (Entringer, Wüst, et al., 2008). These differences were 
independent of factors related to IR such as, birth weight, gestational age, a family history of 
diabetes, gestational diabetes, BMI, smoking and inflammatory conditions. Furthermore, 
offspring of mothers who reported greater prenatal life events had lower HDL-C levels as well as 
higher BMIs, in comparison with offspring of mothers who didn’t report any life events during 
pregnancy. Whilst these studies encompass methodological limitations and proxy measures of 
the metabolic syndrome, their findings support the notion that foetal exposure to maternal 
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psychosocial stress during pregnancy can have adverse effects on cardio-metabolic parameters 
later in life. Tests using prospective designs reaching further along the offspring’s lifespan are 
required to replicate such effects. 
 
In an interesting rodent study, the effects of prenatal stress on pup atherosclerosis and 
inflammation were examined using an apolipoprotein E-deficient (apoE−/−) mouse strain, which 
is a well-established mouse model of hyperlipidaemic-induced atherosclerosis (Ho et al., 2013). 
Ho and colleagues stressed pregnant apoE−/− dams and examined for the presence of 
atherosclerotic plaques, as well as cytokine secretion in stimulated splenocytes in the offspring 
at 15 weeks. ApoE−/− offspring of prenatally stressed dams exhibited more large atherosclerotic 
plaques, as well as raised levels of TNF- α in comparison with apoE−/− pups of non-prenatally 
stressed dams. The authors argue that this finding illustrates an inflammatory-mediated effect of 
prenatal stress on atherosclerosis. Notably, this study also provides evidence for the link 
between prenatal stress and inflammation, and points to an effect on system inflammation. Yet, 
the precise mechanisms by which this programming may occur remain elusive. Candidate 
pathways could include specific programming of metabolic-regulating body organs, as well as 
















Figure 1. Potential targets for foetal programming of metabolic syndrome parameters, adapted 
from Entringer et al., 2012 
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1.9.11.2. Metabolic syndrome and child maltreatment 
In the past decade there has been an explosion of interest in the relationship between childhood 
maltreatment and physical health problems (Norman et al., 2012). Specific to the metabolic 
syndrome, a large number of studies have investigated the effect of childhood maltreatment on 
obesity and other metabolic parameters, many in the context of risk for CVD. These studies have 
included retrospective and prospective epidemiological studies. For example, in a retrospective 
cohort study of 13,177 US adults, reports of CPA predicted obesity (Williamson, Thompson, 
Anda, Dietz, & Felitti, 2002). In a meta-analysis into the effects of CSA that included 31 studies, 
an overall effect of a history of CSA on elevated adulthood BMI was observed (Irish, Kobayashi, 
& Delahanty, 2010). Furthermore, in a recent meta-analysis conducted into the effects of CPA, 
emotional abuse and neglect, which included 124 studies, a significantly increased risk for 
obesity was observed for CPA and emotional abuse (Norman et al., 2012). Finally, in a 
prospective longitudinal study involving 8,471 US adolescent who have been followed into 
young adulthood, child neglect was associated with a faster than average rate of BMI growth 
over time (Shin & Miller, 2012).  
 
In a prospective longitudinal study of 9,310 British adults, a history of child maltreatment was 
associated with elevated glycosylated haemoglobin (HbA1c) and obesity in middle adulthood 
(Thomas, Hyppönen, & Power, 2008). In a longitudinal US study involving 342 middle aged 
women, a history of childhood maltreatment predicted incident metabolic syndrome over the 
course of seven years (Midei, Matthews, Chang, & Bromberger, 2013). Furthermore, in a study 
of 95 first-episode psychosis patients, childhood maltreatment was significantly associated with 
increased TG levels compared to controls (Hepgul et al., 2012). 
 
These studies demonstrate the link between various types of child abuse and neglect and 
components of the metabolic syndrome. Key proposed pathways from child maltreatment to 
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metabolic ill health include chronic inflammation and maladaptive eating patterns (Dallman et 
al., 2003; Danese et al., 2009). 
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1.10. Aims and hypotheses 
 
1.10.1. Aims of the study 
The literature reviewed above has shown clear evidence for an association between offspring 
exposure to prenatal maternal stress and psychopathology in childhood. The best evidence for 
this association has come from prospective longitudinal studies. However, no prospective study 
has yet found evidence for an effect of prenatal maternal depression on offspring affective 
psychopathology in adulthood. Moreover, findings from current research have also shown a 
robust and reliable link between child maltreatment and depression in adulthood. The primary 
aim of this study is to investigate whether offspring exposure to prenatal maternal depression 
predicts offspring depression in young adulthood, and whether offspring experience of child 
maltreatment cumulatively adds to this effect.  
 
The second aim of this study is to characterise the physiological characteristics of young adult 
offspring who were exposed to prenatal maternal depression, in terms of HPA axis function, 
inflammation and metabolic function. The reviewed research has shown that abnormalities in all 
three systems are associated with exposure to prenatal maternal stress, gross psychosocial 
adversity during childhood, and depressive psychopathology. The purpose of this investigation is 
to gain a better understanding of whether dysregulation in these three systems could be 
interlinked mechanisms for the biological embedding of early life stress. These investigations will 
also cast light on whether gestational stress and childhood stress (i.e. child maltreatment) effect 






1.10.2.1. Depressive psychopathology 
1) Exposure to prenatal maternal depression predicts depression in young adulthood (18-
25 years). 
2) This effect of prenatal maternal depression is independent of environmental adversities 
occurring during childhood (birth-17 years). 
3) Experience of childhood maltreatment modulates the effect of offspring exposure to 
prenatal maternal depression on depression in young adulthood. 
 
 
1.10.2.2. Reactivity in biological systems 
 
1.10.2.2.1 HPA axis, inflammation and parameters of the metabolic syndrome 




1.10.2.2.2 HPA axis 
5) Offspring exposed to maternal depression in utero will have an altered diurnal cortisol 
profile at 25 years. 
6) Offspring exposed to prenatal maternal depression and who are depressed in adulthood 
will have the greatest alterations in cortisol levels at 25 years. 
7) Offspring exposed to childhood maltreatment will show similar alterations in cortisol 





8) Offspring exposure to depression in utero will be associated with elevated inflammation 
at 25 years. 
9) Cumulative experience of stress in utero (exposure to prenatal maternal depression) and 
depression in adulthood will result in the greatest inflammation levels. 
10) Offspring exposed to childhood maltreatment will also exhibit elevated inflammation. 
 
 
1.10.2.2.4 Parameters of the metabolic syndrome 
11) Offspring exposed to depression in utero will exhibit metabolic abnormalities 
12) Offspring exposed to prenatal maternal depression and who experience depression in 
adulthood will have the greatest abnormalities in metabolic function. 
13) Offspring exposed to childhood maltreatment will also exhibit abnormalities in 


















This thesis was conducted as a continuation of the South London Child Development Study 
(SLCDS; 1986-2003), which formed a framework for my investigation. The SLCDS is a prospective 
longitudinal birth cohort study that was setup in 1986 as a PhD project by Prof D Sharp (D Sharp, 
1992). The original purpose of the SLCDS was to assess the prevalence of women’s mental health 
problems in the perinatal period. Since, the SLCDS evolved into a longitudinal study of the 
offspring and their families through childhood (4, 11 and 16 years). This PhD project has 
continued the SLCDS by assessing the offspring at 25 years.  
 
 
2.1.1. Contribution of work by the candidate 
It was my responsibility to conduct and coordinate the follow-up of the offspring at 25 years 
under the supervision of Dr S Pawlby (Primary Supervisor and Lecturer, Institute of Psychiatry, 
King’s College London [KCL], UK) and Prof C Pariante (Secondary Supervisor and Professor, 
Institute of Psychiatry, KCL, UK). I was responsible for obtaining ethical approval for the follow-
up and also contributed to the study design. A trained research assistant (RA) helped with the 
tracing of participants and also interviewed 18 (17.5%) of the offspring, whilst I interviewed the 
rest. Phlebotomy staff at the National Institute for Health Research – Wellcome Trust Clinical 
Research Facility at King’s College Hospital (KCH) assisted with the collection of blood samples. 
Staff at KCH Phlebotomy Department processed and assayed all blood samples. Dr P Zunszain 
(Lecturer, Institute of Psychiatry, KCL, UK) carried out all of the salivary cortisol assays. I was 
responsible for all data entry and coding. Dr T Chua (Visiting Psychiatrist, Institute of Psychiatry, 






2.2.1. SLCDS (1986-2003) 
All pregnant women who approached either of two South London National Health Service (NHS) 
General Practitioner (GP) clinics ([i] Lambeth Road Group Practice (LRGP), SE11 6SP; [ii] Gallions 
Reach Health Centre (GRHC), SE28 8BE) for antenatal care between January 1st 1986 and 
December 31st 1986 were invited to take part in the SLCDS. Overall, 395 pregnant women 
presented for antenatal care across the two clinics. Three hundred and seventeen women were 
deemed eligible for participation. 
 
Two hundred and fifty-two women participated in the first assessment visit at 20 weeks 
pregnant. A further three interview assessments were scheduled to take place at 36 weeks 
pregnant, 3 months postnatal and 12 months postnatal. However, due to time constraints, a 
75% randomised subsample1 were selected for interview at 36 weeks pregnant and 3 months 
postnatal, with the remaining 25% completing postal self-report questionnaires only. The 
random sample did not differ statistically in any sociodemographic or clinical characteristics in 
comparison with the non-random sample (D Sharp, 1992). A total of 203 (80.6%) women 
completed the study at 12 months postnatal, 149 of these being of the random sample.  
  
Follow-up assessments were arranged at the offspring’s 4th, 11th and 16th birthdays. At 16 years, 
only participants of the random sample were given a full interview. One hundred and twenty-
seven offspring were fully interviewed at 16 years. 
 
 
                                                          
1 Hereon referred to as “the random sample”. 
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2.2.2. Present study: 25-year follow-up (2012-13) 
For the 25-year assessment, only offspring of the random sample whose mothers agreed to take 
part in follow-up phases after the original perinatal phase were sought for participation (n= 151). 
One hundred and three offspring participated. One hundred and one had been seen previously 
at 16 years, whilst two had been unavailable at 16 years but were previously seen at 11 years. 
This represents a 79.5% retention rate of the random sample based on offspring who 
participated at 16 years.  
 
Of the 48 offspring who did not participate, reasons for non-participation were as follows: 16 
(33.3%) had left the study before the adolescent follow-ups, 8 (16.7%) were not able to be 
contacted, 19 (39.6%) declined to participate (hard refusal) and 5 (10.4%) initially agree to 
participate but evaded further contact (soft refusal). Figure 2 depicts the progress of 







Figure 2. Flow chart of participation in the current follow-up at 25 years 
  
Participated in first assessment at 20 weeks pregnant 
N = 252 
Completed full interview at 36 weeks pregnant  
n = 153 (random sample) 
Non-random sample 
Contact established at 25 years (present study) 
n = 127 (random sample) 
Completed initial phase at 12 months postnatal 
n = 149 (random sample) 
Given full interview at 16 years 
n = 127 (random sample) 
Participated at 25 years (present study) 




2.3.1. SLCDS (1986-2003) 
 
2.3.1.1. Ethics  
Ethical approval was received from the University of London. At the SLCDS onset, informed 
consent was obtained from the pregnant women attending LRGP and GRHC to participate in the 




2.3.1.2. Perinatal phase 
Maternal assessments occurred at 20 and 36 weeks of pregnancy and at 3 and 12 months 
postnatal. Each visit was conducted in the mother’s home by one of two academic GPs, who 
underwent training in the assessments specific to the study at the Institute of Psychiatry. The 
GPs only assessed participants who were patients at the practice where they did not work. At 
the initial 20-week assessment, full sociodemographic and clinical information was collected. At 
further time points current mental health and family information was updated. In addition, RAs 
collected mental health related information from the clinical medical notes and the health 
visitors’ records at 12 months postnatal. 
 
 
2.3.1.3. Four, 11 and 16 year phases 
The families were visited at home at 4, 11, and 16 years. At 11 and 16 years, two interviewers 
who were unaware of the information collected at previous visits, interviewed mothers and 
offspring separately. All interviewers held at least a bachelor’s degree in psychology, and were 
further trained in the assessments specific to the project at the Institute of Psychiatry, King’s 
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College London (KCL). At each time point, mental health, sociodemographic, life history and 
relationship information, current and retrospective to the last visit, was collected. The 
offspring’s schools were also contacted at 16 years to record final GCSE examination results. 
Mothers and offspring individually consented to be traced for future follow-ups. 
 
 
2.3.2. Twenty-five year phase (2012-13) 
 
2.3.2.1. Ethics 
Ethical approval for the 25-year offspring phase was obtained from London – Camberwell St 
Giles National Research Ethics Service Committee (reference number: 11/LO/0812).  
 
 
2.3.2.2. Tracing and interview 
All random sample offspring whose mothers had consented to be traced at previous follow-ups 
were sought. A letter was posted to the mother at her last-known address requesting her 
current telephone contact details. In cases where the offspring was not living with the mother at 
the last visit (i.e. 16 or 11 years), letters were sent to the guardian at that time (e.g. father, 
aunt). Once contact was made, mothers were telephoned to explain that the next phase of the 
study was being conducted and were asked to provide their offspring’s contact details. In cases 
where no letters were returned, the Data Linkage and Extract Service of the Health & Social Care 
Information Centre was employed. Current GP details for untraced mothers and offspring were 
requested. GPs were then contacted via post and asked to forward the letters to the mothers 
and offspring at their currently known address. Tracing was conducted by myself and a RA. 
 
Once telephone contact was made with the offspring, a full description of the study was 
provided followed by an invitation to come for the assessment at the National Institute for 
73 
Health Research – Wellcome Trust Clinical Research Facility at KCH. Participants who were 
unable to travel to KCH were visited in their home. A detailed information sheet (Appendix A) 
was reviewed with the participant, followed by the gaining of informed consent (see Appendix 
B) prior to the commencement of the interview. The interview comprised a combination of 
questionnaires and semi-structured interview assessments. All interviews were audio recorded, 
and sociodemographic, mental health and life history information was collected. A RA trained at 
the Institute of Psychiatry, KCL, assisted with the interviewing of some of the participants. All 
interviewers were blind to participants’ information as collected at previous assessments. For 
the final part of the assessment, offspring were asked to have their height, weight and waist 
ratio measured and to provide a blood sample. In cases where I did not interview the 
participant, a trained phlebotomist from KCH collected the blood samples. All blood samples 
were delivered to KCH Phlebotomy Department within 15 minutes of sample collection. In cases 
where the participant was interviewed at home, samples were transported on ice and deposited 
as quickly as possible. To end the interview, participants were provided with a set of six Salivette 
swabs (Sarstedt, Leicester, UK) to take home in order to provide saliva samples over the course 
of one day. They were provided with a prepaid special delivery package to return the samples. 
Finally, participants were paid £50 for their time and thanked. Participants were given reminders 
to collect their saliva samples via text. Once the saliva samples had been received in the post, 





2.4.1. Maternal mental health 
 
2.4.1.1. Prenatal maternal depression 
A variable was constructed to capture all instances of clinically relevant depression during 
pregnancy. At 20 and 36 weeks, pregnant mothers were interviewed using the Clinical Interview 
Schedule (CIS; Goldberg, Cooper, Eastwood, Kedward, & Shepherd, 1970). International 
Classification of Diseases 9th Revision (ICD-9) diagnoses of women’s current mental state over 
the past two weeks were rated. Criteria for the following depressive disorder diagnoses were 
met: neurotic depression (300.4); a brief depressive reaction (309.0); a prolonged depressive 
reaction (309.1); depression – other (311); depressive personality (301.1). The most common 
diagnosis was neurotic depression. The overall agreement between the two interviewers of the 
reported symptoms on the CIS based on nineteen tape-recorded interviews, given as a weighted 
kappa coefficient, was .81. Twenty-three (22.3%) women were rated as meeting criteria for a 
depressive disorder at 20 weeks pregnant, and twenty-three were classified as depressed at 36 
weeks pregnant (22.3%). A dichotomous variable was created that detailed whether a mother 
had been clinically depressed at either time point in pregnancy (D Sharp, 1992).  
 
 
2.4.1.2. Prenatal maternal anxiety  
Mothers completed the Leeds Anxiety Scale (Snaith, Bridge, & Hamilton, 1976) at 20 and 36 
weeks pregnant. Scores on the anxiety subscale at each time point were averaged to provide an 
index of overall anxiety symptoms during pregnancy.  
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2.4.1.3. Maternal depression from birth to 16 years 
At 3 and 12 months postnatal mothers were interviewed about their current mental state (past 
two weeks) using the CIS, from which ICD-9 depressive disorder diagnoses were rated (300.4, 
309.0, 309.1). Postnatal depression was defined by the combined ICD-9 diagnoses from the 3- 
and 12-month interviews; if the mother had met ICD-9 criteria for a depressive disorder at either 
time, she was rated as having experienced postnatal depression (birth to 1 year). At 4, 11 and 16 
years mothers were interviewed about their current mental state and experience of depressive 
symptoms retrospective to the previous assessment using the lifetime version of the Schedule 
for Affective Disorders and Schizophrenia (SADS-L; Spitzer, Endicott, & Robins, 1978). At these 
assessments diagnoses of major (03), minor (13) and intermittent (14) depressive disorder were 
made in consultation with the lead psychiatrist on the team using Research Diagnosis Criteria 
(RDC). The current and ‘‘retrospective to last visit’’ data were used to assess the occurrence of 
maternal depression over the child’s lifetime. Variables were created to measure the children’s 
exposure to maternal depression in early (between 1 and 4 years), middle (between 4 and 11 
years) and late chilldhood (between 11 and 16 years). For each time interval, depression was 
rated if a mother met criteria for a diagnosis currently at the time of interview or in the period 
retrospective to the last visit. Mothers were also interviewed retrospectively using the SADS-L 
about their mental state during the entire first postnatal year, from which RDC diagnoses of 
depression across the 1st postnatal year were generated. A dichotomous variable of whether the 
mother had ever experienced depression in the period between the child’s 1st and 16th birthday 
was also generated. 
 
2.4.1.4. Maternal previous psychiatric history 
Information on a mother’s personal history of psychiatric problems (depression, anxiety, 
substance use problems, psychotic disturbances) prior to pregnancy was collected using a 
clinical schedule at 20 weeks pregnant. A dichotomous measure of mothers’ personal histories 
of psychiatric problems prior to the index pregnancy was generated (0 = no history; 1 = history).  
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2.4.2. Maternal sociodemographic characteristics 
 
2.4.2.1. Maternal age 
The mother’s age at the birth of the birth of the index child was recorded in whole years. 
 
2.4.2.2. Maternal education 
Information on a mother’s highest educational achievement was obtained at 20 weeks pregnant. 
A dichotomised variable of basic qualifications (O-levels) or higher (0) versus no qualifications (1) 
was generated. 
 
2.4.2.3. Maternal social class 
Information about a mother’s occupation was collected at 20 weeks pregnant, and was used to 
make ratings about their social class according to Goldthorpe and Hope’s (1974) grading of 
occupations. The highest ranked employment a mother had ever held was used to determine 
the mother’s socioeconomic status. Mothers were classified into middle class (0) versus working 
class (1). 
 
2.4.2.4. Maternal ethnicity 
Mothers’ reports of their cultural backgrounds were dichotomised into White British (0) versus 
not White British (1).  
 
2.4.2.5. Maternal marital status 
Mothers reported their marital status at 20 weeks pregnant. A dichotomous variable of whether 
a mother was married (0) versus unmarried (1) was generated. This distinction was selected 
based on the fact that most women with a long-term partner were married in the 1980s. Thus, 
this distinction is believed to index partnership presence.  
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2.4.3. Measures of mothers’ perinatal behaviours 
 
2.4.3.1. Maternal smoking during pregnancy 
During the second- and third-trimester interviews, mothers reported the number of cigarettes 
smoked per day. Composite measures of prenatal smoking were constructed by averaging the 
scores reported at each interview 
 
2.4.3.2. Maternal drinking during pregnancy 
Mothers reported the number alcohol units drunk per week at the second- and third-trimester 
interviews. A composite measure of prenatal drinking was generated by averaging the scores 
reported at each interview. 
 
2.4.3.3. Medical problems during pregnancy 
At the third-trimester interview mothers reported the number of medical problems they had 
during the pregnancy, ranging from none, a few to a lot. Reports were recoded into none (0) 
versus some (1). 
 
2.4.3.4. Breastfeeding 





2.4.4. Obstetric outcomes 
 
2.4.4.1. Offspring birth weight 
Measures of offspring birth weight were obtained from medical records of the birth and were 
recorded in grams.  
 
2.4.4.2. Offspring gestation age 
Length of gestation was recorded in whole weeks rounded up or down to the nearest week.  
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2.4.5. Offspring depression in adulthood 
At 25 years, offspring were interviewed about their current mental state (past month) and 
experience of depressive symptoms retrospective to the previous assessment using the 
Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician Version (SCID-CV; First, 
Spitzer, Gibbon, & Williams, 1996; Appendix F). DSM-IV diagnoses of mood disorders in 
adulthood were rated in conjunction with the psychiatrist on the team. Diagnoses were of major 
depressive disorder (MDD), single episode (296.2x), recurrent episode (296.3x), depressive 
disorder not otherwise specified (NOS; 311) and dysthymic disorder (300.4). A dichotomous 
variable was created to index adulthood DSM-IV depression based on whether an offspring had 
met criterion for any of the above depressive disorders since their 18th birthday. A continuous 
variable was also constructed from the highest number of DSM-IV depressive symptoms 
reported in any given episode.  
 
Furthermore, offspring concurrent depressive symptomatology in the week preceding the 25-
year interview was recorded using the Hamilton Rating Scale for Depression (HAM-D; Hamilton, 
1960; Appendix G). Questions 1-17 were rated and a total depressive symptomatology score 





2.4.6. Offspring experience of childhood maltreatment 
Measures of offspring experience of sexual abuse, physical abuse, emotional abuse and neglect 
were obtained. Emotional abuse and neglect were measured using the Childhood Experience of 
Care and Abuse Questionnaire (CECA.Q; Bifulco, Bernazzani, Moran, & Jacobs, 2005; Smith, Lam, 
Bifulco, & Checkley, 2002; Appendix H) administered to the offspring at 25 years. Physical and 
sexual abuse were rated through a combination of offspring reports provided at 25 years using 
the CECA.Q, plus offspring and parental reports of lifetime instances of sexual and physical 
abuse provided at 11 and 16 years using the Child and Adolescent Psychiatric Assessment (CAPA; 
Angold & Costello, 2000; Appendix I). Maltreatment was rated if any one of the three types of 




2.4.6.1. Emotional abuse and neglect (CECA.Q) 
Emotional abuse was indexed through offspring ratings of severe parental antipathy, whilst 
neglect reflected experience of severe parental neglect. Ratings were based on experiences that 
occurred up to 17 years of age. Scoring of the antipathy and neglect scales on the CECA.Q were 
conducted in accordance with the guidelines published by Bifulco and colleagues (2005), 
whereby the most conservative cut-off points were selected in order to ensure that only severe 
instances of abuse and neglect were counted, thus minimising the possibility of false positives.  
 
Total scores for maternal and paternal antipathy were calculated. Maternal antipathy scores of 
7-27 were recoded into 0 (minimal antipathy) whilst scores ≥ 28 were recoded as 1 (severe 
antipathy). Paternal antipathy scores of 7-29 became 0 (no/non-severe antipathy) whilst scores 
of 30 or more were transformed into 1 (severe antipathy). Total scores for maternal and 
paternal neglect were calculated. Emotional abuse was rated if severe antipathy was 
experienced from either parent (0 = no/minimal emotional abuse; 1 = emotional abuse). 
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Maternal neglect scores of 8-24 were then recoded into 0 (minimal neglect) whilst scores of 25 
or more were recoded as 1 (severe neglect). Paternal neglect scores of 8-25 became 0 (minimal 
neglect) and scores of 26 or more were transformed into 1 (severe neglect). Neglect was rated if 
severe neglect was experienced from either parent (0 = no/minimal neglect, 1 = neglect). 
 
 
2.4.6.2. Physical and sexual abuse (CECA.Q and CAPA) 
At 25 years, offspring reported retrospectively on their experience of sexual and physical abuse 
up to age 17 using the CECA.Q. Physical abuse from maternal and paternal figures was rated 
separately by summing the relevant responses: (i) more than once (1), only once (0); (ii) hit with 
a belt/stick or punched/kicked (1), hit with hand/other (0); (iii) resulted in injury/bruising (1), no 
injuries (0); (iv) perpetrator out of control (1), in control (0). This resulted in scores ranging from 
0 to 4 for each parental figure. Scores of 0-2 were further recoded into 0 (minimal physical 
abuse), whilst scores of 3-4 were coded as 1 (severe physical abuse). CECA.Q parental abuse was 
then rated if an offspring received a score of 1 from either parent (0 = no/minimal physical 
abuse, 1 = physical abuse). 
 
Experiences of sexual abuse (as assessed at 25 years through the CECA.Q) were rated separately 
for each unwanted sexual experience. A total score for each unwanted sexual experience was 
calculated by adding together the responses for the following items: (i) perpetrator known (1), 
not known (0); (ii) perpetrator relative (1), not relative (0); (iii) perpetrator lived in household 
(1), lived outside household (0); (iv) more than once (1), only once (0); (v) perpetrator touched 
child’s private parts (1), didn’t involve this (0); (vi) involved touching perpetrator’s private parts 
(1), didn’t involve this (0); (vii) sexual intercourse (1), not sexual intercourse (0). The possible 
range of scores for each unwanted sexual experience therefore ranged from 0 to 7. In order to 
create a dichotomised sexual abuse variable, firstly scores of 0 or 1 for each unwanted sexual 
experience were recoded as 0 (minimal sexual abuse) and scores of 2-7 were coded as 1 (severe 
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sexual abuse). A rating of 1 for either or both the first or second unwanted sexual experience 
dichotomised variables was rated as indicating CECA.Q sexual abuse and coded as 1 (severe 
sexual abuse) whilst ratings of 0 for both experiences were coded as 0 (minimal sexual abuse). 
 
At 11 and 16 years offspring and the primary caregiver (in most cases the mother) provided 
independent reports about any lifetime experiences of sexual or physical abuse up to that time 
point (Appendix I). Physical abuse was rated if respondents reported incidents of abuse that 
involved at least some physical injury or force with potential for such. Sexual abuse was defined 
as incidents in which a perpetrator involved the offspring in activities for the perpetrator’s own 
sexual gratification. This could include fondling, oral contact, genital or anal intercourse. CAPA 
physical and sexual abuse were rated, respectively, if either offspring or parents reported 
incidents of physical or sexual abuse at 11 or 16 years that met criterion for the CAPA definition 
(0 = no/minimal physical abuse, 1 = physical abuse; 0 = no/minimal sexual abuse; 1 = sexual 
abuse). 
 
Finally, physical/sexual abuse was classified by the combined CECA.Q and CAPA ratings; if 
physical/sexual abuse was rated in either measure, physical/sexual abuse was rated, 
respectively (0 = no/minimal physical abuse, 1 = physical abuse; 0 = no/minimal sexual abuse; 1 
= sexual abuse). 
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2.4.7. Offspring recent stressful life events in adulthood  
Offspring recent life events were rated in order to give a measure of stress in adulthood. At 25 
years, offspring completed a life events questionnaire (Appendix E), which detailed life events 
occurring in the last 6 months, along with the level of distress attached to the event (0 = not 
distress, 1 = mildly distressing; 2 = moderately distressing; 3 = severely distressing). A composite 
variable was created which summed the total number of severely distressing (level 3) life events 






2.4.8. Offspring personal characteristics at 25 years 
A scheduled was devised to collect offspring personal characteristics at 25 years (Appendix C). 
Information on current marital status, children, housing, employment, cultural background and 




2.4.8.1. Offspring ethnicity 




2.4.8.2. Offspring education 
Offspring reported on their highest level of educational achievement. In cases where offspring 
reported only GCSEs, corroborative information on the nature of these qualifications was 
obtained from the information provided by the offspring’s school at 16 years. Where there was 
discrepancy between offspring reports and school reports, the school reports were used. 
Offspring were dichotomised into those with some qualifications (at least one GSCE grade A*-C; 










2.4.9. Offspring lifestyle factors at 25 years 
Lifestyle information was collected via a schedule devised for the study at 25 years (Appendix D). 
This included information on current smoking, drinking, physical fitness and eating habits, as 
well as medication use. The following variables were then computed. 
 
2.4.9.1. Offspring smoking  
A continuous variable of offspring current smoking habits was created as follows: 0 = non-
smoker; 1 = light smoker (1-9 cigarettes per day); 2 = moderate smoker (10-19 cigarettes per 
day); 3 = heavy smoker (20+ cigarettes per day). 
 
2.4.9.2. Offspring alcohol consumption 
Offspring current average drinking consumption was coded as follows: 1 = drinks less than once 
per week; 2 = drinks 1-2 days per week; 3 = drinks 3-4 days per week; 4 = drinks 5-7 days per 
week. 
 
2.4.9.3. Offspring physical activity 
Offspring physical activity was rated based on amount of self-reported average physical activity. 
The following variable was computed: 1 = exercises less than once per week; 2 = exercises 1-2 
times per week; 3 = exercises 3-4 times per week; 4 = exercises 5+ times per week.  
 
2.4.9.4. Offspring fast food consumption 
Offspring’s average consumption of fast food/ready meals was coded as follows: 0 = less than 
once per week; 1 = 1-2 times per week; 3-4 times per week; 3 = 5-7 times per week; 4 = more 
than once a day.  
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2.4.9.5. Offspring medication use 
Offspring reported their medication use at the time of the interview as well as on the day of 
saliva collection. Two variables were constructed one that coded medication use on the day of 
the interview (relevant to blood collection) and one that updated this with medication use on 
the day of the saliva sample (relevant to cortisol analyse). Medication with anti-inflammatory 
effect was coded according to guidance from Danese and colleagues (2007). The following 
medications were rated as having anti-inflammatory effect: contraceptive pill; asthma pump; 
hormone regulation medication (e.g. hair regrowth serums); antidepressants; contraceptive 
injection; non-steroidal anti-inflammatory drugs; corticosteroids; steroid nasal spray; 
prescription anti-inflammatories.    
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2.4.10. Offspring physiological measures at 25 years 
Salivary cortisol was collected to index offspring’s hypothalamic-pituitary-adrenal (HPA) axis 
function using six Salivette swabs (Sarstedt, Leicester, UK), which were given to participants to 
take home at the end of the interview.  
 
Offspring’s inflammatory biomarkers (high sensitivity C-reactive protein [hsCRP]), and metabolic 
parameters (lipid levels and glucose levels [glycosylated hemoglobin]) were measured via blood 
samples collected on the day of the interview. In cases where it was not possible to collect blood 
on the day of the assessment, samples were collected at a later point in time. In total, 82 
(79.6%) participants provided a blood sample. Seventy-three (89.0%) offspring provided a blood 
sample on the day of the interview. Blood samples were taken from the antecubital fossa using 
the BD Vacutainer Safety-Lok™ Blood Collection Set (BD, Oxford, UK). The time of blood 
collection varied, with most (81.7%, n = 67) samples being collected between 10:30 and 15:00 
hours. Blood was collected from nine (11.0%) participants in the afternoon (15:00-18:00) and 
from six (7.3%) participants in the evening (18:00-20:30). Participants were not fasted before 
sample collection. All blood particle measurements were conducted by KCH Phlebotomy 
Department, who received whole blood samples on the day of the interview, usually within 20 
minutes of venepuncture. Analysis took place blind to participant status. 
 
 
2.4.10.1. Salivary cortisol 
The purpose of collecting salivary cortisol was to provide an index of HPA axis function. 
Participants were instructed to collect four saliva samples in the first hour immediately after 
awakening ([i] upon awakening; [ii] +15 minutes after awakening; [iii] +30 minutes after 
awakening; [iv] +60 minutes after awakening) followed by the fifth at midday and the final 
sample at 20:00 hours. Awakening cortisol was collected in order to evaluate the offspring’s 
stress reactivity in response to the stress of awakening: the cortisol awakening response (CAR). 
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Furthermore, midday and evening cortisol samples were collected so that the diurnal profile 
could be characterized. Participants were instructed not to drink, eat, smoke or brush their teeth 
during the first hour after awakening, nor to eat, drink or smoke in the 30 minutes preceding the 
collection of midday and evening samples. Offspring were given an instruction sheet and record 
log to detail the exact times of saliva sample collection (Appendix L). Participants were 
instructed to collect the samples on the closest possible day to the interview (usually the 
following weekend) and to keep them in the fridge until posting. On arrival at the laboratory, the 
samples were frozen at -20°C.  
 
Saliva samples were assayed for cortisol using a standard commercial enzyme linked immuno-
sorbent assay (ELISA; Salimetrics, Newmarket, UK) by Dr P Zunszain (Lecturer, Institute of 
Psychiatry, KCL, UK). Details of the technical protocol and method of calculation are provided in 
Appendix M. Seventy-five (72.8%) participants returned their saliva samples. Cortisol data was 
successfully assayed for 74 of the awakening, +15 minutes, +30 minutes, midday and 20:00 
hours samples, and for 72 of the +60 minutes samples. Criteria for exclusion from data analysis 
were as follows: (i) incomplete record sheets returned (n = 4); reported illness on the day of 
sample collection (n = 1). The mean time of saliva collections were as follows: awakening = 08:31 
(SD = 1:16); +15 minutes = 08:47 (SD = 1:16); +30 minutes = 09:01 (SD = 1:18); +60 minutes = 
09:31 (SD = 1:16); midday = 12:08 (SD = 0:25); evening = 20:14 (SD = 0:33). 
 
In addition to the computation of continuous variables to record saliva concentrations for each 
time point, delta change statistics and area under the curve (AUC) calculations were also 
computed. Delta change statistics were calculated for +15, +30 and +60 minute samples, 
relevant to awakening levels. The purpose of these calculations was to provide an index of stress 
reactivity during the first hour after awakening. AUC statistics were calculated for the cortisol 
awakening response (CAR; awakening, +15, +30, +60 minutes post awakening) and for diurnal 
cortisol levels (awakening, midday, evening). For CAR AUC levels, two statistics were computed: 
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(i) AUC with respect to ground (AUCG); and (ii) AUC with respect to increase (AUCI). CAR AUCG 
estimated total cortisol levels during the first awakening hour, whilst CAR AUCI provided an 
estimate of increasing cortisol levels from the awakening level. For diurnal cortisol levels only 
the AUCG was calculated. AUC calculations have been shown to be a valid and reliable index or 
cortisol levels collected at multiple time points and were based on the trapezoid formula 
(Pruessner, Kirschbaum, Meinlschmid, & Hellhammer, 2003). 
  
 
2.4.10.2. Inflammatory markers 
Peripheral inflammation was indexed through the measurement of high sensitivity C-reactive 
protein (hsCRP). CRP is an acute phase protein that is synthesised in the liver which circulates in 
the plasma. Plasma CRP levels reflect chronic low-grade inflammatory conditions. Measurement 
using the hsCRP assay has been found to be the most reliable. Details of the technical protocol 
used for the measurement of hsCRP are provided in Appendix J. 
 
Of the 82 participants who provided a blood sample, hsCRP data was returned from KCH 
Phlebotomy Department for all. As hsCRP levels greater than 10.0mg/L are indicative of acute 
inflammation (Danese et al., 2007), this upper limit was used as a cut-off to exclude individuals 
with potential acute inflammation from all further analysis. Four participants were excluded 
from analysis on this basis. A continuous variable of offspring’s hsCRP levels was generated. In 
addition, offspring were also dichotomised into low (0) and high (1) inflammation using a cut-off 
of ≥ 3.0mg/L. This cut-off has been shown to predict high risk of CVD (Ridker, 2003) and is also 
considered an acceptable cut-off to identify high inflammation amongst the research community 




2.4.10.3. Metabolic parameters 
 
2.4.10.3.1 Glycosylated haemoglobin 
Glycosylated haemoglobin (HbA1c) provides an indirect measure of general glucose levels over 
the last four months. During the lifespan of the red blood cell (normally 120 days) it is possible 
for plasma glucose to become attached to the haemoglobin in red blood cells. This process is 
referred to as glycosylation of haemoglobin. Once a haemoglobin molecule is glycosylated it 
remains that way. Higher levels of plasma glucose result in increased levels of HbA1c. A build-up 
of plasma HbA1c reflects the average level of plasma glucose to which the cell was exposed 
during its lifecycle, thus providing a marker of average blood glucose levels over the preceding 
months. HbA1c estimates were returned for 98.8% (n = 81) of offspring who provided a blood 
sample. A continuous variable of HbA1c levels was computed. Furthermore, offspring were 
dichotomized into low (0) and high (1) HbA1C levels using a cut-off of > 6%, in accordance with 
recommendations from the International Diabetes Foundation (IDF; 2006).  
 
 
2.4.10.3.2 Full lipid profile 
Measures of offspring’s full lipid profile included measurement of the following, as present in 
serum: total cholesterol (CHOL); triglycerides (TGs); high-density lipoprotein cholesterol (HDL-C); 
low-density lipoprotein cholesterol (LDL-C). Measurement of serum CHOL and TG levels 
provided an estimate of offspring’s overall lipid levels. Raised serum CHOL has been associated 
for many years with an increased risk of atherosclerotic plaque formation leading to an 
increased likelihood cardiovascular disease (CVD), in particular coronary heart disease (CHD).  
TG concentrations (in conjunction with serum CHOL) are useful in the diagnosis and treatment of 
patients with suspected atherosclerosis, a primary risk factor for CVD. 
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Measurement of serum HDL-C and LDL-C allowed for an indirect estimate of high- and low-
density lipoprotein levels, respectively. High-density lipoprotein (HDL) is a lipoprotein that plays 
an essential role in CHOL transport and metabolism, principally by transporting excess CHOL 
from peripheral tissues to the liver. HDL-C measurements enable LDL-C to be calculated, which 
this is one of the most important lipoproteins in the assessment of CHD. HDL levels are also an 
independent risk factor for CHD, demonstrating an inverse relationship to disease risk. The 
Friedwald formula allows for the estimated measurement of LDL particles by subtracting the 
amount of CHOL associated with other measured particles such as HDLs and TGs (Rifai et al., 
1992). Details of the technical protocols used for the calculations of each lipid parameter are 
provided in Appendix K.  
 
Estimates of CHOL, TGs and HDL-C levels were provided for all offspring who provided a blood 
sample (n = 82), whilst LDL-C data was available for eighty-one (98.8%) participants. Continuous 
variables for each lipid parameter were generated. In addition, dichotomous variables were also 
computed to identify offspring with values outside the references ranges for each parameter. 
Dichotomous variables were classified 0 = normal range, 1 = abnormal range. Cut-offs based on 
the most conservative reference ranges as set by either the IDF (2006), the World Health 
Organization  (1999), or the European Group for the Study of Insulin Resistance (EGIR; Beck-
Nielsen, 1999) were applied. CHOL: > 5.0nmol/L = abnormal. TGs: > 2.0nmol/L = abnormal. HDL-
C: < 1.0 = abnormal. LDL-C: > 3.0 nmol/L = abnormal.  
 
 
2.4.10.3.3 Body mass index and waist circumference 
Offspring were weighed using an electronic weighing scale calibrated to the nearest .05kg. 
Offspring were weighed wearing light clothing and without shoes. Height was measured without 
shoes to the nearest 0.5 cm using a measuring tape. Waist circumference (WC) was measured to 
the nearest .5 cm using a measuring tape. Participants were asked to stand straight, exhale, and 
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relax. WC was measured in line with the naval. The body mass index (BMI) provides a statistical 
measure of a person’s weight scaled according to height. BMI was calculated as the individual’s 
body weight (in kilograms) divided by the square of their height (in metres). Height, weight and 
WC measurements were collected from 102 (99.0%) participants. Offspring with BMIs ≥ 30.0 
kg/m2 were classified as obese.  
 
 
2.4.10.3.4 Cumulative risks index 
A cumulative risks index for metabolic syndrome was constructed by summing the number of 
metabolic parameters for which an offspring fell outside the normal range (based on 
dichotomized parameter variables). The following parameters were included in the risk index: (i) 
high HbA1c; (ii) high CHOL; (iii) high TGs; (iv) low HDL-C; (v) high LDL-C; (v) obese BMI. A 
cumulative risks index is consistent with the idea that: (i) although the effect on one parameter 
might be weak, the effects on multiple parameters can be quite large; and (ii) because 
parameter risks tend to cluster together, the number of abnormal parameters, rather than a 
particular parameter, will index greater disturbance in the metabolic system.  
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2.5. Data analysis 
All statistical analyses were conducted in IBM SPSS Statistics Version 21 (IBM Ltd., Portsmouth, 
UK). Data was assessed for normality using probability-probability plots and the Kolmogorov-
Smirnov test, and for homogeneity of variance using Levene’s test. Log and square root 
transformations were applied to improve the normality and homogeneity of the data. For data 
that did not benefit from transformation, non-parametric statistical tests were applied.  
 
Descriptive statistics are presented as mean (M) and standard deviation (SD), or frequency and 
percentage (%), where appropriate. In graphs, standard error of the mean (SE) is presented. For 
univariate analyses, the independent samples t-test was used for group comparisons comprising 
continuous parametric data, whilst the Mann-Whitney test was applied to non-parametric 
continuous data, reported by z score. Pearson’s chi square (χ2) test for independence was used 
for the analysis of categorical data. Fisher’s exact test was applied in cases where one 
contingency cell yielded an expected count of less than five. Pearson’s correlation (r) was used 
for the analysis of association between two parametric continuous variables, whilst Spearman’s 
correlation (rs) was applied to continuous non-parametric data. The point-biserial correlation 
(rpb) was applied to test for association between a continuous parametric variable and 
dichotomous variable, whilst the rpb was applied to raked scores for non-parametric data. Kappa 
(ĸ) statistics are reported for inter-associations between two dichotomous variables.  
 
Hierarchical multiple logistic regressions were applied to data with dichotomous outcome 
variables; whilst hierarchical multiple linear regressions were used for data with continuous 
outcome variables. In call cases, the blockwise (hierarchical) method of entry was used, with the 
variable of interest entered at the final step. Tests for multicollinerarity were conducted for all 
multiple regression analyses. When ANOVAs were used, Gabriel’s test was applied in post hoc 
analyses of pairwise comparisons. Gabriel’s test adjusts for multiple testing as well as for 
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unequal group sizes, and is designed to cope with situations in which small sample sizes are 
different.  
 
As a general rule, statistics are reported to one decimal place except where two decimal places 
would yield particularly informative further information, and when reporting p values. P values > 
.05 are reported to two decimal places, whilst p values < .05 are reported to three. In tables, all 
significant results are highlighted in bold or with the use of an asterisk (*). 
 
 
2.5.1. Mediation analysis 
Mediation analysis is a statistical method used to help answer the question of how some causal 
agent, X, transmits its effect on Y. The most basic of mediation models – the simple mediation 
model – is represented in conceptual form in Figure 3. As can be seen, the model contains two 
consequent variables, Y and M, and two antecedent variables, X and M. In such a model, X is 
proposed to influence outcome Y though M. There are two pathways linking X to Y. One 
pathway leads from X to Y without passing through M, the direct effect (path  ’), and a second 
passes from X to M (path a) and then from M to Y controlling for X (path b). This latter pathway 
is known as the indirect effect (path ab), and is quantified by computing the product term of the 
coefficients a multiplied by b (ab). Quantitatively, the indirect effect (ab) and direct effect ( ’) 
sum to make the total effect (c) of X on Y. This nomenclature has become customary in 
mediation methodology (Hayes, 2013).  
 
When empirically testing a causal process that involves mediation, it is necessary to estimate the 
size of the direct and indirect effects, along with conducting inferential tests of their values (i.e. 
are they significantly different from zero). Estimates of these effects can be calculated simply by 
using ordinary least square regression (OLS) techniques to estimate the individual paths (e.g. 
path b = coefficient of Y regressed on M controlling for X).  
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In classic mediation techniques, such as the causal steps approach, as popularised by Baron and 
Kenny (1986), there is no formal quantification of the indirect effect. Rather, support for the fact 
that M functions as a mediatory between X and Y focuses on the outcomes of a series of tests of 
significance for each path in the causal system. First, one must establish that X and Y (path c) are 
associated by regressing Y on X. Assuming this criterion is met, evidence that X affects M (path a) 
is sought through regressing M on X. Third, a test of whether M affects Y controlling for X (path 
b) is undertaken by regressing Y on both X and M. If the null hypothesis that b equals zero 
cannot be rejected, then the procedure stops. If however, the null hypothesis can be rejected, 
then the size of the total effect (path c) is compared to the size of the direct effect (path  ’; Y 
regressed on X controlling for M). If  ’ is closer to zero than c and  ’ is not statistically significant, 
then it is claimed that M completely mediates X’s effect on Y. By contrast, if  ’ is closer to zero 
than c but  ’ is statistically significant then is it claimed that M partially mediates X’s effect on Y. 
Whilst this methodology is popular, it has many problems. Chiefly, there is no formal 
quantification of the indirect effect; rather the existence of an indirect effect is inferred using 
logic about the set of outcomes from tests about the quantification of something other than the 
indirect effect. Furthermore, this assertion rests upon the rebuttal of three null hypotheses, 
which inflates type II error and consequently reduces power. 
 
The alternative is the formal quantification of the indirect effect (ab) followed by an inferential 
test that it does not equal zero. There are numerous approaches to statistical inference of the 
indirect effect (see MacKinnon, Lockwood, Hoffman, West, & Sheets, 2002; Preacher & Hayes, 
2008). However one of the most robust methods is the use of bootstrap confidence intervals 
(Hayes, 2013). This technique is superior as it does not make any assumptions about the nature 
of the distribution of the indirect effect, thus it is a non-parametric statistical method. 
Bootstrapping is the process of generating a population estimate of the statistic of interest by 
treating the collected sample as a miniature representation of the population. Observations in 
the sample are resampled with replacement, and the statistic of interest is calculated in the new 
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sample of size n that was constructed through the resampling process.  To perform an inference 
test for the size of the indirect effect (ab), bootstrap confidence intervals (CIs) of ab are 
generated through this resampling procedure: 
1) create a bootstrap sample of n cases by randomly sampling cases with replacement from 
the original dataset;  
2) for each bootstrap sample estimate the indirect effect ab; 
3) repeat steps 1 and 2 a total of j times, with j being at least 1,000 but not more than 
10,000; 
4) sort the bootstrap estimates from low to high; 
5) generate the desired upper and lower CIs of the estimate (of ab) by selecting the 
estimates that define the percentiles of interest (e.g. 2.5th and 97.5th percentiles for α = 
.05). 
 
Once this process is completed, the (percentile) bootstrap CIs of ab are then used to signify 
whether ab is different from zero. If the CIs include zero the null hypothesis cannot be rejected, 
however if they do not contain zero, the null hypothesis can be rejected with q confidence, 
where q is the s percentile level selected in step 4. A variation of this method is the generation 
of biased-corrected bootstrap CIs. These are very similar to percentile bootstrap CIs, but have 
the endpoints adjusted according to the proportion of j estimates of ab that are less than the 
original ab estimate. These endpoints are adjusted upwards or downwards to varying degrees 
depending on the proportion, thus giving a more valid CI estimate. 
 
Throughout this thesis, the generation of 95% bias-corrected bootstrap CIs are generated as an 
inferential test of the indirect effect in mediation analyses. All statistical analyses were 















CHAPTER 3: RESULTS  
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3.1. Part 1: Depression in young adulthood 
 
3.1.1. Overview 
The primary goal of the first set of analyses was to test the hypothesis that offspring exposure to 
maternal depression during gestation represents a very early life environmental insult that 
elevates risk for depressive psychopathology during young adulthood. The secondary goal was 
to test whether child maltreatment moderates this association. First, descriptive statistics are 
provided for the sample at 25 years. Next, I investigate the interrelationships between risk 
factors spanning the gestational period through to young adulthood. Regression analyses are 
then applied in order to quantify the impact of prenatal risk factors for offspring depression. 
Next, possible psychosocial pathways from offspring exposure to depression in utero to 
adulthood depression are explored using moderation and mediation analyses. Finally, to further 
quantify these pathways, ANOVAs are performed. 
 
 
3.1.2. Descriptive analyses 
 
3.1.2.1. Sample characteristics at 25 years 
One hundred and three offspring participated in the 25-year follow-up. Basic offspring 
sociodemographic characteristics are presented in Table 3. The majority (72.8%) of offspring 
were of white British origin. There was a comparable ratio of males (47.6%) to females (52.4%). 
Less than half (45.6%) of the sample had pursued higher education at 25 years. 8.7% of offspring 
had married, whilst a large proportion (39.8%) still lived in the family home. Almost a fifth of 
offspring (18.5%) were unemployed. Over a third (36.9%) had fathered/borne at least one child.  
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Table 3. Offspring sociodemographic characteristics at 25 years 
Characteristic Statistic 
Age, M (SD) 25.1 (.7) 

















Highest level of education, % 
No qualifications 
GCSEs 













Marital status, % 
Single 










Privately rented accommodation 
Accommodation rented from housing association 
Council housing 
Parental home  


















Borne/fathered a child, % 36.9 
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3.1.2.2. Adult offspring DSM-IV depression 
DSM-IV diagnoses of offspring depressive disorders through young adulthood (18-25 years) were 
rated at 25 years in order to capture instances of clinically relevant emotional psychopathology. 
Thirty-nine (37.9%) offspring met DSM-IV criteria for a diagnosis of depression (major depressive 
disorder [MDD], dysthymic disorder, depressive disorder not otherwise specified [NOS]) 
between the ages of 18 and 25. Twenty-nine (28.2%) offspring had experienced at least one 
MDD episode, five (4.9%) offspring experienced dysthymia and five (4.9%) offspring met 
criterion for a diagnosis of depressive disorder NOS. The mean number of DSM-IV depressive 
symptoms throughout this period was 2.3, SD = 3.1. Eleven (10.7%) offspring were currently 
depressed at the time of the interview.  
 
 
3.1.2.3. Maternal depression from pregnancy to 16 years 
 
3.1.2.3.1 Perinatal period 
Thirty-five (34.0%) of the offspring’s mothers had experienced a depressive episode during 
pregnancy (20 and/or 36 weeks gestation). Twenty-six (25.2%) mothers were depressed at 3 
months postpartum, and 19 (18.8%) mothers were depressed at 1 year postpartum. Thus, there 
was a pattern of decreasing rates of maternal depression through the perinatal period into 
offspring infancy. There was a high degree of association between prenatal and postnatal 
depression. Of the 35 mothers depressed during pregnancy, 16 (45.7%) were depressed at 3 
months postpartum, χ2(1) = 11.8, p = .001, OR = 4.9, 95% CI [1.9, 12.6], whilst a total of 20 
(57.1%) mothers went on to experience depression again at some point during the first 





The prevalence of maternal depression across the offspring’s childhood years was calculated. 
Thirty-nine (38.2%) mothers were depressed at some point during the offspring’s early 
childhood (1-4 years), 22 (21.8%) mothers were depressed at some point during the offspring’s 
middle to childhood (4-11 years) and 29 (29.9%) mothers were depressed at some point during 
the offspring’s late childhood (11-16 years).  Overall, 64 (62.7%) mothers experienced at least 
one depressive episode between the offspring’s birth and 16 years.  
 
There was a high degree of association between maternal depression during pregnancy and 
maternal depression through childhood (birth to 16). The majority (88.6%, n = 31) of mothers 
who were depressed prenatally went on to experience another episode of depression at some 




3.1.2.4. Offspring childhood maltreatment 
Offspring experience of severe abuse and neglect up to age 17 was rated in order to ascertain a 
measure of childhood maltreatment. Twenty (19.4%) offspring experienced physical abuse, 11 
(10.7%) offspring experienced sexual abuse, 17 (16.5%) offspring experienced parental 
emotional abuse and 15 (14.6%) offspring experienced parental neglect. The distribution of 
these prevalence rates across offspring were as follows: 23 (22.3%) offspring experienced one 
form of maltreatment, 3 (2.9%) offspring experienced two forms of maltreatment, six (5.8%) 
offspring experienced three types of maltreatment and four (3.9%) offspring experienced all 
forms of maltreatment. The inter-associations between types of maltreatment are presented in 
Table 4. Given that maltreatment was rated if an offspring experienced one or more forms of 
abuse and neglect, overall, 36 (35.0%) offspring were classed as having been maltreated in 
childhood. 
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Table 4. Inter-associations between types of maltreatment  
 1 2 3 4 
(1) Physical abuse -    
(2) Sexual abuse .14 -   
(3) Emotional abuse .38*** .43*** -  
(4) Neglect .28** .47*** .63*** - 
Note. Kappa coefficients are presented. 
**p < .01, ***p < .001. 
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3.1.2.4.1 Perpetrators of offspring physical and sexual abuse 
Parents were observed to be perpetrators for the majority (90.0%, n  = 18) of cases of physical 
abuse, but were not perpetrators to any instances of sexual abuse. Non-family members 
accounted for the largest proportion of perpetrators of sexual abuse (63.6%, n  = 7). Frequency 
statistics for all perpetrator groups across all instances of physical and sexual abuse are 
presented in Table 5. 
 
 
3.1.2.4.2 Perpetrators of offspring emotional abuse and neglect 
Fathers were found to account for the majority of perpetrators of parental emotional abuse 
(64.7%, n  = 11) and neglect (73.3%, n  = 11). Rates of emotional abuse and neglect by 
perpetrators are presented in Table 6.  
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Physical abuse, % (n) 
n = 20 
Sexual abuse, % (n) 
n = 11 
Parent 90.0 (18) – 
Stepparent 5.0 (1) 9.0 (1) 
Other family member 15.0 (3) 36.3 (4) 
Non-family member – 63.6 (7)  
Note. Frequency statistics index prevalence rates for each perpetrator class. Where offspring 
experienced abuse involving multiple perpetrators, all perpetrators are reported separately. 
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Offspring parental emotional abuse and neglect 
Emotional abuse, % (n) 
n = 17 
Neglect, % (n) 
n = 15 
Mother only 35.3 (6) 26.7 (4) 
Father only 47.1 (8) 66.7 (10) 
Both parents 17.6 (3) 6.6 (1) 
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3.1.2.4.3 Agreement between prospective and retrospective reporting of abuse 
Whilst offspring experience of emotional abuse and neglect was rated at 25 years through 
retrospective report, reports of physical and sexual abuse were provided both prospectively 
during the offspring’s child and adolescent years, as well as retrospectively at 25 years. At 11 
and 16 years both offspring and parents provided interview reports about any lifetime incidents 
of sexual and physical abuse, and at 25 years offspring provided interview reports about any 
incidents of sexual and physical abuse occurring since the start of memory up until age 17. 
 
Of the 20 offspring rated as having experienced physical abuse, reports for 7 (35.0%) cases were 
provided only during childhood, reports for 8 (40.0%) cases were provided only in adulthood, 
whilst reports for 5 (25.0%) of the cases were provided in both childhood and adulthood. This 
translates into a kappa of .32, p = .001. Of the 11 offspring who experienced sexual abuse, 
reports for 3 (27.3%) cases were provided in only childhood, reports for a further 3 cases  
(27.3%) were provided in only adulthood, and reports for 5 (45.4%) cases were provided in both 
childhood and adulthood. Thus, agreement between prospective and retrospective reports of 




3.1.3. Does prenatal maternal depression predict offspring depression in young 
adulthood? 
The first step to testing the first hypothesis that prenatal maternal depression predicts offspring 
depression in young adulthood, involved comparing offspring whose mothers had suffered 
depression during pregnancy and those whose mothers had not, on their (offspring) experience 
of clinically relevant depressive psychopathology across the entire young adulthood period (18-
25 years). I performed analyses on both diagnoses of depression and symptom levels. 
Categorical between-group comparisons were performed using diagnostic status. Further, more 
fine-grained analyses considered symptom levels. 
 
 
3.1.3.1. Association between prenatal maternal depression and offspring adulthood 
depression 
There was a significant association between prenatal maternal depression and offspring 
depressive disorders in young adulthood, χ2(1) = 8.4, p = .004, OR = 3.4, 95% CI [1.5, 8.1]. Of the 
35 offspring exposed to maternal depression in utero, 20 (57.1%) were rated with a depression 
diagnosis in young adulthood. In contrast, of the 68 offspring not exposed to maternal prenatal 
depression, only 19 (27.9%) were rated with a depression diagnosis in young adulthood. 
Similarly, the mean number of adult offspring DSM-IV depressive disorder symptoms was 
significantly greater, M = 3.4, SD = 3.2, amongst offspring exposed to maternal depression in 
utero, compared to non-prenatally exposed offspring, M = 1.7, SD = 2.8, z = -2.8, p = .004. 
 
 
3.1.3.2. Group differences between offspring exposed to maternal depression in utero 
and non-exposed offspring 
In order to examine the interrelationships between exposure to prenatal maternal depression 
and further adversity factors, offspring exposed to maternal depression in utero were compared 
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to non-exposed offspring on all further potential risk variables. Data for these analyses are 
presented in Table 7. 
 
To summarise, mothers who were depressed during pregnancy did not differ on any 
sociodemographic characteristics compared to mothers who were not depressed during 
pregnancy (see Table 7). However, mothers who were prenatally depressed did report 
significantly more anxiety symptoms during pregnancy, M = 6.6, SD = 3.3, compared to non-
depressed mothers, M = 4.2, SD = 3.0; z = -3.6, p < .001. Whether an offspring had or had not 
been exposed to maternal depression in utero, was not associated with any of their (offspring) 
sociodemographic characteristics. In contrast, offspring exposure to prenatal maternal 
depression was significantly associated with further exposure to maternal depression across all 
developmental periods from birth to 16 years (see Table 7). Furthermore, the prevalence of 
childhood maltreatment was significantly higher amongst offspring exposed to maternal 
depression in utero (48.6%), compared to non-exposed offspring, 27.9%, χ2(1) = 4.3, p = .038, OR 
= 2.4, 95% CI [1.0, 5.7]. This is a replication, using newly collected data, of the findings published 
by Pawlby and colleagues (2011) that were based on ratings of offspring experiences of physical 
abuse, sexual abuse and harsh discipline at 11 years (see 1.7.2)  
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Table 7. Group differences between offspring exposed to prenatal maternal depression 
compared to non-exposed offspring 
 Exposure to maternal 





 None Exposed 
n = 68 n = 35 
Offspring adulthood psychopathology 
Depressive disorder diagnosis, % 





χ2(1) = 8.4, p = .004 
z = -2.8, p = .004 
Maternal characteristics 
Age at index pregnancy, M (SD) 
Ethnicity, % 
White British 









t(101) = .4, p = .68 
 
χ2(1) = .01, p = .93 










χ2(1) = .1, p > .99 a 
Education, % some qualifications 77.9 71.4 χ2(1) = .5, p = .47 










χ2(1) = 1.5, p = .23 
Previous psychiatric history, % b 23.9 37.1 χ2(1) = 2.0, p = .16 
Maternal perinatal factors 
Anxiety in pregnancy, M (SD) 4.2 (3.0) 6.6 (3.3) z = -3.6, p < .001 
Medical problems in pregnancy, % c 28.1 44.1 χ2(1) = 2.5, p = .11 
Prenatal smoking (cigarettes/day), M (SD) 3.4 (6.1) 5.0 (6.3) z = -1.3, p = .18 
Prenatal drinking (drinks/week), M (SD) 1.1 (2.0) .6 (2.0) z = -.9, p = .36 
No. weeks breastfed, M (SD) d 8.6 (9.2) 6.8 (9.0) z = -1.2, p = .23 
Postnatal depression, % 
During 1st postnatal year 
3 months 










χ2(1) = 11.5, p = .001 
χ2(1) = 11.8, p = .001 
χ2(1) = 9.1, p = .003 
Offspring obstetric outcomes 




t(101) = .1, p = .89 
Gestational age, M (SD) 39.9 (1.7) 39.7 (1.8) z = -.8, p = .44 
Childhood factors 
Maternal depression 1 to 16 years, % 
 1-16 b 
1-4 b 













χ2(1) = 15.2, p < .001 
χ2(1) = 5.8, p = .016 
χ2(1) = 14.0, p < .001 
χ2(1) = 7.4, p = .007 













χ2(1) = 4.3, p = .038 
χ2(1) = 7.5, p = .006 
(continued) 
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 Exposure to maternal 





 None Exposed 
n = 68 n = 35 









χ2(1) = 4.8, p = .028 a 
χ2(1) = 5.6, p = .018 
χ2(1) = 2.9, p = .09 
Offspring characteristics 
Gender, % female 50.0 57.1 χ2(1) = .5, p = .49 
Ethnicity, % 
White British 








χ2(1) = .5, p = .49 
Education, % some qualifications 91.2 85.7 χ2(1) = .7, p = .50 a 
IQ, M (SD) h 96.3 (15.1) 93.0 (15.5) t(97) = 1.0, p = .31 
Note. Group effects are based upon (i) Pearson’s χ2 test for independence for associations with 
two dichotomous variables, (ii) the independent samples t-test for associations with a 
dichotomous and continuous variable that permitted parametric analyses, and (iii) the Mann-
Whitney test for associations with a dichotomous and continuous variable that did not permit 
parametric analyses. a Fisher’s exact test applied due to one contingency table cell yielding an 
expected cell count less than five; b n = 102 (non-exposed: 67, exposed: 35); c n = 98 (64, 34); d n = 
59 (37, 22); e n = 101 (67, 34); f n = 101 (66, 35); g n = 97 (63, 34);  h n = 99 (65, 34).  
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3.1.3.3. Univariate analyses of further potential risk factors for offspring adulthood 
depression 
In order to identify additional risk factors for offspring adulthood depression, depressed versus 
non-depressed offspring were compared on all potential risk variables. Results for the analyses 
performed using depressive disorder diagnoses are presented in Table 8, whilst results for 
depressive symptoms are presented in Table 9. I also conducted univariate analyses of the inter-
associations between risk variables, the results for which are presented in Table 10. 
 
The pattern of findings was highly similar between offspring diagnoses and symptoms. Amongst 
sociodemographic characteristics, maternal marital status was significantly associated with adult 
offspring depressive disorders, χ2(1) = 5.2, p = .022, OR = 2.6, 95% CI [1.1, 25.1], and symptoms,  
rpb = .24, p = .013. Significantly more mothers of depressed offspring were unmarried in 
pregnancy (48.7%) compared to mothers of non-depressed offspring (28.6%). There was a trend 
(p < .10) for more female offspring to have a depressive disorder diagnosis. This association 
(between gender and adult offspring depressive symptoms) was found to be statistically 
significant for symptom levels, rpb = .20, p = .048. 
 
In terms of childhood factors, offspring exposure to maternal depression during early childhood 
(1-4 years) and late childhood (11-16 years) were both associated significantly with adult 
offspring depressive disorder diagnoses, 1-4 years: n = 102, χ2(1) = 6.5, p = .011, OR = 2.9, 95% CI 
[1.3, 2.7]; 11-16 years: n = 97, χ2(1) = 11.0, p = .001, OR = 4.5, 95% CI [1.8, 11.4], and symptoms, 
1-4 years: n = 102, rpb = .25, p = .011; 11-16 years: n = 97, rpb = .31, p = .002. There was also a 
positive association between offspring exposure to childhood maltreatment and elevated rates 
of offspring adulthood depressive disorders, χ2(1) = 5.2, p = .022, OR = 2.6, 95% CI [1.1, 6.1], and 
symptoms, rpb = .26, p = .009.   
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Table 8. Group differences between depressed versus non-depressed adult offspring 
 Adult offspring  
 
Group effect 
 Well Depressed 
n = 64 n = 39 
Maternal characteristics 
Age at index pregnancy, M (SD) 26.5 (4.8) 25.8 (4.9) t(101) = .7, p = .47 
Ethnicity, % 
White British 








χ2(1) = .4, p = .53 










χ2(1) = 3.2, p = .12 a 
Education, % some qualifications 79.9 69.2 χ2(1) = 1.4, p = .23 










χ2(1) = 5.2, p = .022 
Previous psychiatric history, % b 25.4 33.3 χ2(1) = .7, p = .39 
Maternal perinatal factors 
Depression in pregnancy, % 23.4 51.3 χ2(1) = 8.4, p = .004 
Anxiety in pregnancy, M (SD) 4.7 (3.1) 5.6 (3.6) z = -1.2, p = .25 
Medical problems in pregnancy, % c 38.1 25.7 χ2(1) = 1.5, p = .21 
Prenatal smoking (cigarettes/day), M (SD) 3.7 (5.8) 4.1 (6.8) z = -.1, p = .90 
Prenatal drinking  (drinks/week), M (SD) .8 (1.5) 1.1 (2.0) z = -1.3, p = .19 
Breastfeeding (weeks), M (SD) d 7.8 (8.3) 8.3 (10.4) z = -.7, p = .46 
Postnatal depression, % 
1st postnatal year 
3 months 










χ2(1) = 2.1, p = .15 
χ2(1) = 3.8, p = .052 
χ2(1) = .03, p = .86 
Offspring obstetric outcomes 




t(101) = .4, p = .66 
Gestational age, M (SD) 40.1 39.6 z = -1.1, p = .27 
Childhood factors 
Maternal depression 1 to 16 years, % 
1-16 b 














χ2(1) = 7.6, p = .006 
χ2(1) = 6.5, p = .011 
χ2(1) = .56, p = .46 
χ2(1) = 11.0, p = .001 



















χ2(1) = 5.2, p = .022 
χ2(1) = 3.1, p = .08 
χ2(1) = 10.1, p = .002 a 
χ2(1) = 6.2, p = .013 
χ2(1) = 3.7, p = .06 
Offspring characteristics 
Gender, % female 45.3 64.1 χ2(1) = 3.4, p = .06 
   (continued) 
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 Adult offspring  
 
Group effect 
 Well Depressed 
n = 64 n = 39 
Ethnicity, % 
White British 








χ2(1) = 1.2, p = .27 
Education, % some qualifications 92.2 84.6 χ2(1) = 1.5, p = .33 a 




t(97) = .5, p = .56 
Note. Group effects were based upon (i) the Pearson’s χ2 test for independence for associations 
with two dichotomous variables, (ii) the independent samples t-test for associations with a 
dichotomous and continuous variable that permitted parametric analyses, and (iii) the Mann-
Whitney test for associations with a dichotomous and continuous variable that did not permit 
parametric analyses.  
a Fisher’s exact test applied due to one contingency table cell showing an expected cell count less 
than five; b n = 102 (well: 63, depressed: 39); c n = 98 (63, 35); d n = 59 (37, 22); e n = 101 (62, 39); f 
n = 101 (62, 39); g n = 97 (61, 36); h n = 98 (61, 37). 
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Table 9. Correlations between adult offspring depressive disorder symptoms and risk variables 
 Adult offspring DSM-IV depressive 
symptoms 
Coeff. p value 
Maternal characteristics 
Age at index pregnancy -.10 .33 
Ethnicity (white British vs. not white British) .04 .68 
Social class (middle class vs. working class) .19 .06 
Education (some vs. no qualifications) .12 .25 
Marital status at pregnancy (married vs. unmarried) .24 .013 
Previous psychiatric history a .06 .54 
Maternal perinatal factors 
Prenatal depression .28 .004 
Prenatal anxiety .08 .41 
Prenatal medical problems b -.12 .23 
Prenatal smoking  (cigarettes/day) -.03 .74 
Prenatal drinking  (drinks/week) .16 .12 
No. weeks breastfed c -.08 .54 
Postnatal depression 
1st postnatal year 
3 months 









Offspring obstetric outcomes 
Birth weight -.05 .60 
Gestational age -.12 .22 
Childhood factors 
Maternal depression 1 to 16 
1-16 a 
1-4 a  
4-11 d 

































Gender (male vs. female) .20 .048 
Ethnicity (white British vs. not white British) .08 .45 
Education (some vs. no qualifications) .04 .66 
IQ f -.07 .48 
Note: Spearman’s correlation coefficients are reported for continuous predictor variables, whilst point-
biserial correlation coefficients based on ranked scores are reported for dichotomous predictors.  
a 
n = 102; 
b 
n = 98; 
c 




n = 97; 
f 
n = 99.  
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Table 10. Inter-associations between risk variables 
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 n 
Maternal characteristics                     
(1) Age at  preg. –                    103 
(2) Ethnicity  .18† –                   103 
(3) Social class  -.19† -.09
*
 –                  103 
(4) Education  .06 -.14 .09
*
 –                 103 




 -.05 -.03 –                103 
(6) Psychiatric hx. .18† .13 -.01 -.11 .18† –               102 
Maternal perinatal factors                     
(7) Preg. dep. -.04 .01 .01 .07 .12 .14 –              103 
(8) Preg. anxiety .27
**
 .06 .02 .12 -.02 .11 .36
***
 –             103 
(9) Preg. med. prob. .13 .05 .01 .01 .03 .15 -.16 .26
**
 –            98 




 -.08 .13 .06 .14 –           103 
(11) Preg. drinking .27
**
 -.04 -.19† -.07 .12 -.03 -.09 -.02 .05 -.06 –          103 
(12) Breastfeeding  .17 .32* -.33
*
 -.18 -.01 -.10 -.16 -.13 -.18† -.31† .20 –         59 








 -.08 .14 -.08 -.06 –        103 
Offspring obstetric outcomes                    
(14) Birth weight .08 -.25
*




 -.01 .02 -.18 -.34
***
 -.02 -.01 -.15 –       103 




 -.08 .14 -.21* -.18† .06 .03 -.04 .48
***
 –      103 
Childhood factors                      






 .10 .11 .06 -.22 .50
***
 -.11 -.09 –     102 
(17) Maltreatment -.25
*
 .05 .08 .06 .10 .17† .21
*
 .01 .07 .10 -.11 .07 .20† -.19† -.12 .16† –    103 
Offspring characteristics                     
(18) Gender -.20
*




 .10 .06 .01 -.03 .05 .03 -.11 .04 -.22
*
 -.06 .04 .01 –   103 
(19) Ethnicity .13 .49
***
 -.10 -.12† .14† .10 .05 .09 .08 -.16 -.08 .11 .07 -.17† -.16 .02 .11 .05 –  103 
(20) Education  -.16 -.10 .03 .15† .06 -.05 .07 -.04 .07 .18† .02 -.25† .01 -.01 -.06 -.01 .16
*
 -.01 .06 – 103 
(21) IQ  .03 .14 -.26
*




 .11 .08 -.12 -.09 .05 -.12 -.26
*
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Note. Pearson’s r coefficients are presented for continuous variables that permitted parametric analysis. Spearman’s correlation coefficients are presented for continuous variables 
that did not permit parametric analysis. Point biserial correlation coefficients are reported for associations between a continuous and a dichotomous variable (based on rank scores 
for continuous variables not permitting parametric analysis), whilst kappa coefficients are presented for associations between two dichotomous variables. Preg. = pregnancy; hx. = 
history; dep = depression; med. = medical; prob. = problems; gest. = gestational; mat. = maternal. (2) white British vs. non-white British; (3) middle class vs. working class; (4) some 
qualifications vs. no qualifications; (5) married vs. unmarried; (10) cigarettes/day; (11) drinks/week; (18) boy vs. girl; (19) white British vs. non-white British; (20) some qualifications 
vs. no qualifications. †p < .10, 
*
p < .05, 
**
p < .01, 
***
p < .001. 
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3.1.3.4. Multiple regression analyses of adult offspring depression 
Hierarchical multiple logistic regression analyses were conducted to assess whether mothers’ 
depression during pregnancy explained the variance in offspring depressive disorder diagnoses 
in young adulthood. The analyses proceeded in three steps. At the first step, sociodemographic 
characteristics that were found to be associated significantly with offspring depressive disorder 
diagnoses (namely, maternal marital status) were entered into the model. At the second step, 
prenatal maternal depression was entered. At this step, prenatal depression was found to 
predict significantly adult offspring depressive disorders, Wald statistic = 7.0, p = .008, OR = 3.3, 
95% CI [1.4, 7.8], model χ2(2) = 12.4, p = .002. At the final step, further childhood risk variables 
were added ([i] offspring childhood maltreatment and [ii] maternal depression at 1- 4 years 
(early childhood)/11-16 years (late childhood). When the effects of offspring childhood 
maltreatment and maternal depression in early and late childhood were taken into account, the 
effect of prenatal maternal depression was reduced to a trend level of significance, Wald 
statistic = 3.0, p = .085, OR = 2.6, 95% CIs [.9, 5.7], model χ2(4) = 20.3, p < .001. 
 
The same analytic procedure was performed, but using hierarchical multiple linear regression 
models, to assess whether prenatal maternal depression explained the variance in adult 
offspring depressive symptoms. At the first step, maternal marital status and offspring gender 
(both found to be associated significantly with depressive symptoms in preceding univariate 
analyses, see Table 9) were entered into the model. At the second step, prenatal maternal 
depression was added. A significant effect of prenatal maternal depression on adult offspring 
depressive symptoms was observed at this step, B = 1.6, t = 2.6, p = .011, 95% CI [.4, 2.8], model 
R2 = .14, F(3, 99) = 5.4, p = .002. At the final step, offspring childhood maltreatment and 
exposure to maternal depression at 1-4 and/or 11-16 years were entered into the model. In the 
context of controlling for these childhood risk factors, the effect of prenatal maternal depression 
was reduced to non-significance, B = 1.0, t = 1.7, p = .10, 95% CI [-.2, 2.3], model R2 = .20, F(5, 96) 
= 4.8, p = .001. 
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There are numerous possible interpretations to these findings. One plausible interpretation is 
that, as the univariate analyses revealed (i) that mothers who were depressed during pregnancy 
were highly likely to become depressed again during the offspring’s childhood (see 3.1.2.3) and 
(ii) that a high degree of association exists between offspring childhood maltreatment and 
prenatal maternal depression (see Table 7), the fact that prenatal depression was found not to 
explain any significant variance in offspring adulthood depression (diagnoses or symptoms) 
when entered alongside offspring exposure to maternal depression post birth and childhood 
maltreatment may be indicative of confounding between prenatal maternal depression and the 
aforementioned childhood risk factors. Alternatively, prenatal depression may exert an effect 
that is indeed distinct to the effects of later childhood risks (maternal post-birth depression and 
offspring childhood maltreatment), yet the effects of these ensuing childhood insults may 
moderate and/or mediate the effects of prenatal maternal depression. Given the natural 




3.1.4. Is the effect of prenatal maternal depression on offspring depression 
influenced by environmental insults after birth?   
To investigate the second hypothesis that psychosocial adversities during childhood contribute 
to the association between exposure to maternal depression during gestation and later life 
depressive psychopathology, the roles of (i) post-birth maternal depression and (ii) childhood 
maltreatment were assessed. 
 
 
3.1.4.1. Independence of maternal post-birth depression and offspring childhood 
maltreatment 
Maltreated offspring were no more likely than non-maltreated offspring to be exposed to 
maternal depression across their entire childhood (birth to 16), n = 102, χ2(1) = 3.6, p = .06, or 
specifically in early (1-4 years) and late childhood (11-16 years), n = 102, χ2(1) = 1.9, p = .17. 
However, partial correlation analyses revealed a significant positive association between 
offspring maltreatment and adulthood offspring depressive symptoms, n = 99, rpb = .28, p = .022, 
when controlling for maternal depression in early and/or late childhood. Similarly, when 
controlling for offspring childhood maltreatment, there was a significant positive correlation 
between maternal depression in early and/or late childhood and offspring depressive symptoms, 
n = 99, rpb = .25, p = .011. These findings suggest that maternal depression post-birth and 
childhood maltreated represent distinct insults that should be treated as separate risk variables 
when assessing the influence of environmental adversities occurring during childhood.  
 
 
3.1.4.2. Moderation analysis: prenatal maternal depression on offspring adulthood 
depression by post-birth environmental insults 
Moderation analyses are aimed at illustrating the conditions under which a purported effect 
may exist or be amplified or supressed. In order to test whether (i) maternal depression in early 
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and/or late childhood and (ii) offspring childhood maltreatment (M) moderated the effect of 
prenatal maternal depression (X) on offspring depression (Y), multiple regression analyses with 
interaction terms were added. The same analytic procedure was conducted for depressive 
diagnoses using hierarchical multiple logistic regression models, and for depressive symptoms 
using hierarchical multiple linear regression models. Two two-way interaction models were 
tested separately; the first model tested for an interaction of prenatal maternal depression by 
maternal depression in early and/or late childhood on offspring adulthood depression whilst 
controlling for offspring maltreatment (and associated sociodemographic characteristics), whilst 
the second model tested for an interaction of prenatal maternal depression by offspring 
childhood maltreatment on adult offspring depression, adjusted for maternal depression in 
childhood on offspring depression (and sociodemographic characteristics). In a final model, a 
three-way interaction of prenatal maternal depression by maternal depression in early/late 
childhood by offspring childhood maltreatment was tested. Results indicated no evidence of any 




3.1.4.3. Mediation analysis: prenatal maternal depression on offspring adulthood 
depression through maternal depression in childhood 
The purpose of mediation analysis is to cast light on putative mechanisms by which an effect is 
exerted. In the case of longitudinal cohort studies, mediation analyses can be used to discern the 
pathways by which an effect is transmitted.  
 
As mediation analytic techniques require the outcome variable to be continuous, all mediation 
analyses were conducted on offspring depressive symptoms, but not diagnoses. A mediation 
analysis using ordinary least squares path analysis was conducted to assess whether the effect of 
prenatal maternal depression (X) on adult offspring depressive symptoms (Y) was mediated by 
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the number of times offspring were exposed further to maternal depression after birth (1-4 
years and/or 11-16 years) (M). These developmental time periods were selected on the basis 
that they were the only time periods in which exposure to maternal depression was significantly 
associated with offspring depressive symptoms (see Table 9). In all regression models, maternal 
marital status, offspring gender and offspring childhood maltreatment were entered as 
covariates (Ci). Inference about the statistical significance of the indirect effect was made 
through the construction of 95% bias-corrected bootstrap CI in which 10,000 bootstrap samples 
were generated. A visual illustration of this conceptual mediation model is presented in Figure 4 
whilst the statistical results of the analyses are presented in Table 11. 
 
The mediation analysis revealed that offspring exposure to maternal depression in utero 
indirectly led to increased offspring depressive symptoms in young adulthood through further 
offspring exposure to maternal depression in childhood. As can been seen in Table 11, prenatal 
maternal depression predicted cumulative exposure to maternal depression post birth (a = .45), 
and cumulative post-birth maternal depression predicted adult offspring depressive symptoms 
(b = .94). A 95% bias-corrected bootstrap CI for the indirect effect (ab = .42) based on 10,000 
bootstrap samples was entirely above zero (.03, 1.15).   
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Figure 4. Conceptual mediation model for the effect of prenatal maternal depression (X) on adult 
offspring depressive symptoms (Y) through maternal depression in childhood (M), controlling for 

















c /  ’ 
b 
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Table 11. Model coefficients for the mediation model of the effects of prenatal maternal 









95% bias corrected bootstrap 
CI 
c (total effect) 1.30 (.62) .07 – 2.53   
a .45 (.15) .16 – .75   
b .94 (.42) .09 – 1.78   
c’ (direct effect) .88 (.64) -.39 – 2.14   
ab (indirect effect)   .42 (.28) .03 – 1.15 
Note: n = 100. The regression coefficients presented are unstandardized B coefficients. All path 
estimates were calculated whilst controlling for maternal marital status (C1), offspring gender 
(C2) and offspring exposure to childhood maltreatment (C3). An estimate of the total effect  (c 
path coefficient) was obtained from the model that regressed Y on X, and excluded M  (but 
controlled for all other associated risks). The indirect effect estimate  (ab) is calculated as the 
product of the “a” and “b” path coefficients. Inference about the significance of the effect of this 
pathway (ab) was made through the calculation of 95% bias-corrected bootstrap CIs, whereby 
the number of bootstrap samples was set to 10,000. All regression models were significant at 
the p < .01 level.  
  
124 
3.1.4.4. Influences of childhood maltreatment 
The next step of investigation was to determine whether offspring exposure to childhood 
maltreatment influenced the impact of prenatal maternal depression on adulthood offspring 
depression. Given that in prior analyses there was no evidence of an effect of either a two-way 
prenatal maternal depression by offspring childhood maltreatment, or three-way moderation 
(prenatal maternal depression by offspring childhood maltreatment by maternal depression 
post-birth) on offspring adulthood depression (see 3.1.4.2), I sought first to assess whether 
offspring childhood maltreatment (i) moderated the observed effect of prenatal maternal 
depression on offspring depressive symptoms through maternal depression in childhood (see 
Figure 5), or (ii) whether offspring maltreatment served as an independent mediator in the 
pathway between prenatal depression and offspring depressive symptoms (see Figure 6). 
 
3.1.4.4.1 Conditional process analysis: moderated mediation 
A diagram of the conceptual model for the moderated mediation model for the effect of 
prenatal maternal depression (X) on adult offspring depressive symptoms (Y) through maternal 
depression in early/late childhood (M), moderated by offspring childhood maltreatment (W) is 
depicted in Figure 5. A conditional process analysis using ordinary least squares path analysis 
was conducted, in which maternal marital status and offspring gender were entered as 
covariates (Ci) at all steps. In order to assess whether offspring childhood maltreatment 
moderated the observed effect of prenatal maternal depression through cumulative maternal 
depression in childhood, the b pathway was measured at each level of childhood maltreatment 
(absent versus present). This allowed for assessment of the conditional effect of M on Y at each 
level of W. Inference about the statistical significance of the conditional indirect effect was made 




Results from the conditional process analysis did not reveal any significant interaction between 
cumulative maternal depression in childhood and offspring childhood maltreatment (simple 
effect: B = .91, p = .11; interactive effect:  B = .40, p = .62). Indeed, 95% bias-corrected bootstrap 
confidence intervals for the conditional indirect effects (maltreatment absent versus 
maltreatment present) based on 10,000 bootstrap samples crossed zero [-.03, 1.37] and [-.01, 
1.64], respectively. These data suggests that the mediated pathway from prenatal maternal 
depression to adult offspring depression through cumulative maternal depression post-birth is 
not moderated by the occurrence (or absence) of offspring childhood maltreatment. 
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Figure 5. Conceptual moderated mediation model for the effect of prenatal maternal depression 
(X) on adult offspring depressive symptoms (Y) through maternal depression in childhood (M), 


























3.1.4.4.2 Multiple mediation 
I sought to investigate whether the effect of prenatal maternal depression on adult offspring 
depression was mediated by childhood maltreatment. A strong rational for this analysis comes 
from the results of prior univariate analyses: offspring childhood maltreatment was highly 
associated with both prenatal maternal depression and offspring depression (see 3.1.3.2 and 
3.1.3.3). Given (i) that evidence of mediation of prenatal maternal depression through 
cumulative post-birth maternal depression was observed, and (ii) that maternal depression 
during early/late childhood is conceptually distinct from offspring childhood maltreatment (in 
addition to their effects being found to be independent, see 3.1.4.1), a multiple moderation 
model was tested in which offspring childhood maltreatment was conceptualised as a separate 
mediator to maternal post-birth depression, see Figure 6. 
 
The multiple mediation analysis was conducted using ordinary least squares path analysis, with 
prenatal maternal depression entered as X, adult offspring depressive symptoms entered as Y 
and cumulative post-birth maternal depression entered as M1. As mediation analysis also 
requires the mediator variables to be in continuous format, rather than dichotomous, a variable 
was constructed that summed the forms of maltreatment that each offspring had been exposed 
to. This cumulative maltreatment variable was entered into the analysis as M2. In all regression 
models, maternal marital status and offspring gender were entered as covariates (Ci). Inference 
about the statistical significance of the indirect effects was made through the construction of 
95% bias-corrected bootstrap CIs in which 10,000 bootstrap samples were generated. 
 
The multiple mediation analysis revealed evidence of two indirect effects. That is, offspring 
exposure to maternal depression in utero indirectly led to increased offspring depressive 
symptoms in young adulthood through both further offspring exposure to maternal depression 
in early/late childhood and cumulative offspring childhood maltreatment. As can been seen in 
Table 12, prenatal maternal depression predicted both childhood risks (a1 = .49, a2 = .65). Both 
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cumulative post-birth maternal depression (b2 = 1.01) and cumulative offspring childhood 
maltreatment (b2 = .63) predicted adult offspring depressive symptoms. 95% bias-corrected 
bootstrap CIs for the two indirect effects (a1b1 = .50, a2b2= .42) were entirely above zero [.28, 





Figure 6. Conceptual multiple mediation model for the effect of prenatal maternal depression (X) 
on adult offspring depressive symptoms (Y) through maternal depression in childhood (M1) and 









































Table 12. Model coefficients for the multiple mediation model of the effects of prenatal 
maternal depression on adult offspring depression mediated by (i) maternal depression in 













c (total effect) 1.53 (.61) .31 – 2.76   
a1 .49 (.14) .20 – .78   
a2 .65 (.21) .24 – 1.06   
b1 1.01 (.42) .19 – 1.84   
b2 .63 (.29) .06 – 1.21   
c’ (direct effect) .62 (.65) -.67 – 1.91   
a1b1 (indirect effect of 
maternal post birth 
depression) 
  .50 (.30) .28 – 1.90 
a2b2 (indirect effect of 
offspring childhood 
maltreatment) 
  .42 (.25) .04 – 1.09 
Total indirect effect    .91 (.41) .28 – 1.90 
Note: n = 100. The regression coefficients presented are unstandardized B coefficients. All path 
estimates were calculated whilst controlling for offspring gender and maternal marital status. An 
estimate of the total effect  (c path coefficient) was obtained from the model that regressed Y 
on X, and excluded M1 and M2  (but controlled for all other associated risks). Estimates of the 
indirect effects were calculated as the product of the respective “a” and “b” path coefficients for 
each pathway. Inference about the significance of the effects the direct paths were made 
through the calculation of 95% bias-corrected bootstrap CIs, whereby the number of bootstrap 
samples was set to 10,000. All regression models were significant at the p < .01 level.  
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3.1.4.5. Quantifying the impact of post birth environmental insults 
To elaborate further on the finding that an offspring’s exposure to psychosocial adversity after 
birth mediates the effects of prior exposure to maternal depression during gestation on her 
propensity to experience depression as a young adult, I examined the mean number of offspring 
depressive symptoms as a function of insult exposure. Given that exposure to maternal 
depression after birth and childhood maltreatment were observed to function as two distinct 
mediators, I assessed the mean number of depressive symptoms for these two pathways 
separately.  
 
Turning first to the influence of maternal depression in childhood, offspring were categorised 
into the following four groups: (i) never exposed to maternal depression; (ii) exposure to only 
prenatal maternal depression; (iii) exposure to maternal depression in early/late childhood; (iv) 
exposure to maternal depression during gestation and during early and/or late childhood. The 
mean numbers of depressive symptoms in young adulthood were calculated for each group. 
Figure 7 displays these group means and standard errors (SE). As can be seen from Figure 7, 
offspring never exposed to maternal depression, n = 40, M = 1.1, SD  = 2.4, had the lowest level 
of depressive symptoms. The mean number of depressive symptoms amongst offspring exposed 
only to maternal prenatal depression, n = 10, M = 2.7, SD  = 3.6, or only maternal depression 
after birth, n = 28, M = 2.5, SD  = 3.2 was similar. Offspring exposed to depression both before 
and after birth, n = 35, M = 3.7, SD  = 3.1, had the highest level of adulthood depressive 
symptoms.  
 
To test for group differences in symptom levels, a one-way ANOVA was performed, which 
yielded an overall significant effect, F[3, 99] = 4.5, p = .005. To account for differences in the 
sample size for each group, Gabriel’s procedure was applied as post hoc analyses. These analyses 
revealed that offspring exposed to maternal depression in both pregnancy and childhood had 
significantly greater depressive symptoms (mean difference = 2.7, SE = .7, p = .004) in 
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comparison with offspring never exposed to maternal depression. Offspring exposed to 
maternal depression either only in utero, or only after birth, were not found to have significantly 
different levels of symptoms compared to (i) offspring who were never exposed, or (ii) 
compared to offspring exposed both before and after birth. This pattern of results complements 
those found in previous analyses (see 3.1.4.3). The finding that offspring exposed to both 
prenatal maternal depression and also maternal depression in childhood had significantly more 
adulthood depressive symptoms compared to offspring never exposed to maternal depression 





Figure 7. Mean adult offspring depressive symptoms as a function of timing of exposure to 
maternal depression, with SE 
 
Note. **Offspring exposed to maternal depression in pregnancy and after birth have significantly 













































Turning to the influence of childhood maltreatment, offspring were categorised into the 
following four groups: (i) not exposed to either prenatal maternal depression or childhood 
maltreatment; (ii) exposed to only prenatal maternal depression; (iii) exposed to only childhood 
maltreatment; (iv) exposed to prenatal maternal depression and childhood maltreatment. The 
mean numbers of depressive symptoms across young adulthood were calculated for each group, 
and are presented in Figure 8. As can be seen, offspring never exposed to any insult, n = 49, M = 
1.2, SD = 2.5, had the lowest depressive symptoms in young adulthood. The mean number of 
adulthood depressive symptoms amongst offspring exposed to only maternal prenatal 
depression, n = 18, M = 3.1, SD = 3.1, or to only childhood maltreatment, n = 19, M = 3.0, SD = 
3.4, was similar.  Offspring exposed to both prenatal maternal depression and childhood 
maltreatment, n = 17, M = 3.8, SD = 3.4, had the highest mean adulthood depressive symptoms.  
 
A one-way ANOVA revealed an effect of environmental insult, F[3, 99] = 4.7, p = .004. Gabriel’s 
procedure revealed that offspring exposed to prenatal maternal depression and childhood 
maltreatment had significantly greater depressive symptoms in adulthood, mean difference = 
2.6, SE = .8, p = .009, in comparison to offspring exposed to neither insult. There was no 
evidence for any statistical effect of cumulative exposure to both insults compared to one. Nor 
was there any evidence that offspring who were exposed to only one insult had any significant 
difference in the number of depressive symptoms they experienced in young adulthood in 






Figure 8. Mean adult offspring depressive symptoms as a function of exposure to early adversity, 
with SE 
  
Note. **Offspring exposed to prenatal maternal depression and childhood maltreatment had a 
significantly higher number of depressive symptoms in adulthood compared to offspring never 














































3.2. Part 2: Biological reactivity  
 
3.2.1. Overview 
The aim of the second part of the study was to investigate changes in biological systems in 
relation to exposure to prenatal maternal depression. Hypothalamus-pituitary-adrenal (HPA) 
axis activity, inflammation and metabolic status were measured at 25 years in order to evaluate 
reactivity in the respective neuroendocrinological, inflammatory and metabolic systems. The 
main goal was to evaluate whether offspring exposure to prenatal maternal depression was 
associated with reactivity in each biological system. A secondary goal was to assess the impact of 
childhood maltreatment on these systems’ reactivity. First, descriptive analyses are provided for 
each biological system. Next, inter-associations between parameters of each system are 
examined. Univariate analyses are then performed to investigate the impact of concurrent stress 
and lifestyle and personal factors at 25 years on biological reactivity. I then assess the effects of 
prenatal maternal depression and childhood maltreatment on each system, followed by 
cumulative effect of adulthood depression. Multiple group comparisons are conducted in an 
attempt to distinguish the effects of early life stress from the effects of adulthood factors. 
 
 
3.2.2. Descriptive analyses 
 
3.2.2.1. HPA axis activity  
The cortisol awakening response (CAR) was indexed through the measurement of salivary 
cortisol upon awakening, and at 15, 30 and 60 minutes post awakening. Cortisol levels at midday 
and at 8pm were collected in order to index the diurnal cortisol rhythm. Mean cortisol values at 
each time-point were calculated and plotted on two separate graphs: Figure 9 illustrates mean 
cortisol levels during the first hour after awakening, whilst Figure 10 illustrates mean cortisol 
levels across the day.  
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As can be seen from Figure 9, the mean cortisol level upon awakening was 8.9 nmol/L (n = 69, SD 
= 4.1). Cortisol levels rose during the first 15 minutes after awakening to a mean peak of 11.1 
nmol/L (n = 69, SD = 4.4) at 15 minutes post awakening. They decreased slightly during the 
ensuing 15 minutes but remained relatively high with a mean level of 10.7 nmol/L at 30 minutes 
post awakening (n = 69, SD = 4.4). By 60 minutes post-awakening, the mean cortisol level had 
returned to a similar level as was observed upon awakening (n = 67, M = 8.2, SD = 4.8). To 
quantify the CAR further, area under the curve (AUC) calculations were performed for each 
participant, based on awakening, 15-, 30- and 60-minute cortisol levels. First, the total AUC 
based on the four respective time points was calculated, hereon referred to as the AUC with 
respect to ground (AUCG), followed by the AUC with respect to awakening cortisol levels, hereon 
referred to as AUC with respect to increase (AUCI). The mean AUCG for cortisol levels across the 
first hour after awakening was 589.9 (n =67, SD = 211.1), whilst the mean AUCI for cortisol levels 
in the hour following awakening was 60.1 (n =67, SD = 247.5). Collectively, these results provide 
an index for the CAR, which can be interpreted as reflecting the natural physiological 
responsiveness to the stress of awakening.  
 
Turning to the diurnal cortisol rhythm, as can be seen from Figure 10, mean cortisol levels 
decreased through the morning to a mean level of 4.8 nmol/L (n = 69, SD = 3.7) at 12 pm, and 
further decreased through the rest of the day to a mean level of 2.1 nmol/L (n = 69, SD = 2.8) at 
8pm. This pattern of results is consistent with the natural trend of decreasing cortisol levels 
through the course of the day. In order to quantify cortisol levels throughout the day, the AUCG 
for awakening, 12pm and 8pm cortisol levels was calculated. The mean AUCG for cortisol across 




Figure 9. Cortisol awakening response as indexed by mean cortisol levels within the first hour 
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3.2.2.2. Inflammation 
Plasma high sensitivity C-reactive protein (hsCRP) was measured as a biomarker of peripheral 
inflammation. The mean hsCRP level was 1.5 mg/L (n = 78, SD = 1.7). Thirteen (16.7%) offspring 
were categorised has having high levels of general inflammation (hsCRP ≥ 3.0), whilst 65 (83.3%) 
offspring were categorised as having normal levels of inflammation.  
 
 
3.2.2.3. Metabolic parameters 
Parameters associated with the metabolic syndrome were measured. Offspring’s lipid profiles 
were assessed through the measurement of serum cholesterol (CHOL) and triglyceride (TG) 
levels. Low-density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol (HDL-
C) levels were measured as a means to quantifying levels of the respective lipoproteins. Plasma 
glycated haemoglobin (HbA1c) was measured to index regular plasma glucose levels, whilst body 
mass index (BMI) and waist circumference (WC) measurements provided an index of peripheral 
fat deposits. Mean metabolic parameter levels, along with frequencies for participants with 
clinically abnormal levels are presented in Table 13. The cumulative risk index marks the number 




Table 13. Descriptive statistics for metabolic parameters 
Metabolic parameter Statistic 
CHOL (nmol/L) 
M (SD)  
% > 5.0 





% > 2.0 





% < 1.0 





% > 3.0 





% > 6.0 





%  > 30.0 (obese) 





n = 102 
88.4 (14.4) 
Cumulative risks index 
M (SD) 
n = 81 
.8 (1.1) 
Note. CHOL = cholesterol; TG = triglyceride; HDL-C = high density lipoprotein cholesterol; LDL-C = 
low density lipoprotein cholesterol; HbA1c = glycated haemoglobin; BMI = body mass index; WC 
= waist circumference.  
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3.2.2.4. Associations between cortisol, hsCRP and metabolic parameters 
Exploratory intra-associations between parameters of each biological system were examined, 
along with the inter-associations across systems. Data for these univariate analyses are 
summarised in Table 14. Awakening cortisol levels were negatively correlated with delta 
statistics for cortisol levels at 30 and 60 minutes after awakening, respectively, as well as with 
AUCI estimates for cortisol in the first hour. No associations were observed between awakening 
cortisol and cortisol levels at midday (12pm) and in the evening (8pm).  
 
 Inflammation levels were negatively correlated with the CAR, as indexed by significant negative 
correlations between hsCRP levels and delta statistics for cortisol at 30 minutes after awakening, 
and AUCI estimates for cortisol in the first hour. In contrast, overall hsCRP levels were positively 
associated with BMI and WC.  
 
Amongst metabolic parameters, BMI and WC were positively associated with CHOL, TG and LDL-
C levels, and negatively correlated with HDL-C levels, suggesting an association between 




Table 14. Inter-correlations between offspring cortisol, hsCRP and metabolic parameters 
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 n 
(1) Awakening cort. –                69 
(2) Δ +15 mins. cort. -.17 –               69 




 –              69 






 –             67 
(5) 12pm cort. .04 .12 .05 .22† –            69 
(6) 8pm cort. .13 -.16 -.33
**
 -.19 .17 –           69 






 .08 .11 -.10 –          67 












 –         67 
(9) Day cort AUCG .43
***




 .23† -.12 –        67 
(10) hsCRP .14 -.04 -.33
*
 -.22† .16 .11 -.11 -.29
*
 .18 –       78 
(11) CHOL .02 -.06 -.07 .02 -.09 -.15 -.07 -.06 -.11 .03 –      82 
(12) TGs .14 .07 .04 -.14 -.20 -.02 .18 -.02 -.07 .15 .46
***
 –     82 
(13) HDL-C -.14 -.02 .10 .23† .28
*
 .23† -.06 .14 .24† -.22 -.09 -.40
***
 –    82 
(14) LDL-C .02 -.06 -.11 -.02 -.17 -.28
*






 –   81 
(15) HbA1c -06 -.10 -.13 -.10 -.16 .05 -.29
*
 -.15 -.14 .07† .25
*
 .18 -.19† .27
*
 –  81 
















 .01 – 102 
(17) WC .23† .07 -.18 -.28
*













Note. Spearman’s correlation coefficients are presented. Cortisol change statistics are the differences between the respective time points and awakening. Cort. = cortisol; mins. = 
minutes; CAR = cortisol awakening response; AUCG = area under the curve with respect to ground; AUCI = area under the curve with respect to increase; hsCRP = high sensitivity C-
reactive protein; CHOL = cholesterol; TGs = triglycerides; HDL-C = high density lipoprotein cholesterol; LDL-C = low density lipoprotein cholesterol; HbA1c = glycated haemoglobin; 
BMI = body mass index; WC = waist circumference.  
†p < .10, 
*
p < .05, 
**




3.2.3. Univariate analyses between biological parameters and risk factors 
As a first step to exploring reactivity in the respective biological systems as a function of early 
life adversity, univariate analyses were performed to assess potential associations between 
biological parameters and concurrent (at 25 years) lifestyle factors, stress and personal 
characteristics. Next, the impact of gross early life adversities, such as exposure to prenatal 
maternal depression and offspring childhood maltreatment were examined. 
 
 
3.2.3.1. Associations with adulthood stress, lifestyle factors and personal 
characteristics 
Indices of stress in adulthood comprised (i) current depression (DSM-IV depressive disorder 
diagnosis at 25 years), (ii) adulthood depression (DSM-IV depressive disorder diagnosis between 
18 to 25 years), (iii) current depressive symptomatology (HAM-D) and (iv) recent stressful life 
events. Lifestyle factors included current (i) smoking, (ii) physical activity, (iii) alcohol 
consumption, (iv) fast food consumption and (v) medication use. Personal characteristics 
included (i) gender, (ii) ethnicity, (iii) educational attainment (iv) family of origin social class and 
(v) maternal marital status in pregnancy.  
 
 
3.2.3.1.1 Adulthood stress 
There was trend for a negative correlation between concurrent depression (DSM-IV disorders) 
and lower cortisol levels at 15 minutes post awakening, rpb = -.23, p = .06. This association 
reached statistical significance for depression (DSM-IV diagnoses) during adulthood, 18-25 years; 
rpb = -.24, p = .044. Delta cortisol at 15 minutes from awakening was negatively associated with 
adulthood depression, rpb = -.30, p = .013. These findings suggest blunting of the CAR in offspring 
who experienced depression (DSM-IV diagnoses) recently. Current depression (DSM-IV 
diagnoses) was positively associated with CHOL levels, rpb = .25, p = .026, and cumulative 
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metabolic risk index, rpb = .24, p = .031. There were no associations between current or 
adulthood depression (DSM-IV diagnoses) and hsCRP levels. Depressive symptomatology (HAM-
D) was not associated with any biological parameters. The number of current stressful life events 
was significantly negatively associated with overall hsCRP levels, rs = -.25, p = .029.  
 
 
3.2.3.1.2 Lifestyle factors 
The use of medication with anti-inflammatory effects was negatively associated with cortisol 
levels at 15 and 30 minutes after awakening, rpb = -.35, p = .003 and rpb = -.24, p = .044, 
respectively, as well as with cortisol delta +15 minutes, rpb = -.31, p = .010, and CAR AUCG, rpb = -
.27, p = .025. Notably, there was no evidence of statistical outliers in the above mentioned raw 
cortisol values in participants who used medication. This would suggest that medication use did 
not significantly affect cortisol levels. There was a trend for a positive association between 
medication use and overall hsCRP levels, rpb = .22, p = .06. Medication use was not associated 
with any metabolic parameters. Exercise frequency was negatively correlated with BMI, WC and 
cumulative metabolic risks index, rs = -.29, p = .003, rs = -.32, p = .001 and, rs = -.26, p = .021, 
respectively. Frequency of alcohol consumption was also negatively correlated with BMI, rs = -
.27, p = .008. Fast food consumption was positively correlated with HbA1c levels, rs = .23, p = 
.045. Smoking was not associated with any biological parameters.  
 
 
3.2.3.1.3 Personal characteristics 
Offspring education was positively associated with HDL-C levels and cumulative metabolic risks 
index, rpb = .27, p = .015 and rpb = .23, p = .038, respectively, and negatively associated with LDL-C 
levels, rpb = -.23, p = .037. There was a significant association between ethnicity and both TG and 
WC, whereby not being white British was positively associated with larger WCs, rpb =.23, p = .020, 
and higher TG levels, rpb = .29, p = .008. Gender was also significantly associated with TG levels, 
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WC and HDL-C levels, whereby girls had lower TGs, rpb = -.35, p = .001, smaller WCs (rpb = -.21, p = 
.039) and higher HDL-C levels, rpb = .28, p = .010. Family of origin social class was positively 
associated with the cumulative metabolic risks index, rpb = .29, p = .009. Maternal unmarried 
status in pregnancy was positively correlated with TG levels, rpb = .26, p = .020 and AUCG diurnal 
cortisol levels, rpb = .32, p = .009. 
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3.2.3.2. Associations with distal risk factors 
The primary purpose of the next set of analyses was to test the hypothesis that prenatal 
maternal depression and offspring childhood maltreatment modulate biological changes in HPA 
axis function, peripheral inflammation levels and parameters associated with metabolic 
syndrome. In addition to performing univariate analyses to test the effects of (i) prenatal 
maternal depression and (ii) childhood maltreatment, I also tested for effects of (iii) maternal 
prenatal drinking, (iv) maternal prenatal smoking, (v) maternal prenatal anxiety, (vi) medical 
problems during pregnancy, (vii) gestational age, (viii) birth weight, (ix) breastfeeding and (x) 
exposure to maternal depression from birth to 16. 
 
Minimal group differences were observed amongst the main predictors. No group differences 
were observed between offspring exposed to prenatal maternal depression compared to those 
not so exposed. There were no differences in the proportion of maltreated offspring with 
clinically high (≥ 3.0mg/L) inflammation compared to non-maltreated offspring, but maltreated 
offspring, M, = 1.2, SD = 1.2, were found to have lower overall levels of hsCRP compared to non-
exposed offspring, M, = 1.6, SD = 1.8, z = -2.0, p = .042. Statistics for these analyses are 
presented in Table 15. 
 
Additional distal risk factors had no effects on hsCRP levels. Amongst cortisol levels, exposure to 
prenatal maternal smoking was positively correlated with AUCG diurnal cortisol levels, rs = .26, p 
= .037, whilst exposure to prenatal drinking was positively correlated with evening cortisol 
levels, rpb = .28, p = .020. Exposure to prenatal maternal anxiety was positively correlated with 
cortisol levels at 12pm. rs = .25, p = .041, and negatively associated with HbA1c levels, rpb = -.29, p 
= .008. Medical problems during pregnancy were positively correlated with LDL-C levels, rpb = .23, 
p = .040. Lengthier breastfeeding was positively correlated with HDL-C levels, rs = .29, p = .039, 
and negatively correlated with BMI and WC, rs = -.31, p = .018 and rs = -.28, p = .034, respectively. 
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 Table 15. Univariate analyses between prenatal maternal depression, offspring childhood 
maltreatment and biological parameters at 25 years 
 Exposure to prenatal maternal 
depression M (SD) 
Exposure to childhood 
maltreatment M (SD) 
 None 
n = 44-67a 
Exposed 




n = 33-67a 
Exposed 
















 p = .70 
+15 mins, M 11.1 (4.4) 11.0 (4.5) p = .86 11.0 (4.3) 11.1 (4.7) p = .64 
+30 mins, M 10.6 (4.6) 10.7 (4.2) p = .62 10.2 (3.9) 11.4 (5.2) p = .25 
+60 mins, M 8.4 (5.4) 7.7 (3.3) p = .79 7.9 (5.2) 8.7 (4.2) p = .27 
Δ +15 mins, M 2.3 (3.4) 2.0 (4.4) p = .72 2.2 (6.7) 2.1 (3.8) p = .98 
Δ +30 mins, M 1.8 (5.1) 1.8 (5.5) p = .82 1.4 (5.2) 2.4 (5.4) p = .57 
Δ +60 mins, M -.3 (6.8) -1.2 (6.4) p = .89 -.9 (7.1) -.3 (6.1) p = .59 








p = .52 








p = .52 
12pm, M 5.2 (4.2) 4.1 (1.9) p = .57 5.2 (3.8) 4.4 (3.3) p = .37 
8pm, M 1.9 (1.5) 2.6 (4.6) p = .55 2.5 (3.5) 1.5 (.8) p = .52 








p = .50 
Inflammation 
hsCRP,  M (mg/L) 








p = .46 








p = .042 
p = .76b 
Metabolic  




4.4  (.8) 
 






p = .92 
TGs, M (nmol/L) 1.1 (.6) 1.4 (1.1) p = .58 1.3 (.9) 1.1 (.6) p = .89 
HDL-C, M (nmol/L) 1.5 (.4) 1.3 (.3) p = .25 1.5 (.4) 1.4 (.3) p = .28 
LDL-C, M (nmol/L) 2.6  (.8) 2.4 (.7) p = .38 2.4 (.6) 2.7 (.9) p = .25 
HbA1c, M (%) 5.3 (.3) 5.3 (.2) p = .37 5.3 (.2) 5.3 (.2) p = .38 
BMI, M (kg/m2) 26.1 (6.9) 25.4 (4.7) p = .94 25.9 (6.4) 25.8 (5.8) p = .96 
WC, M (cm) 88.4 (15.3) 88.4 (12.6) p = .88 88.8 (15.0) 87.6 (13.4) p = .84 
Cumulative risks, M .7 (1.0) .9 (1.3) p = .98 .7 (1.0) .9 (1.3) p = .43 
Note. Group effects were based upon the independent samples t-test for associations that 
permitted parametric analysis, and the Mann-Whitney test for associations that did not permit 
parametric analysis. Cortisol change statistics are the differences between the respective time 
points and awakening. CAR = cortisol awakening response; AUCG = area under the curve with 
respect to ground; AUCI = area under the curve with respect to increase; hsCRP = high sensitivity 
C-reactive protein; CHOL = cholesterol; TGs = triglycerides; HDL-C = high density lipoprotein 
cholesterol; LDL-C = low density lipoprotein cholesterol; HbA1c = glycosylated haemoglobin; BMI 
= body mass index; WC = waist circumference. 
a ns vary due to missing data. b Fisher’s exact test applied due to one contingency table cell 
showing an expected cell count less than five. 
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3.2.4. Group comparisons for distal risks stratified by adulthood depression 
One potential explanation for a lack of group differences on biological parameters between 
offspring exposed to prenatal maternal depression versus those not so exposed, and between 
offspring exposed to maltreatment versus those who did not experience maltreatment, could be 
due to modulation by later insults in adulthood that are known to be correlated with changes in 
the biological systems (i.e. depression).  
 
To test this premise, a split group analysis was performed in order to conduct between group 
comparisons of distal risks separately for depressed and non-depressed adult offspring. A 
variable indicating whether offspring had ever experienced a depressive disorder during 
adulthood (18-25 years), including current depressive symptomatology at 25, years was used to 
split the sample. Between-group comparisons for prenatal maternal depression and offspring 
childhood maltreatment were conducted separately for depressed and non-depressed offspring. 
Results from these analyses are presented in Table 16 and Table 17. In instances where 
significant effects were observed within a single group, moderation analyses and ANOVAs were 
then performed on the whole sample to qualify these findings further. 
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Table 16. Group comparisons of exposure to prenatal maternal depression and childhood 
maltreatment amongst offspring not depressed in adulthood 
 Non-depressed adult offspring 
Exposure to prenatal maternal 
depression M (SD) 
Exposure to childhood 
maltreatment M (SD) 
 None 
n = 35-48a 
Exposed 




n = 33-46a 
Exposed 
















p = .45 
+15 mins, M 11.6 (4.2) 13.0 (3.9) p = .23 11.3 (4.4) 13.6 (3.0) p = .07 
+30 mins, M 10.8 (4.5) 12.4 (3.8) p = .16 10.1 (3.8) 14.3 (4.6) p = .004 
+60 mins, M 8.3 (5.3) 8.6 (4.7) p = .60 7.7 (5.4) 10.2 (3.8) p = .018 
Δ +15 mins, M 2.8 (3.0) 3.8 (5.0) p = .56 2.6 (3.4) 4.2 (3.4) p = .19 
Δ +30 mins, M 2.0 (5.0) 3.1 (7.2) p = .54 1.4 (5.1) 4.9 (5.8) p = .07 
Δ +60 mins, M -.4 (6.9) -.6 (8.1) p = .94 -.9 (7.4) .8 (6.0) p = .50 








p = .004 








p = .10 
12pm, M 5.0 (4.0) 4.0 (1.4) p = .87 5.3 (4.1) 3.3 (1.0) p = .15 
8pm, M 1.8 (1.4) 4.1 (6.9) p = .70 2.5 (3.7) 1.3 (1.1) p = .18 








p = .21 
Inflammation 
hsCRP,  M (mg/L)  








p = .08 








p = .10 
p = . 67b 
Metabolic  












p = .65 
TGs, M (nmol/L) 1.2 (.6) 1.2 (.6) p = .58 1.2 (.6) 1.2 (.6) p = .37 
HDL-C, M (nmol/L) 1.4 (.4) 1.4 (.2) p = .81 1.4 (.4) 1.3 (.3) p = .25 
LDL-C, M (nmol/L) 2.5 (.7) 2.3 (.7) p = .71 2.4 (.7) 2.5 (.7) p = .59 
HbA1c, M (%) 5.3 (.2) 5.3 (.2) p = .78 5.3 (.2) 5.4 (.2) p = .08 
BMI, M (kg/m2) 27.0 (7.5) 26.6 (5.5) p = .89 26.9 (7.1) 27.0 (7.3) p = .98 
WC, M (cm) 90.7 (16.7) 89.8 (12.5) p = .86 89.9 (16.5) 92.3 (13.8) p = .28 
Cumulative risks, M .7 (1.0) .5 (.9) p = .59 .7 (1.0) .7 (1.1) p = .97 
Note. Group effects were based upon the independent samples t-test for associations that 
permitted parametric analysis, the Mann-Whitney test for associations that did not permit 
parametric analysis, and Pearson’s χ2 test for independence for associations with two 
dichotomous variables. Cortisol change statistics are the differences between the respective 
time points and awakening. CAR = cortisol awakening response; AUCG = area under the curve 
with respect to ground; AUCI = area under the curve with respect to increase; hsCRP = high 
sensitivity C-reactive protein; CHOL = cholesterol; TG = triglyceride; HDL-C = high-density 
lipoprotein cholesterol; LDL-C = low-density lipoprotein cholesterol; HbA1c = glycosylated 
haemoglobin; WC = waist circumference.  
a ns vary due to missing data. b Fisher’s exact test applied due to one contingency table cell 
showing an expected cell count less than five.  
151 
Table 17. Group comparisons of exposure to prenatal maternal depression and childhood 
maltreatment amongst offspring who experienced depression in adulthood 
 Depressed adult offspring 
Exposure to prenatal maternal 
depression M (SD) 
Exposure to childhood 
maltreatment M (SD) 
 None 
n = 10-19a 
Exposed 




n = 7-21a 
Exposed 
















p = .95 
+15 mins, M 9.4 (4.8) 9.5 (4.4) p = .94 9.8 (3.7) 9.3 (5.0) p = .95 
+30 mins, M 10.0 (5.0) 9.6 (4.2) p = .78 10.7 (4.4) 9.3 (4.6) p = .41 
+60 mins, M 8.9 (6.2) 7.1 (1.9) p = .94 8.6 (4.5) 7.5 (4.3) p = .35 
Δ +15 mins, M .4 (4.1) .8 (3.5) p = .94 .6 (4.6) .6 (3.3) p = .90 
Δ +30 mins, M 1.0 (5.7) .8 (4.1) p = .94 1.5 (5.8) .6 (4.3) p = .34 
Δ +60 mins, M -.1 (7.1) -1.6 (5.3) p = .44 -.5 (6.2) -1.1 (6.2) p = .71 








p = .49 




p = .89 35.6 
(271.9) 
6.1 (227.4) p = .35 
12pm, M 5.8 (4.8) 4.1 (2.2) p = .35 4.4 (2.6) 5.1 (4.1) p = .91 
8pm, M 2.2 (1.5) 1.5 (.7) p = .33 2.2 (1.9) 1.6 (.6) p = .74 








p = .87 
Inflammation 
hsCRP,  M (mg/L)  








p = .79 








p = .10 
p = .28b 
Metabolic  












p = .63 
TGs, M (nmol/L) 1.1 (.4) 1.5 (1.4) p = .84 1.7 (1.5) 1.1 (.6) p = .37 
HDL-C, M (nmol/L) 1.5 (.3) 1.3 (.4) p = .14 1.5 (.4) 1.4 (.3) p = .57 
LDL-C, M (nmol/L) 3.0 (.9) 2.5 (.8) p = .13 2.5 (.5) 2.8 (1.0) p = .49 
HbA1c, M (%) 5.4 (.3) 5.3 (.2) p = .15 5.3 (.3) 5.3 (.2) p = .71 
BMI, M (kg/m2) 23.7 (3.9) 24.8 (4.1) p = .50 23.8 (4.0) 24.8 (4.0) p = .57 
WC, M (cm) 82.7 (9.2) 87.5 (12.9) p = .51 86.5 (11.1) 83.8 (11.9) p = .30 
Cumulative risks, M .8 (.8) 1.1 (1.6) p = .86 .7 (1.0) 1.1 (1.4) p = .58 
Note. Group effects were based upon the t-test for associations that permitted parametric 
analysis, the Mann-Whitney test for associations that did not permit parametric analysis, and 
Pearson’s χ2 test for associations with dichotomous variables. Cortisol change statistics are the 
differences between the respective time points and awakening. CAR = cortisol awakening 
response; AUCG = area under the curve with respect to ground; AUCI = area under the curve with 
respect to increase; hsCRP = high sensitivity C-reactive protein; CHOL = cholesterol; TG = 
triglyceride; HDL-C = high-density lipoprotein cholesterol; LDL-C = low-density lipoprotein 
cholesterol; HbA1c = glycosylated haemoglobin; WC = waist circumference. 
a ns vary due to missing data. b Fisher’s exact test applied due to one contingency table cell 




3.2.4.1.1 Prenatal maternal depression 
Findings from the split group analysis did not reveal any statistical effects of prenatal maternal 
depression on offspring cortisol levels in either the non-depressed or depressed group. 
Descriptively however, amongst non-depressed offspring, those exposed to prenatal maternal 
depression showed a propensity for a higher CAR compared to non-depressed offspring, as 
indexed by elevated mean cortisol levels at 15 and 30 minutes post awakening. Within the 
depressed group, this inclination was not observed; rather, mean cortisol levels at 15 and 30 
minutes after awakening were lower amongst depressed offspring, irrespective of exposure to 
prenatal maternal depression. Tests of moderation across the whole sample did not reveal any 
interaction between prenatal maternal depression and offspring adulthood depression on any 
cortisol measurements. Figure 11 presents mean cortisol levels for the CAR as a function of 






Figure 11. Cortisol awakening response as a function of exposure to prenatal maternal 





















Time of day 
Non-depressed, non-exposed (n = 35 - 37)
Non-depressed, prenatal maternal depression (n = 9)
Depressed, non-exposed (n = 10)
Depressed, prenatal maternal depression (n = 13)
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3.2.4.1.2 Childhood maltreatment 
The CAR, as indexed by mean cortisol levels for maltreated and non-maltreated offspring split by 
depression status in adulthood, is depicted in Figure 12. Findings from the split group analysis 
revealed that amongst offspring who were not depressed in adulthood, those who were 
maltreated exhibited a higher levels of cortisol at 30 minutes, n = 11, M, = 14.3, SD = 4.6, z = -
2.9, p = .004, and 60 minutes, n = 11, M, = 10.2, SD = 3.8, z = -2.4, p = .018, post awakening, and 
a significantly larger CAR AUCG, n = 11, M, = 750.0, SD = 179.5, z = -2.9, p = .004, compared to 
offspring who were not maltreated, n = 35, M, = 10.1, SD = 3.9, n = 33, M, = 7.7, SD = 5.4 and n = 
33, M, = 566.4, SD = 185.0, respectively. There was also a trend for maltreated offspring to have 
higher cortisol levels at 15 minutes, n = 11, M, = 13.6, SD = 3.0, z = -1.8, p = .07, and a larger 
delta at 30 minutes post-awakening, n = 11, M, = 4.2, SD = 3.4, z = -1.8, p = .07, compared to 
non-maltreated offspring, n = 35, M, = 11.3, SD = 4.4 and n = 35, M, = 2.6, SD = 3.4, respectively.  
 
In contrast, there were no statistical differences in the CAR between maltreated and non-
maltreated offspring who had become depressed during adulthood. Descriptively, depressed 
offspring exhibited a flatter CAR, irrespective of maltreatment status. Moderation analyses 
conducted across the whole sample revealed a significant interaction between childhood 
maltreatment and adulthood depression on cortisol levels at 30 minutes post awakening, B = -
5.2, t = -2.2, p = .028, 95% CI [-9.8, -.58], model R2 = .18, F(4, 64) = 3.6, p = .010, controlling for 
covariates (anti-inflammatory medication, see 3.2.3.1.2), and on CAR AUCG, B = -243.0, t = -2.1, p 
= .036, 95% CI [-469.2, -16.8], model R2 = .12, F(3, 63) = 2.9, p = .04. These analyses also 
confirmed the conditional effect of exposure to maltreatment on 30-minute cortisol levels, B = 
4.0, t = 2.8, p = .007, 95% CI [1.1, 6.8], and CAR AUCG, B = 183.6, t = 2.6, p = .011, 95% CI [42.76, 
324.37], amongst only those offspring who were not depressed in adulthood. Interaction terms 
for cortisol levels and 60 minutes post awakening did not meet statistical significance, B = -3.6, t 
= -1.4, p = .18, 95% CI [-9.0, 1.7].  
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To evaluate further the modulatory effects of adulthood depression, one-way ANOVAs were 
performed (in the whole sample) to compare (i) non-depressed non-maltreated, (i) non-
depressed maltreated, (ii) depressed non-maltreated, and (iv) depressed maltreated offspring. 
There was a significant main effect for cortisol levels and 30 minutes, F[3, 65] = 3.4, p = .021, and 
for CAR AUCG, F[3, 63] = 2.9, p = .040. Gabriel’s procedure post hoc analyses revealed that 
offspring exposed to childhood maltreatment but who were not depressed in adulthood had 
significantly higher 30-minute cortisol (mean difference = 4.2, SE = 1.5, p = .024) and CAR AUCG 
(mean difference = 183.6, SE = 70.4, p = .011) in comparison to those non-depressed and non-
maltreated, and in comparison to those maltreated but also depressed (mean difference = 5.0, 
SE = 1.7, p = .021 and mean difference = 223.4, SE = 80.3, p = .04, respectively). These data 
complement the findings from the split analyses suggesting hyperactivity in the cortisol response 
system amongst maltreated (but not depressed) offspring. Furthermore, they also add to these 
findings by revealing that the experience of depression in conjunction with childhood 
maltreatment leads to blunting of the CAR. In terms of diurnal cortisol levels, no statistical 
differences were observed amongst measures of cortisol through the day, in either the split 





Figure 12. Cortisol awakening response as a function of exposure to childhood maltreatment and 
depression in adulthood, with SE  
 
Note. **Cortisol levels at 30 minutes post awakening were significantly higher amongst non-
depressed, maltreated offspring in comparison with non-depressed, non-maltreated offspring (p 
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3.2.4.2.1 Prenatal maternal depression 
Results from the split group analysis revealed that amongst offspring who were not depressed in 
adulthood, there was a trend for those exposed to prenatal maternal depression to have higher 
overall hsCRP levels, n = 12, M, = 2.8, SD = 2.8, than those not so exposed, n = 37, M, = 1.3, SD = 
1.2, z = -1.7, p = .08. Notably, a significantly greater proportion (41.7%) of offspring exposed to 
prenatal maternal depression had clinically high (≥ 3.0 mg/L) hsCRP compared to offspring not 
so exposed, 10.1%, χ2(1) = 5.8, p = .029, OR = 5.9, 95% CI [1.3, 27.7]. These statistics are 
presented in Figure 13. In contrast, amongst offspring who were depressed in adulthood, there 
were no statistical group differences in hsCRP levels between offspring exposed and not exposed 
to prenatal maternal depression. A moderation analysis on the whole sample revealed a trend 
for an interaction between prenatal maternal depression and offspring depression in adulthood 
on overall hsCRP levels, B = -1.4, t = -1.7, p = .09, 95% CI [-2.98, .01], model R2 = .16, F(4, 73) = 
3.4, p = .01, controlling for covariates (recent stressful life events, see 3.2.3.1.1). 
 
 
3.2.4.2.2 Childhood maltreatment 
There was no effect of exposure to childhood maltreatment on hsCRP levels within either non-
depressed or depressed adult offspring. Moderation analyses did not reveal any evidence of a 




Figure 13. Proportions of non-depressed adulthood offspring with clinically high and low hsCRP 
as a function of exposure to prenatal maternal depression.  
 
Note. *A significantly greater proportion of offspring exposed to prenatal maternal depression 
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3.2.4.3. Metabolic parameters 
 
3.2.4.3.1 Prenatal maternal depression 
Findings from the split analysis did not reveal any effects of prenatal maternal depression on any 
metabolic parameters in either group. Similarly, there was no evidence of any interaction 




3.2.4.3.2 Childhood maltreatment 
The split group analysis revealed a trend for a positive significant effect of childhood 
maltreatment on HbA1c levels amongst offspring not depressed in adulthood, z = -1.7, p = .08. A 
moderation analysis on the whole sample revealed a trend for an interaction between offspring 
childhood maltreatment and offspring depression in adulthood on HbA1c levels, B = -.2, t = -1.8, 
p = .08, 95% CIs [-.43, .02], model R2 = .16, F(5, 71) = 2.6, p = .032, controlling for covariates 



















This thesis used a prospective longitudinal design to investigate the psychological and biological 
adulthood consequences of offspring exposure to maternal depression during gestation. First, 
results of the present study, the 25-year offspring follow-up, as a continuation of the 
prospective longitudinal South London Child Development Study (SLCDS), are summarised. 
Subsequent sections embed these findings into a broader literature context, highlight strengths 
and limitations of the study, as well as provide suggestions for future research. Finally, clinical 
implications are discussed. 
 
 
4.2. Summary of main findings 
 
4.2.1. Adulthood depression 
The findings from this study demonstrate for the first time using a prospective design, that 
offspring exposure to maternal depression in utero predicts clinical depression (DSM-IV MDD, 
dysthymic disorder and depression NOS) during young adulthood (18-25 years). This association 
is independent of the effects of other associated maternal stressors during pregnancy as well as 
offspring characteristics. Moreover, the data reveals this to be a robust effect that exists for 
both categorical diagnoses of depressive disorders and symptom levels. These findings provide 
clear support for the 1st hypothesis of an association between prenatal maternal depression and 
offspring adulthood depression.  
 
When considering the impact of further environmental adversities occurring after birth, the 
results demonstrate that both offspring exposure to childhood maltreatment and maternal 
depression during the childhood years, influence the effect of prenatal maternal depression on 
offspring adulthood depression. That is, when taking these post-birth psychosocial adversities 
into account, prenatal maternal depression alone does not independently predict offspring 
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adulthood depression; rather, offspring childhood maltreatment and post-birth maternal 
depression are found individually to mediate this. Two sets of analyses provide support for this 
finding: (i) mediation analyses and (ii) ANOVA analyses.  
 
These results reveal that mothers who were depressed in pregnancy are more likely to (i) expose 
their child to greater levels of childhood maltreatment, and (ii) have further depressive episodes 
during the offspring’s childhood. Both of these psychosocial adversities subsequently compound 
the risk of the offspring becoming depressed in adulthood. In particular, post-birth 
environmental adversities are found to be distinct psychosocial mechanisms for the transmission 
of gestational stress exposure into risk for depressive psychopathology in young adulthood. 
Overall, these data provide partial support for the second and third hypotheses. Whilst the 
effect of prenatal maternal depression on offspring adulthood depression is not found to be fully 
independent of post-birth environmental insults (hypothesis 2), childhood maltreatment is 
found to contribute detrimentally to this effect (hypothesis 3).  
 
 
4.2.2. Biological sequelae 
At 25 years, a blunted cortisol awakening response (CAR) was correlated with higher overall 
inflammation (high sensitivity C-reactive protein; hsCRP) levels. Amongst metabolic parameters, 
visceral fat deposition (body mass index [BMI], waist circumference [WC]) was positively 
correlated with serum lipid levels (cholesterol [CHOL], triglycerides [TGs], low-density 
lipoprotein cholesterol [LDL-C]). High-density lipoprotein cholesterol (HDL-C) levels were 
negatively correlated with TG levels and physical obesity indices. There was also a positive 
association between higher plasma glucose levels (indexed by glycosylated haemoglobin; HbA1c) 
and serum lipids (CHOL, LDL-C). These results demonstrate significant cohesion amongst 
metabolic syndrome risk parameters. Furthermore, higher visceral fat deposits were positively 
correlated with inflammation levels, but negatively correlated with cortisol levels. These findings 
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provide support for hypothesis 4: alterations in cortisol levels, inflammation and metabolic 
parameters are associated. 
 
 
4.2.2.1. Hypothalamic-pituitary-adrenal axis 
With regard to the ramifications of exposure to maternal depression in utero on cortisol levels at 
25 years, no significant effects were observed. Thus, no support was found for hypothesis 5, that 
prenatal maternal depression predicts altered cortisol levels at 25 years. However, offspring who 
experienced depression during adulthood had lower cortisol levels as indexed by a blunted CAR. 
These data provide partial support for the 6th hypothesis, as they indicate a link between 
adulthood depression and altered cortisol levels. However, this finding was not influenced by a 
history of exposure to prenatal maternal depression. The 7th hypothesis proposed that exposure 
to childhood maltreatment would be associated with altered cortisol levels. Results revealed 
that non-depressed offspring with a history of childhood maltreatment exhibited elevated HPA 
axis activity, as indexed by an increased CAR, whilst depressed maltreated offspring exhibited a 
blunting of the CAR. These findings suggest two important points: (i) that maltreatment leads to 
dysregulation in cortisol activity, showing hyperactivity in the absence of adulthood depression, 
and (ii) that depressive psychopathology contributes cumulatively to dysregulation in the HPA 




Results demonstrated that a significantly greater proportion of non-depressed adult offspring 
who were exposed to prenatal maternal depression had clinically high (≥ 3.0 mg/L) inflammation 
at 25 years in comparison to non-depressed non-prenatally exposed offspring. When testing for 
this association amongst depressed offspring, no evidence for an effect was found. These 
findings provide partial support for the 8th hypothesis – prenatal maternal depression predicts 
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adult offspring inflammation – but do not provide support for the 9th hypothesis: depression in 
adulthood will contribute cumulatively to this effect. The 10th hypothesis proposed that a 
history of childhood maltreatment would predict elevated inflammation at 25 years. Results 
revealed no significant differences in the proportion of offspring with clinically high 
inflammation as a function of maltreatment exposure. However, in regards to overall hsCRP 
levels, offspring not exposed to childhood maltreatment were found to have higher overall 
hsCRP levels compared to non-maltreated offspring. 
 
 
4.2.2.3. Metabolic parameters 
Findings show that offspring experiencing depression (DSM-IV diagnosis) currently at 25 years 
had elevated total CHOL levels, as well as a greater number of cumulative metabolic risk 
parameters, elevated to a clinically abnormal range (indexed by collective metabolic risks index). 
This provides partial support for the 12th hypothesis: combined early life stress and adulthood 
depression will result in the greatest abnormalities in metabolic function. However, there was 
no evidence that exposure to depression during gestation or to childhood maltreatment 
affected metabolic function at 25 years; thus, hypotheses 11 – prenatal maternal depression 
predicts 25-year metabolic abnormalities – and 13 – childhood maltreatment predicts metabolic 
abnormalities at 25 years – were not supported. 
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4.3. Prenatal maternal depression, offspring childhood maltreatment and 
offspring depression in young adulthood 
The finding that offspring exposure to depression in utero predicts depression in adulthood is a 
completely novel finding that has not previously been found in any prospective investigations. It 
extends previous findings from our South London Child Development study which have shown 
that prenatal maternal depression predicts offspring depressive psychopathology (Pawlby et al., 
2009) as well as externalising psychopathology (Hay et al., 2010) in childhood. These results are 
also consistent with the wealth of clinical studies that have demonstrated an association 
between prenatal maternal stress (mood disorders and stressful experiences during pregnancy) 
and offspring emotional psychopathology in childhood (Glover, 2011; O’Donnell, 2010; Van Den 
Bergh et al., 2005; Van den Bergh et al., 2008). Notably, the prevalence of depressive disorders 
amongst adult offspring was fairly high. This finding is consistent with prevalence rates of 
common mental disorders in an urban sample. Indeed, Hatch and colleagues (2012) recently 
found a four-fold greater proportion of depressive disorders amongst residents of south east 
London in comparison with residents across the rest of the England.  It is also possible that this 
high prevalence could reflect intergenerational transmission of depression given the high 
prevalence of maternal depression in this cohort. 
 
 Furthermore, these results extend our previous finding in the South London Child Development 
Study, that mothers who are depressed during pregnancy are more like to have offspring who go 
on to experience childhood physical, sexual abuse and harsh discipline (although not necessarily 
perpetrated by the mother) at 11 years (Pawlby et al., 2011). They demonstrate that prenatal 
maternal depression predicts not only physical and sexual abuse, but also emotional abuse, as 
well as cumulative abuse and neglect up to 17 years of age. These findings are also in line with 
recent findings using data from the Avon Longitudinal Study of Parents and Children (ALSPAC) 
which have revealed that maternal depression and anxiety during pregnancy predict 
victimisation in middle childhood (Lereya & Wolke, 2013). These results inform the discussion 
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about child-driven and maternal-driven mechanisms that likely potentiate this association. The 
fact that offspring who were exposed to maternal depression during gestation reported 
significantly greater emotional abuse than non-prenatally exposed offspring suggests that 
mother-driven effects are just as likely to play a part as play as offspring-elicited punitive 
parenting due to a more externalising temperament: an initial explanation for this association. 
The fact that fathers accounted for a large proportion of the perpetrators of parental emotional 
abuse and neglect does not stand in opposition with a mother-driven effects model. It is quite 
plausible that in instances of paternal emotional abuse, mothers are struggling to protect their 
offspring from this emotional abuse by their partner.  Furthermore, our data are more in line 
with clinical and animal findings which show that prenatally stressed mothers express lower 
maternal care and attachment-related behaviours and attitudes towards their offspring 
(Alhusen, 2008; Champagne & Meaney, 2006; Feldman et al., 2007; Stronach et al., 2011). 
Whether this finding generalises to other forms of prenatal maternal stress remains to be seen; 
yet, this finding identifies prenatal maternal depression as a clear and robust risk factor for child 
maltreatment potential. 
 
The finding that the effects of prenatal maternal depression on offspring depressive 
psychopathology in adulthood were mediated by offspring exposure to childhood maltreatment 
are also consistent with our previous finding that sexual and physical abuse modulated the 
association between prenatal maternal depression and offspring externalising and internalising 
psychopathology at 16 years (Pawlby et al., 2011). It is interesting to note that contrary to our 
findings regarding offspring psychopathology at 16 years, at 25 years we did not find an effect of 
prenatal maternal depression that was independent of the effects of offspring exposure to 
childhood maltreatment. There are several possible reasons for this. One reason could be that 
the definition of child maltreatment in this present study was much broader, encompassing 
emotional abuse and neglect as well as sexual and physical abuse, and also spanned a greater 
time period (birth to 17 years). These differences suggest that the present findings might reflect 
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a more comprehensive account of the role of maltreatment, which was not captured in our 
earlier work when examining the role of sexual and physical abuse and harsh discipline.  
 
These differences could also reflect changes in the nature of psychopathology between 
childhood and adolescence. Indeed, depression tends to rise through the transition from 
adolescence to young adulthood (Costello et al., 2011) as well as being preceded by externalising 
problems in earlier childhood (Hipwell et al., 2011; Plant et al., 2013). This would indicate that 
these findings at 25 years are likely indexing a different form of psychopathology to our findings 
at 16 years. It is also worth noting that at 16 years we assessed depression and conduct disorder, 
whilst at 25 years we assessed only depression. The reason for this is that in childhood antisocial 
behaviour psychopathology such as conduct disorder is classified as an axis I disorder, whilst in 
adulthood antisocial behaviour is classified as an axis II personality disorder, such as antisocial 
personality disorder. Interestingly, the present study’s findings are also in line with those from 
the only other prospective study that has investigated the modulatory effects of environmental 
adversity on the link between prenatal maternal depression and offspring emotionality. Sharp 
and colleagues (H Sharp et al., 2012) found that prenatal maternal depression predicted infant 
negative emotionality only in offspring whose mothers showed low maternal care (low stroking 
behaviour)  
 
The finding that the effect of prenatal maternal depression is mediated by offspring childhood 
maltreatment is also consistent with the wealth of clinical and animal studies demonstrating an 
association between childhood adversity and depressive psychopathology in young adulthood 
(Antonia Bifulco et al., 2002; Green et al., 2010; Keyes et al., 2012; Nanni et al., 2012; Widom et 
al., 2007). The present data add to these findings not only by replicating this robust association, 
but by extending them through highlighting the remarkable similarity in outcomes between 
offspring exposed to prenatal maternal depression and offspring exposed to childhood 
maltreatment, as well as finding evidence for a maltreatment-mediated effect. Moreover, they 
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support the notion that prenatal maternal depression and childhood maltreatment are part of 
the same putative pathway linking early life environmental adversity (gestational and childhood) 
to risk for depression in adulthood. 
 
The results of the present study also demonstrate the important role of maternal depression 
after birth, through the offspring’s childhood years, on offspring depression in adulthood. The 
data demonstrate that depression in the child’s early (4-11 years) and late (11-16 years) 
childhood predicted depression during adulthood. These findings are consistent with 
prospective epidemiological and clinical studies that demonstrate an effect of maternal post-
birth depression on offspring depressive psychopathology (E Barker, Copeland, Maughan, Jaffee, 
& Uher, 2012; Halligan, Murray, Martins, & Cooper, 2007; Mars et al., 2012; Murray et al., 2011).  
Notably however, we find that the impact of post-birth maternal depression plays a mediating 
role in the pathway between prenatal maternal depression and offspring adulthood depression. 
None of the aforementioned studies included measurement of maternal psychopathology 
during pregnancy. Given the strong comorbidity between maternal depression during pregnancy 
and after birth it is likely that many of the reported effects of postnatal depression were also 
indexing the potential confounding effects of prenatal maternal depression that went 
unmeasured. It is also interesting to note that the effects of maternal depression after birth 
have been shown to index further environmental risk factors such as low socioeconomic status, 
low education and family adversity, and that when these factors are taken into account, the 
effect size of maternal depression per se is dramatically reduced (E Barker et al., 2012). This 
suggests that the mediated effect of prenatal maternal depression on offspring adulthood 
depression by maternal post-birth depression characterises risk from mothers who experience 
recurrent depression themselves as well as wider familial adversity. 
 
Overall, the observed links between prenatal maternal depression, offspring childhood 
maltreatment and offspring adulthood psychopathology cast light on the natural course of the 
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development of depressive disorders as a consequence of maternal depression during 
pregnancy. The fact that the data are from a naturalistic birth cohort study is testament to the 
immense ecological validity of these findings. They illuminate two putative pathways linking 
offspring exposure to prenatal maternal depression with depressive disorders in young 
adulthood: (i) the cumulative and mediating effects of exposure to childhood maltreatment and 
(ii) the aggregating effect of further exposure to maternal depression after birth. The fact that 
there is a mediated effect of exposure to prenatal maternal depression on offspring adulthood 
depression, with no direct effect of prenatal maternal depression that is independent of the 
influence of psychosocial adversities after birth means that these data do not conclusively 
support a foetal programming hypothesis. Rather, these data cast light on the developmental 
trajectories linking prenatal maternal depression to offspring adulthood depression. It is likely, 
given a sample size of 103 and the high correlation between exposure to insults prenatally (i.e. 
maternal prenatal depression) and postnatally (i.e. maternal depression in childhood and 
adolescence, offspring childhood maltreatment) that the absence of an independent direct 
effect is an artefact of a low number of cases with only prenatal maternal depression and 
adulthood depression and no further insults after birth. 
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4.4. Reactivity in biological systems 
 
4.4.1. Correlations between HPA axis activity, inflammation and metabolic 
parameters 
The finding that a blunted CAR response is correlated with elevated overall inflammation levels 
is consistent with the literature that proposes that dysregulation in the HPA axis system and 
inflammatory systems are interlinked (A Miller, 2009). Indeed, theory postulates that under 
normal circumstances the HPA axis system and inflammatory system exist in balance with one 
another and chronic stress can disrupt this balance in favour of inflammatory processes at the 
expense of glucocorticoid receptor (GR) signalling (Horowitz et al., 2013). As a blunted CAR is 
indicative of impaired GR-mediated negative feedback, a process commonly referred to as GC 
resistance, this data supports this theoretical premise by demonstrating that abnormalities in GC 
response to the stress of awakening are correlated with elevated hsCRP levels, a marker of 
systemic inflammation. According to this theoretical account, these data are indicative of stress-
induced dysfunction in both systems. Findings for the strong inter-association between 
amplified physiological parameters related to metabolic function are in line with the notion of 
the metabolic syndrome as a clustering of risk factors for cardiovascular disease (CVD). My data 
show that elevated CHOL, TGs, LDL-C, HbA1c, BMI and reduced HDL-C were associated. These 
have been identified previously as markers of the metabolic syndrome and risk factors for CVD 
(Beck-Nielsen, 1999; Ford, 2005; International Diabetes Federation, 2006; World Health 
Organization, 1999). With regards to the relationship between metabolic parameters and 
inflammation and HPA axis function, central obesity (high BMI, large WC) was positively 
correlated with overall hsCRP levels and negatively correlated with cortisol levels. This former 
finding is consistent with existing theory that proinflammatory cytokines are overexpressed by 
adipose tissues in cases of obesity (Emanuela et al., 2012; Hotamisligil et al., 1993). Obesity 
thereby represents a state of chronic low-grade inflammation (Leonard, 2013).  
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GCs have been found to lead to hyperglycaemia, obesity dyslipidaemia and hypertension 
(Reynolds, 2013). Abnormalities in HPA axis function are thought to contribute to cardio-
metabolic risks through hormonal and psychosocial pathways. It has been argued that stress-
induced HPA axis changes can precipitate increase in the intake of high-caloric food (Dallman et 
al., 2003), which may represent one the psychosocial mechanisms linking HPA axis dysfunction 
to adult obesity. In terms of biological mechanisms, Dinan and colleagues (2004) reviewed a 
series of studies demonstrating that excessive HPA axis activity is associated with elevated 
visceral fat deposition, whereby this link was argued to be mediated by the antagonising effects 
on insulin action, thereby inducing insulin resistance (Reynolds & Walker, 2003) and the 
promoting effects on lipoprotein lipase, leading to an increase of storage of TGs and CHOL in 
adipocytes. It is conceivable that all of these mechanisms are at play amongst offspring in this 
study, which could account for the correlation between a blunted cortisol response and visceral 
obesity. It is also possible that interplay between inflammation, HPA axis dysregulation and 
obesity resulted in aggregated enhancing effects on one another. 
 
 
4.4.2. Biological consequences of depression in adulthood 
The present findings demonstrate that offspring who were depressed during young adulthood 
(18-25 years) show a blunted cortisol response to awakening. A dysregulated HPA axis is a well 
documented component of MDD (Pariante & Lightman, 2008). Functional impairment of the 
glucocorticoid receptor (GR) is theorised to be the key candidate mechanism for this 
dysregulation which results in overall functional impairment in HPA axis activity that has most 
commonly been observed to manifest as hypercortisolemia (Bhagwagar et al., 2003, 2005; 
Nemeroff & Vale, 2005; Vreeburg et al., 2009). Yet, hypoactivity has also been observed (Jarcho 
et al., 2013). Whilst these findings might seem paradoxical, impaired negative feedback (as 
evidenced through reduced suppression of cortisol following dexamethasone administration) 
was observed amongst patients who exhibited a hyperactive CAR as well as amongst those who 
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exhibited a blunted CAR. This would suggest that (i) HPA axis dysregulation is the core 
neurobiological facet of depression, (ii) that cortisol levels are merely one index of this wider 
dysregulation and (iii) that the manifestation of this dysregulation in terms of abnormalities in 
cortisol secretion is likely to be modulated by numerous other related factors such as illness 
severity and chronicity as well as other personal characteristic (e.g. age, previous psychiatric 
history), all of which varied in these studies. In light of these facts, the blunted CAR observed in 
this study is viewed as an index of overall HPA axis dysfunction that most likely reflects a state of 
GC resistance. However, without measures of other parameters of GC resistance, such as data 
from a cortisol suppression test, or more direct assessments of GR function like the DNA 
expression status of the GR, the precise underlying mechanisms of impairment remain 
speculative. 
 
The finding that currently (at 25 years) depressed offspring exhibited a greater number of 
clinically elevated metabolic parameters is consistent with existing literature that documents 
high comorbidity between depression and obesity, CVD and the metabolic syndrome (Barth et 
al., 2004; Luppino et al., 2010; Pan et al., 2012). Given the cross-sectional nature of this finding, 
with both metabolic parameters and current depression measured concurrently at 25 years, it is 
not possible to draw conclusions on the directionality of these effects. Nevertheless, this finding 
shows that young adults with a current clinically diagnosed DSM-IV depressive disorder exhibit 
comorbid components of the metabolic syndrome, which are also risk factors for CVD. 
Interestingly, there was no evidence of an association between elevated metabolic parameters 
and the experience of depression earlier during young adulthood (i.e. 18-25 years). One could 
speculate, therefore, that the ramifications of depression on the metabolic profile are short-
lived, whereby changes that may have occurred with the experience of earlier depression have 
dissipated after remission. However, drawing conclusions based on negative findings is 
unjustified, so this remains an anecdotal observation rather than scientific conclusion. 
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4.4.3. Biological sequelae of early life stress 
The impact of early life adversity, namely exposure to prenatal maternal and offspring childhood 
maltreatment, on biological reactivity was modulated by the experience of depression in young 
adulthood. Findings revealed that a significantly greater proportion of offspring who had been 
exposed to prenatal maternal depression had clinically high levels of systemic inflammation at 
25 years compared to offspring who were not so exposed, yet this association was only observed 
amongst offspring who did not experience depression during adulthood. One interpretation is 
that for offspring who did not experience depression during adulthood, these data are indicative 
of the influences of these distal factors in the absence of the impact of more proximal adulthood 
stress (i.e. depression during young adulthood). In contrast, the biological systems of offspring 
who experienced depression in young adulthood would be reflective of the impact of 
depression, given that alterations in the three respective biological systems are reported 
amongst depressed individuals (see 1.9.2, 1.9.6, 1.9.10). Indeed in the present data, offspring 
depression per se was associated with abnormalities in HPA axis function and metabolic 
function. Following this logic, the present findings could be interpreted as demonstrating the 
novel association between prospectively assessed exposure to depression during gestation and 
elevated inflammation 25 years later in adult life. This notion is consistent with recent findings 
from animal and human studies demonstrating that prenatal maternal depression is associated 
with a dysregulated immune response and systemic inflammation (Diz-Chaves et al., 2013; 
Entringer, Kumsta, et al., 2008; O’Connor, Winter, et al., 2013). It is hypothesised that prenatally 
depressed mothers would have elevated inflammation and HPA axis activity, both of which 
could operate as candidate mechanisms for the programming of foetal immune reactivity and 
HPA axis-inflammatory dysregulation. 
 
In line with this premise, we would predict that offspring exposed to prenatal maternal 
depression would also exhibit dysregulation in HPA axis activity. In the current findings, there 
was no statistical effect for the influence of exposure to prenatal maternal depression on HPA 
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axis activity, although there was a pattern for non-depressed offspring exposed to prenatal 
maternal depression to show an elevated CAR.  
 
In contrast, there was a significant effect of offspring exposure to childhood maltreatment on 
HPA axis function, as indexed by a heightened CAR amongst non-depressed maltreated offspring 
and a blunted CAR amongst depressed maltreated offspring. This data is in line with existing 
human and animal literature documenting abnormalities in HPA axis activity as a function of 
exposure to maltreatment as well as the experience of depression (Bhagwagar et al., 2005; De 
Bellis et al., 1994; de Kloet & Oitzl, 2003; Francis et al., 1999; Heim et al., 2002; Jarcho et al., 
2013; Pariante & Lightman, 2008). One possible explanation for these findings is that they reflect 
the impact of cumulative exposure to chronic psychosocial adversities. That is, in the absence of 
adulthood depression, maltreatment is associated with hypercortisolemia, which likely reflects a 
state of GC resistance. In individuals who experienced both childhood maltreatment and 
depression during adulthood, the hypoactivity in the HPA axis may reflect severe dysregulation 
and system exhaustion. Indeed, several studies have demonstrated that in the context of chronic 
trauma hypoactivity is observed (Hart et al., 1996; G. Miller, Chen, & Zhou, 2007).   
 
This account is in line with the theoretical premise of biological sensitivity to context (BSC) 
advocated by Ellis and colleagues (2008). BSC theory proposes that adaptive phenotypic 
plasticity, the capacity for a single genotype to support a range of phenotypes in response to 
particular ecological conditions, is malleable to the environmental conditions within which an 
organism develops. Importantly, BSC articulates a U-shaped neurobiologically-mediated 
sensitivity to context which enables an individual to match their biological and behavioural 
systems to the parameters of their developmental environments. Ellis and colleagues (2005) first 
found evidence for this curvilinear phenomenon when studying stress reactivity in children 
exposed to varying degrees of stressful family environments. They observed that the level of 
stress reactivity in the children followed a U-shaped pattern as the level of enrichment in the 
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environment decreased and adversity increased. BSC could therefore explain why maltreated 
children who differ in their experience of later depression show stress responses of opposite 
valence.  
 
An alternative explanation for the opposing effects of maltreatment amongst depressed and 
non-depressed offspring could be that the blunting observed amongst maltreated depressed 
offspring could reflect the overall dysregulation (in this case hypoactivity) that was observed 
amongst all depressed offspring. That is, the influence of this proximal stress, depression, could 
“trump” alterations precipitated by early insults. Nevertheless, irrespective of this latter 
interpretation whereby the biological sequelae in depressed maltreated individuals reflects 
perpetuated stress exposure or the effects of adulthood depression per se, the fact that non-
depressed maltreated offspring exhibited a significantly different CAR from non-depressed non-
maltreated offspring, suggests that exposure to maltreatment itself results in neurobiological 
changes to the function of the HPA axis that persist into young adulthood. 
 
In this study there was no evidence of an association between exposure to childhood 
maltreatment and high inflammation levels as documented in other clinical cohorts such as the 
Dunedin Multidisciplinary Health and Development Study (DMHDS; Danese et al., 2008, 2007). 
Possible reasons for this could include the fact that individuals in the DMHDS were older (32 
years of age). The pathophysiological process of establishing persistently high levels of systemic 
inflammation may require a lengthier period of time between insult and observation. 
Furthermore, the definition of child maltreatment in the DMHDS was broader, encompassing 
indices of maternal rejection, ratings of mothers’ interaction with the index child, harsh 
discipline, and disruptive caregiver changes, in addition to reports of sexual and physical abuse. 
It is possible that these differences may account for the lack of evidence in our sample of an 
association between childhood maltreatment and clinically high levels of inflammation. 
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The fact that no link between early life adversities and markers of the metabolic syndrome were 
observed could be attributed to differences in the nature of sample and measurement methods 
of the present study compared to those of published studies that do report such an association. 
For example, the studies conducted by Barker and colleagues (D Barker, Gluckman, et al., 1993; 
D Barker, Hales, et al., 1993) demonstrating an association between low birth weight and 
dyslipidaemia and impaired glucose tolerance, comprised adults who were in their late stages of 
adulthood. It is likely that these documented associations could be a consequence of enduring 
sequelae that built up over the course of adulthood, which may not have been detectable in the 
mid-twenties, the age of the participants in the present study. Furthermore, in the retrospective 
study carried out by Entringer and colleagues (2008) into the effects of prenatal maternal stress 
on offspring glucose metabolism, an effect was observed for the glucose tolerance test but no 
differences were observed for plasma glucose levels. This suggests that effect sizes are small and 
require a higher level of power for differences to be detected. 
 
Studies that have documented an association between childhood maltreatment and metabolic 
parameters have reported effects of physical and sexual abuse on BMI, but not other forms of 
abuse or neglect (Irish et al., 2010; Norman et al., 2012; Williamson et al., 2002). Moreover, an 
association between childhood maltreatment and hyperglycaemia was observed amongst 
middle-aged adults (Midei et al., 2013; Thomas et al., 2008). It is possible that in the present 
study the wider definition of maltreatment that encompassed physical, sexual, and emotional 
abuse as well as neglect, in conjunction with a younger age at the time of sampling could 





4.5. Methodological limitations and directions for future research 
Alongside the numerous strengths of this study, such as the use of a prospective design starting 
in pregnancy through 26 years to chart offspring development, and the collection of data 
through one-to-one interviews from which clinical diagnoses of DSM-IV diagnoses were rated, 
there are limitations that need to be highlighted. 
 
First, the use of a longitudinal birth cohort study design meant that the group sizes for the 
variables of interest could not be selected artificially as would have been done in an 
experimental design. As a consequence, it is plausible that some of the results are skewed by 
uneven sample sizes. Whilst, statistical techniques were applied to correct for these differences, 
this came at the expense of reduced power, thereby increasing the likelihood of type II error. 
Furthermore, it has frequently been observed that risk factors often aggregate. This means that 
it was difficult to separate out the effects of particular risks, for example different abuse types 
when examining the effect of childhood maltreatment, as the group sizes would have become 
too small to yield any meaningful results. The converse of this phenomenon is that the study has 
strong ecological validity and illuminates natural risk trajectories, but also means that there is 
the risk of residual confounding from factors that have gone unmeasured. However, in an 
attempt to control for this, as many potential associated risks were included in initial univariate 
analyses. 
 
A second limitation is the relatively small sample size. Given that a wide range of influences 
spanning over 25 years were investigated, a sample size of just over one hundred for the 
psychopathology analyses, and circa seventy for the physiological analyses, means that it was 
not possible to discern all potential risk influences. For example, in the biological reactivity 
analyses, the ideal analysis strategy would be to separate offspring groups based on the three 
main factors of interest, prenatal maternal depression, offspring childhood maltreatment and 
adulthood depression. However, this resulted in group sizes of miniscule numbers. The effects of 
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prenatal maternal depression and offspring childhood maltreatment were thus conducted 
separately. The small sample size also meant that analyses were not separated by gender, which 
could be a moderating factor for some effects. 
 
Third, the SLCDS is drawn from an urban, predominantly working class population of families of 
White ethnic origin. Thus, these results may not be representative of the wider UK population. 
Indeed, this limitation is linked to the fact that psychosocial vulnerabilities for depression, such 
as the impact of a problem partner interaction, lack of support, and low self-esteem, in line with 
Brown and colleagues’ (G. W. Brown & Harris, 1986; G. W. Brown & Prudo, 1981) 
stress/vulnerability model, were not directly tested in this thesis. Given the nature of the 
sample, the decision was made to investigate the impact of gross psychosocial adversities, such 
as experiences of severe abuse and neglect. 
 
Fourth, the majority of mothers were diagnosed with ICD-9 neurotic depression during 
pregnancy. It is worth noting that this diagnoses states that along with depressed mood, anxiety 
is frequently present in this categorisation, and that mixed states of depression and anxiety are 
classified as “neurotic depression” (World Health Organization, 1978). Whilst maternal anxiety 
during pregnancy was explicitly measured using the Leeds Anxiety Scale, and accounted for in 
analyses, it is still possible that some of the observed foetal programming effects can be 
attributed to mixed states of maternal depression and anxiety during pregnancy. 
 
Fifth, participants varied in the length of time between interview and returning their saliva 
samples. It was also not possible to be sure how closely participants adhered to the time 
schedule for the collection of their samples. There was a high use of medication with anti-
inflammatory effect, with a large proportion of girls using hormonal contraception. Given the 
high proportion of medication use, exclusion of these participants would have considerably 
reduced the sample size. For future analyses it may be better to exclude participants with 
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medication use that may be particularly problematic to cortisol levels (e.g. anti-inflammatories, 
asthma inhalers, cortisone cream). Nevertheless, there were no significant statistical outliers in 
raw cortisol values among those who used medication in my reported significant findings. 
 
Sixth, information about offspring lifestyle factors such as consumption of fast food, smoking, 
drinking and exercise habits were collected through a schedule devised for the study asking 
participants to provide personal weekly estimates. In hindsight, the study would have benefited 
from a more formal quantification of these behaviours based on concrete examples for each day 
of the past week. This would have increased reliability and validity of these measures. 
 
Seventh, the fact that assessment of antisocial psychopathology in adulthood consists of 
generating Axis II personality disorders means that I was not able to extend earlier findings at 16 
years in this domain. Given that only Axis I disorders was assessed at 25 years the findings relate 
only to depressive disorders. Indeed, at 16 we found that maltreatment moderated the effects 
of prenatal depression on offspring psychopathology, with this effect being strongest for 
antisocial psychopathology, namely for offspring with a conduct disorder diagnosis. 
 
Finally, it would have been useful to take into account possible genetic contributions to offspring 
vulnerability to depression and physiological characteristics. This data would have helped to 
distinguish between observed programming effects and possible genetic predispositions.  
 
Future research would benefit from examining psychosocial and biological mechanisms linking 
prenatal maternal depression to offspring child maltreatment. Identification of such pathways 
would provide the opportunity for the provision of preventive interventions. Furthermore, the 
role of fathers in the association between prenatal maternal depression, offspring childhood 
maltreatment and offspring depression would cast light on other psychosocial mechanisms at 
play. Also, given the high comorbidity between depressive and anxiety disorders, studies should 
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examine the impact of prenatal maternal stress on the development of each, when controlling 
for the other. This would illuminate whether prenatal maternal stress represents a risk 
specifically for offspring adulthood depression or for a more generalised vulnerability for 
internalising psychopathology. 
 
To cast light further on the neurobiological mechanisms underpinning the link between prenatal 
maternal depression and offspring psychopathology, longitudinal studies should measure GCs, 
inflammatory markers and metabolic parameters in pregnant women in addition to 
psychological measures of stress. Research would also benefit from discriminating the 
neurobiological effects of prenatal maternal depression from childhood maltreatment, and also 
from considering the cumulative effects of both. This would provide important theoretical 
information on the putative biological mechanisms underpinning the link between early life 
adversity and stress reactivity and cardio-metabolic dysfunction. 
 
Future studies should also consider a wider range of markers of inflammation including a battery 
of cytokines, chemokines and adhesion molecules. It would also be worth investigating the 
epigenetic changes in gene expression particularly for genes relating to the GR receptor. Animal 
studies have shown down-regulation of candidate genes for the GR as a function of exposure to 
maternal depression in utero. Human evidence for this mechanism would provide greater insight 
into the function mechanisms underpinning HPA axis dysregulation in offspring exposed to 
prenatal maternal stress. 
 
Finally, neuroimaging studies into the functional and structural changes that may occur as a 
consequence of exposure to prenatal maternal stress may provide biological correlates for the 




4.6. Clinical implications 
The findings of this thesis have significant implications for policy and clinical practice. Until 
recently, UK policy primarily advocated the screening of maternal depression during the 
postnatal period. In the last few years there has been a shift in focus to the prenatal period. 
Indeed, a recently released UK cross-party manifesto, “1001 Critical Days: The Importance of the 
Conception to Age Two Period. A Cross-Party Manifesto” (Leadsome, Field, Burstow, & Lucas, 
2013) advocates the importance of addressing maternal mental health issues during pregnancy 
to ensure the healthy development of the child. Previously published findings from the SLCDS 
have contributed to this manifesto, and results from the current 25-year phase provide clear 
evidence for the long-term detrimental effects of untreated maternal depression specifically 
during pregnancy.  
 
My findings demonstrate that untreated prenatal maternal depression predicts offspring child 
maltreatment and depression during young adulthood, with ramifications for offspring 25 years 
after mothers were first identified as depressed. By intervening during pregnancy, the 
prevalence of child maltreatment could be reduced, as well as rates of affective disorders in the 
young adult population. Targeting prenatal maternal depression during pregnancy could 
increase the wellbeing of our offspring as well as reduce the financial burden on the NHS due to 
the high prevalence of depression amongst our youth. All pregnant women should be screened 
for depression early on during their pregnancy and offered support and monitoring from 
professionals such as midwives and general practitioners, as well as being prioritised for access 
to psychological therapies for the treatment of depressive episodes.   
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4.7. Conclusions 
In summary, several novel findings emanate from the data of this PhD thesis. Offspring exposed 
to maternal depression during gestation were found to experience significantly more episodes of 
clinically diagnosed depression during young adulthood. Key pathways comprised an increased 
risk of exposure to maltreatment, as well as further exposure to maternal depression during 
childhood, both of which contributed additively to the heighted risk of suffering depression as a 
young adult. Furthermore, offspring exposed to prenatal maternal depression were observed to 
show elevated levels of systemic inflammation, whilst offspring exposed to childhood 
maltreatment exhibited abnormalities in their HPA axis activity. Dysregulation in both of these 
systems has been shown to be involved in the pathogenesis of depression. This observed 
biological dysfunction likely represents biological embedding of psychosocial stress into risk for 
depressive psychopathology. Overall, these findings demonstrate that exposure to prenatal 
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What are the young adult health outcomes for the children of the South London Child 
Development Study? 
 
Invitation paragraph  
We would like to invite you to participate in the eighth phase of the South London Child 
Development Study, which you and your family have been a part of since before your birth. We 
remain greatly appreciative of your willingness to participate in previous stages of our research 
study. Before you decide, you need to understand why the research is being done and what it 
would involve for you. Please take time to read the following information carefully. Talk to 
others about the study if you wish. Part 1 tells you the purpose of this study and what will 
happen to you if you take part. Part 2 gives you more detailed information about the conduct of 
the study. Please ask us if there is anything that is not clear or if you would like more 





What is the purpose of the study? 
We have been interested in investigating your personal development, social and family life, 
cognitive development and emotional well being from your birth until adolescence. We are now 
interested in examining your adulthood development. 
 
Why have I been invited? 
You have been invited to participate as you have taken part in at least one of the previous study 
sessions of the South London Child Development Study, and we would like to visit you now that 
you are an adult. 
 
Do I have to take part? 
No, it is up to you to decide. We will describe the study and go through this information sheet, 
which we will then give to you. We will then ask you to sign a consent form to show you have 
agreed to take part. You are free to withdraw at any time, without giving a reason. 
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What will happen to me if I take part? 
Participation in this phase of the study will be similar to previous stages that you have taken part 
in. We will invite you to visit us, or request your permission to visit you in your home for a 2-3 
hour interview session. We will also arrange a visit with your mother/parental figure, but that 
will take place at a different time. During the visit we will interview you about your emotional 
well-being, your relationship with your mother/parental figure, your social and occupational life 
and assess your cognitive abilities. We will also measure your weight, height, waist 
circumference and stress levels by taking a blood sample and saliva sample. 
The interview will be conducted by a trained researcher and will be scheduled for a time that is 
convenient to you. During the interview we will use a mixture of questionnaires and interviews. 
You will not have to answer any questions which make you feel uncomfortable, and you will be 
able to stop the interview whenever you wish. We will ask for your permission to audio-record 
the interviews, and these recordings will be deleted once we have transcribed them. We will 
also take a blood sample to look at hormone and protein levels and DNA for genetic studies 
(30mls blood – about 2 tablespoons) and a saliva sample to look at proteins relevant to 
inflammation. You will be asked to provide 6 specimens of your saliva on one day during the 
week after our visit. You will be shown how to do this during the assessment visit. We are 
looking at cortisol (“stress hormone”) levels in saliva. 
Everything that you tell us during the assessment session will remain confidential between 
yourself and us. The only exception would be if there was something that would pose a danger 
to yourself or someone else, in which case we may need to contact another professional body 
such as your GP 
 
Expenses and payments 
You will receive £50 for participating, plus we will reimburse your travel expenses. 
 
What will I have to do? 
If you wish to take part in the study, you will be asked to sign the consent form at the end of this 
document; you will be given a copy to keep. You should be prepared to undertake the study 
visits, as detailed above, in the research lab or in your own home. If you have recent or current 
participation in other research studies please consider whether you should also participate in 
this study. 
 
What are the possible disadvantages and risks of taking part? 
You may experience some minor discomfort and/or bruising from the blood sample. 
 
During the study, it is possible that other conditions are discovered of which you were unaware, 
which may have implications for your future health, or otherwise impacts on your interests. If 
anything is identified, your GP will be informed, with your agreement. 
 
What are the possible benefits of taking part? 
There are no direct benefits to you of taking part in the study; however the knowledge gained 
from this study may be of help to other people in the future. 
 
What do I do if I want to withdraw from the study? 
You are free to withdraw from the study at any time you like. You will not be required to give us 
any reasons for withdrawal. 
 
What if there is a problem? 
Any complaint about the way you have been dealt with during the study or any possible harm 
you might suffer will be addressed; detailed information on this is given in Part 2. 
 
Will my taking part in the study be kept confidential? 
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Yes. We will follow ethical and legal practice and all information about you will be handled in 
confidence; details are included in Part 2. 
 
 
If the information in Part 1 has interested you and you are considering participation, please 
read the additional information in Part 2 before making any decision 
Part 2 
 
What will happen if I don’t want to carry on with the study? 
Should you wish to stop participating in the study, in addition to withdrawing yourself from the 
study, you have the right to withdraw any data/information you have provided up until it is 
included in final report that have been submitted for publication. We will start to write-up our 
findings within the year after completing the study, so you can request your data be withdrawn 
within this time period. After publication we will not be able to withdraw your data from the 
published articles, but we will still be able to withdraw it from the study database to prevent its 
future use. 
 
What if there is a problem? 
If you have a concern about any aspect of this study, you should ask to speak to the researchers 
who will do their best to answer your questions (tel. 0207 848 0353). If you remain unhappy & 
wish to complain formally, you can do this through the King’s College Complaints Procedure; 
details can be obtained from the college. 
 
Will my taking part in the study be kept confidential? 
Yes, your confidentiality will be safeguarded during and after the study, which is conducted in 
accordance with the Data Protection Act 1998.  The same identification code used at previous 
study phases will be allocated to you. We will use this ID code to label your questionnaires, 
interviews and biological samples, and your personal details will not be linked to the information 
you give us, nor will they be shared with anyone outside of the research team. The information 
we collect will be recorded and put into electronic databases using this code rather than your 
name. Paper and electronic records are stored securely to which only the study researchers will 
have access. The custodian of all study materials is Dr Susan Pawlby (Chief Investigator).  
 
Study data will be analysed and results will be submitted for publication; your identity will not 
be revealed. Study data will be retained and may be used in future studies, if this happens, 
further Research Ethics Committee approval will be sought. Authorised persons such as 
researchers, sponsors, regulatory authorities and Research and Development audit will have 
access to view identifiable data, for monitoring of the quality of the research. Study data will be 
retained for 10 years after completion of the study; and will be disposed of securely. You have 
the right to check the accuracy of data held about you and correct any errors according to local 
law and procedures. 
 
What will happen to any samples I give? 
All samples will be processed then stored prior to analysis using the identification code already 
described. The researchers and laboratory scientists will have access to the samples, and the 
researchers will link your other study data to data from the analysis of your sample by the 
identification code. Blood and saliva samples will be kept for three years. 
 
Will any genetic tests be done? 
Yes, we will look at genetic material (DNA) which might be relevant to the development of 
stress, inflammation, emotional and behavioural problems. 
 
What will happen to the results of the research study? 
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The data and results from this study may be published in medical journals or used in scientific 
reports and may be communicated to the regulatory authorities. You will not be identified by 
name. Once the study has been completed, a report of the findings will be prepared for 
participants and will be posted to you upon completion of the study. 
 
Who is organising the research study? 
The chief investigator, Dr Susan Pawlby, is organising the research, which is sponsored by the 
Institute of Psychiatry, King’s College London. The study is funded by the Psychiatry Research 
Trust charity. This phase of the study is being carried out as PhD project. The researchers 
involved in conducting this study to not receive any financial incentives for including you in this 
study and do not benefit financially from this study.  
 
Who has reviewed the study? 
This research has been looked at by an independent group of people called a Research Ethics 
Committee to protect your safety, rights, wellbeing and dignity. This study has been reviewed 
and given favourable opinion by the London – Camberwell St Giles Research Ethics Committee. 
 
 
Further information and contact details 
 
Primary contact: Dominic Plant (02078480353 or 07574682067 or dominic.plant@kcl.ac.uk) 
 
Secondary contact: Dr Susan Pawlby (02078480353 or susan.pawlby@kcl.ac.uk) 
 
 
Thank you for reading this information sheet. 
  
205 








Study Title: What are the young adult health outcomes for the children of the South 
London Child Development Study? 
Participant Identification Number:   Initial 
I confirm that I have read & understood the participant information sheet 
dated 05.01.12 for the above study. I have had the opportunity to consider 
the information, ask questions & have had these answered satisfactorily. 
 
I understand that my participation is voluntary & that I am free to withdraw 
at any time without giving any reason and without medical care or legal 
rights being affected. Furthermore, I understand that I will be able to 
withdraw my data up until publication of the study findings. 
 
I agree to be contacted in the future by King’s College London researchers 
who would like to invite me to participate in follow up studies to this 
project, or in future studies of a similar nature. 
 
I understand that information held by the NHS and maintained by the 
Information Centre may be used to keep in touch with me 
 
I agree to give either a sample of blood or cheek swab, and saliva samples 
for research in the above project. I understand how the sample will be 
collected, that giving the sample is voluntary and that I am free to withdraw 
at any time without giving a reason, and without my medical treatment or 
legal rights being affected. I understand that the blood and saliva samples 
will be kept for the duration of the project (3 years) 
 
I understand that research using the sample I give will involve genetic 
analysis aimed at understanding the role of genes in stress and health, that 
the data produced are for research rather than clinical purposes, and that 
these results will have no implications for me personally 
 
I understand I will not receive any 'test' results from this study, because the 
assessment I will undergo, does not produce clinically relevant information 
but just research data. The project newsletter will describe the general 
importance of any research results obtained. 
 
I agree that the research team may use my data for future research and 
understand that any such use of identifiable data would be reviewed and 
approved by a research ethics committee.  (In such cases, as with this project, 
data would not be identifiable in any report). 
 
I understand that the information I disclose will be treated as strictly 
confidential, with the exception of something that may pose a danger to 
myself or others, in which case a relevant third party such as my GP may be 
contacted. 
 
I agree to take part in the above study.  
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Name of participant: __________________________________ 
 
 
Signature of participant: __________________________________ Date:  
 
 
Name of researcher:  __________________________________ 
 
 








South London Child Development Study 




Date of interview dd/mm/yy  
……/.….../…… 




Section A: Background Information 
 
Questions should be completed prior to the interview and clarified with interviewee 
 
1 Interviewer’s name (code) 
(DP=1; SP = 2; JW = 3) 
 










4 Gender:       
                         M           F 






         
Codes:  
 
-8 if not answered/not applicable 
-9 if missing  
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I am now going to ask you about your living circumstances and current relationships.  
 
Do you live alone? Who else lives with you? (If you are a student who has a term-time and 
fixed home address please describe your home/family residence) 
8a No = 0 
Yes = 1 
 
 i) Name  
(in full) 
ii) Sex iii) Relationship to you 
(use codes below) 
iv) Age (DOB 
if offspring) 
b     
c     
d     
e     
f     
g     
 
 Code Relationship  
  1 Biological mother 
 2 Biological father 
 3 Stepmother 
 4 Stepfather 
 5 Foster/adoptive mother 
 6 Foster/adoptive father 
 7 Biological sibling 
 8 Half brother/half sister 
 9 Biological child (offspring) 
 10 Adoptive child 
 11 Foster sibling 
 12 Grandparent 
 13 Partner 
 14 Other 
 
 
9 What type of housing are you living in now? (Circle one code) 
 Owner/occupier 1 Rented from local authority 5 
 Privately rented 2 Temporary accommodation 6 
 Shared ownership (part buy/rent) 3 Living with parents/family home 7 
 Rented from housing association 4 na -8 
 
10 How would you describe your current marital status? Code (circle) 
 Single 0 
 Married 1 
 Partner (co-habiting) 2 
 Partner (not-cohabiting) 3 
 Widowed: single 4 
 Widowed: remarried 5 
 Widowed: cohabiting 6 
 Divorced: single 7 
 Divorced: remarried 8 
 Divorced: cohabiting 9 
209 
 Separated: single 10 
 Separated: remarried 11 
 Separated: cohabiting 12 
 Other ……………………………………….. 13 
 n/a -8 
   
11 If not single - How long have you been with your current partner? Code (circle) 
 < 1 year 0 
 1-2 years 1 
 > 2 years 2 
 N/a -8 
   
 
12a Do you have a child that doesn’t live with you? Code (circle) 
 No 0 
 Yes 1 
b Yes: lives with partner 1 
 Yes: lives with relatives 2 
 Yes: state care 3 
 Yes: other [state] ………………………………. 4 
 N/A -8 
 
13i Do you have a child; if so how many? Code (circle) 
 No 0 
 Yes 1 
ii Enter number  
 N/A -8 
   
14 Is your current partner the father/mother of x? Code (circle) 
 No 0 0 0 
 Yes 1 1 1 
 N/A -8 -8 -8 
   
19 Does your partner work? Code (circle) 
 NO 0 
 Yes, part time (<20 hrs/week) 1 
 Yes, full time 2 
 Studying 3 
 Other ………………………………………………... 4 
 N/A -8 
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20 Where was your partner born? Code (circle) 
 UK 0 
 Europe 1 
 Ireland 2 
 West Indies 3 
 Africa 4 
 Bangladesh 5 
 Pakistan 6 
 India 7 
 Cyprus, Turkey, Greece 8 
 New Zealand, Australia, Canada, USA, SA 9 
 Other [state] ………………………………. 10 
 N/A -8 
 
21 How would you describe your partner’s ethnicity? Code (circle) 
 White British 0 
 White Other 1 
 Black: Black British (born in UK) 2 
 Black British / Caribbean 3 
 Black British / African 4 
 Mixed: Mixed White & Black Caribbean 5 
 Mixed White & Black African 6 
 Mixed White & Asian 7 
 Asian: Asian - Indian 8 
 Asian - Pakistani 9 
 Asian - Bangladeshi 10 
 Chinese 11 
 Other [state] ……………………………………… 12 
 n/a -8 
   
 
22 How old was your partner when X was born? Code 
(1 column/child) 
22a 22b 22c 
 Enter age    
 n/a -8 -8 -8 
   
23 How old where you when you had X? 23a 23b 23c 
 Enter age    
 n/a -8 -8 -8 
     
24a Have you had any previous pregnancies?    
 No 0 0 0 
 Yes 1 1 1 
 Na -8 -8 -8 
24b If yes, how old were you?    
 (Record age)    
     
24c If yes, what was the outcome?    
 Termination 1 1 1 
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 Miscarriage 2 2 2 
 Still birth 3 3 3 
 Other ………………………………………………….. 4 4 4 
 Na -8 -8 -8 
     
 
Education, Employment & Earnings 
 
                 ’    k     k  w  b                                         p           /   
student activities. 
25 Please list ALL qualifications , INCLUDING details of course, university etc 
 No qualifications 1 
 Some GCSEs 2 
 A Levels 3 
 BTech / NVQ levels 1-3 (apprenticeship) 4 
 Professional Qualification without degree (e.g. HND, SRN) 5 
 University degree 6 
 Post bachelors (i.e. Masters/PhD) 7 
 Other ………………………………………. 8 
 na -8 
   
26a Are you currently working?  Code (circle) 
 No 0 
 Yes 1 
b Ft (1) or PT (2) 1/ 2 
 na -8 
   
27 When was your first job? (include temporary work/holiday etc) Code (circle) 
 <16 (i.e. during school) 1 
 16-17 2 
 18-19 3 
 20-21 4 
 22-23 5 
 24-25 6 
 >25 7 
 Never worked 8 
 Na -8 
28a Have you had any period of unemployment when you were not studying 
or travelling? (total number of months). How long? 
Code (circle) 
 No; Always either employed/studying/travelling 0 
 Yes 1 
b <6 months 1 
 6-12 months 2 
 12-18 months 3 
 18-24 months 4 
 <24 months 5 
 na -8 
29a Have you ever been dismissed from a job? Code (circle) 
 No 0 0 0 
 Yes 1 1 1 
29b Yes: minor misconduct [state] ………………………………… 1 1 1 
 Yes: gross misconduct [state] ……………………………………. 2 2 2 
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 Resignation [state] ……………………………….…………. 3 3 3 
 Redundancy  4 4 4 
 na -8 -8 -8 
30a Are you currently receiving any of the following government benefits? Code  
(-8 if na) 
 No 0 
 Yes 1 
30b Council tax benefit 1 
 Child benefit 2 
 Tax credit 3 
 Invalidity benefit 4 
 Housing benefit  5 
 Job seekers allowance 6 
 Income support 7 
 Disability living allowance 8 
 Incapacity benefit 9 
 Hardship fund 10 
31 What is your approximate household annual income (include partner’s if 
living with partner or parents) GROSS, pre-tax 
Code 
 Up to £10,000 1 
 £11,000 - £20,000 2 
 £21,000 – £30,000 3 
 £31,000 – £40,000 4 
 £41,000 – £50,000 5 
 £51,000 - £60,000 6 
 £61,000 - £70,000 7 
 £71,000+ 8 
 na -8 
   
32 Do you have financial problems that you consider unmanageable? Code 
 No 0 
 A few 1 
 A lot 2 




Appendix D: Lifestyle and health schedule 
Health Behaviours 
35a Do you exercise regularly Code 
 No 0 
 Yes 1 
 Na -8 
35b If yes, how often per week on average?  
 Less than once a week 1 
 1-2 times per week 2 
 3-4 times per week 3 
 Almost everyday (5-7) 4 
 NA -8 
   
   
35c What kind of exercises do you do? (code all)  
 Run/jog 1 
 Weights 2 
 Swim 3 
 Walk 4 
 Row 5 
 Cycle 6 
 Other 7 
 Na -8 
   
36 How often do you eat take-out/ready meals per week  
 Less than once per week 0 
 1-2 times per week 1 
 3-4 times per week 2 
 Almost every day (5-7) 3 
 More than once a day 4 
 N/A -8 
   
37a Do you currently smoke?  
 No 0 
 Yes 1 
 N/A -8 
   
37b If yes, on average how many per day?  
 <5 1 
 >6<10 2 
 >11<15 3 
 >16<20 4 
 >21 5 
   
37c Did you used to smoke?  
 No 0 
 Yes 1 
 N/A  
   
37d Previous smoking duration? (code if 1 month or more)  
 < 1 year 1 
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 1-2 years 2 
 >  2 years 3 
 NA -8 
38a Do you drink?  
 No 0 
 Yes 1 
 Na 2 
   
38b If yes, on average how many nights per week?  
 Less than once per week 1 
 1-2 times per week 2 
 3-4 times per week 3 
 Almost every day (5-7) 4 
 N/A -8 
 
 
 CURRENT MEDICATION 
34. Are you currently taking any medications, including oral medication 
(including dietary  supplements), creams and inhalers? 
          0 = No      1 = Yes 
a)  Drug Name_____________________________________________________________ 
i)   Dose (mg/day) ___________ 
ii)  Start date (month / year) ______________ / ______________ 
iii) Route of administration: ______________ 
 
b)  0 = No      1 = Yes 
Name_____________________________________________________________ 
i)   Dose (mg/day) __________ 
ii)  Start date (month / year) ______________ / ______________ 
iii) Route of administration: ______________ 
 
c)  0 = No      1 = Yes 
Name_____________________________________________________________ 
i)   Dose (mg/day) ___________ 
ii)  Start date (month / year) ______________ / ______________ 
iii) Route of administration: ______________ 
 
d)   Record any other drugs here in the same way 




Appendix E: Life events schedule 
Life Events   
 
7)  ’    k           b               b         p        v                                       
w    16          .   ’   p                           k b  k  v       w     9      p     .  ’     v  
          x  p           k   ’             ’      k      . 
 
Code: 0 = Not at all distressing 
 1 = Mildly distressing 
 2 = Moderately distressing 






0 = no; 1 = 
yes; don’t  




Details of event Distress 
(1 column/ 
event) 
Ai) Bi)     Aii) Bii) 
7a) A serious illness 





       
b) A serious illness or  
injury to a close       






       
c) The death of a     






       







       
e) Separation from       







       







       
g) A serious problem 
with a close friend, 
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h) Been unemployed/    
seeking work for         






       
i) Been sacked from 







       








       







       
l) Had something          








       







       
EXTRAS: (enter 
number) 
        
   
 




Appendix F: Structured Clinical Interview for DSM-IV Axis I 
Disorders, Clinician Version  (SCID-CV) – mood disorders section 
 
STRUCTURED CLINICAL INTERVIEW 
 
FOR DSM-IV AXIS I DISORDERS 
 
 
A. MOOD EPISODES 
  
 
CURRENT MAJOR DEPRESSIVE EPISODE CRITERIA 
 
 
Now I am going to ask 
you some more 
questions about your 
mood. 
(A)  Five (or more) of the following symptoms have been present 
during the same 2-week period and represent a change from 
previous functioning; at least one of the symptoms is either (1) 
depressed mood or (2) loss of interest or pleasure. 
 
A1    In the past month . . 
.    
 
… has there been a 
period of time when you 
were feeling depressed 
or down most of the day 
nearly every day?  (What 
was that like?) 
 
IF YES: How long did it 
last? (As long as 2 
weeks?) 
 
(1) depressed mood most of the day, nearly every day as 
indicated by either subjective report (e.g., feels sad or 




?  -   + 
A2   . . . what about 
losing interest or 
pleasure in things you 
usually enjoyed? 
 
IF YES: Was it nearly 
every day? How long did 






(2) markedly diminished interest or pleasure in all, or 
almost all, activities most of the day, nearly every day (as 
indicated by either subjective account or observation 























FOR THE FOLLOWING QUESTIONS, FOCUS ON THE WORST TWO WEEKS OF THE LAST MONTH 
(OR PAST  
TWO WEEKS IF EQUALLY DEPRESSED FOR THE ENTIRE MONTH) OR SINCE LAST VISIT IF NO 
CURRENT SYMPTOMS 
 
During [2-WEEK PERIOD] …    From: …../…../……  To: …./…../…...  (insert dates) 
 
A3  . . .did you lose or 
gain any weight? 
(How much? Were 
you trying to lose 
weight?) 
 
IF NO: How was your 
appetite? (What 
about compared with 
your usual appetite?) 
Did you have to force 
yourself to eat? Eat 
[less/more] than 
usual?  Was that 
nearly every day?)  
 
(3) significant weight loss when not dieting or weight gain 
(e.g. a change of more than 5% of body weight in a month), 









?  -   + 
 
 
A4  . . how were you 
sleeping?  (Trouble 
falling, waking 
frequently, trouble 
staying asleep, waking 
too early, OR sleeping 
too much?  How many 
hours a night 
compared with usual?  
Was that nearly every 
night?) 
 










If neither A1 nor A2 is “+” during the current month, check for past Major Depressive episode by 
asking questions A1 and A2 again looking for lifetime (since last assessment) episodes, beginning with 
“Has there EVER since we last visited you (11 or 16)…” 
IF AT LEAST ONE PAST DEPRESSED PERIOD: Have you had more than one time like that? Which one 
was the worst? 
 
If neither A1 nor A2 has ever been “+”, go to A16, (Manic Episode). 
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A5  . . were you so 
fidgety or restless that 
you were unable to sit 
still?  (Was it so bad 
that other people 
noticed it? What did 
they notice? Was that 
nearly every day?) 
 
IF NO: What about the 
opposite - talking or 
moving more slowly 
than is normal for 
you?  (Was it so bad 
that other people 
noticed it? What did 
they notice? Was that 
nearly every day?) 
 
(5) psychomotor agitation or retardation nearly every day 
(observable by others, not merely subjective feelings of 
restlessness or being slowed down) 
 
NOTE: ALSO CONSIDER BEHAVIOUR DURING THE INTERVIEW 
A5 
?  -   + 
A6 . . what was your 
energy like? (Tired all 






(6) fatigue or loss of energy nearly every day A6 
?  -   + 
A7  . . how did you 
feel about yourself?  
(Worthless? Nearly 
every day?)  
 
IF NO:  What about 
feeling guilty about 
things you had done 
or not done?  (Nearly 
every day?) 
(7) feelings of worthlessness or excessive or inappropriate 
guilt  (which may be delusional) nearly every day (not merely 
self-reproach or guilt about being sick) 
 





?  -   + 
A8 . . did you have 
trouble thinking or 
concentrating?  (What 
kinds of things did it 
interfere with? Nearly 
every day?) 
 
IF NO: Was it hard to 
make decisions about 
everyday things?   
 
(8) diminished ability to think or concentrate, or 
indecisiveness, nearly every day (either by subjective account 




?  -   + 
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A9 . . were things so 
bad that you were 
thinking a lot about 
death or that you 
would be better off 
dead?  What about 
thinking of hurting 
yourself? 
 
IF YES: Did you do 
anything to hurt 
yourself? 
 
(9) recurrent thoughts of death (not just fear of dying), 
recurrent suicidal ideation without a specific plan, or a suicide 
attempt or a specific plan for committing  suicide 
A9 
?  -   + 
 
A10   
AT LEAST FIVE  OF A1 TO A9 ARE “+” AND AT LEAST ONE OF THESE IS ITEM A1 OR A2 
A10 













A11  IF UNCLEAR: Has (the 
depression/OWN WORDS) made it 
hard for you to do your work, take 
care of things at home, or get 
along with other people? 
 
C. The symptoms cause clinically significant 
distress or impairment in social, occupational, or 
















A12  Just before this began, were 
you physically ill? 
  
Just before this began, were you 
taking any  
medications? 
 
IF YES: Any change in the amount 
you were taking? 
 
Just before this began, were you 
D. The symptoms are not due to the direct effects 
of a substance (e.g. a drug of abuse, medication) 
or to a general medical condition. 
 
Etiological general medical conditions include: 
degenerative neurological illnesses (e.g., 
Parkinson’s disease), cerebrovascular disease (e.g., 
stroke), metabolic conditions (e.g., Vitamin B-12 
deficiency), endocrine conditions (e.g., hyper- and 
hypothyroidism, hyper- and hypoadreno-
corticism); viral or other infections (e.g., hepatitis, 
A12 
?  -   + 
 
 
If A11 above is “-“ (i.e. symptoms not clinically significant) ask the following if unknown:  Has there 
been any other times since we last saw you when you’ve been depressed and it had more of an 
effect on your life? 
 
IF “yes”, go to A1 and ask about that episode.    
 
IF “no” go to A16 (Manic Episode) 
If A10 above is “-“ (i.e. fewer than five are “+”) ask the following if unknown:  Has there been any other 
times since we last saw you, when you’ve been depressed and had even more of the symptoms that 
we’ve just talked about?      
 
IF “yes” go back to to A1 and ask about that episode.    
 















mononucleosis, HIV), and certain cancers (e.g., 
carcinoma of the pancreas). 
 
Etiological substances include: alcohol, 
amphetamines, cocaine, hallucinogens, inhalants, 
opioids, phencyclidine, sedatives, hypnotics, 
anxiolytics.  Medications include 
antihypertensives, oral contraceptives, 
corticosteroids, anabolic steroids, anticancer 













A13  IF UNKNOWN: Did this 
begin soon after someone close 
to you died? 
E. The symptoms are not better accounted for by 
Bereavement, i.e., after the loss [death] of a loved 
one, the symptoms persist for longer than 2 
months or are characterized by marked functional 
impairment, morbid preoccupation with 
worthlessness, suicidal ideation, psychotic 





















?  -   + 
A15 How many separate times 
have you been (depressed/ OWN 
WORDS) nearly every day for at 
least 2 weeks and had several of 
the symptoms that you described, 
such as (SYMPTOMS)? 
 
Total number of Major Depressive Episodes 
including current. (CODE 99 if too numerous or 
indistinct to count).                                                                                                  





If A13 above is “-“ (i.e. the depressed mood is better accounted for by Bereavement), ask:   Have 
there been any other times since we last saw you when you’ve been depressed and it was not 
because of the loss of a loved one? 
 
  IF “yes”, go to A1 and ask about that episode.    
 
If “no” go to A16 (Manic Episode) 
 
If A12 above is “-“ (i.e. mood is due to substance or general medical condition), ask:  
Have there been any other times since we last saw you when you’ve been depressed and 
it was not because of [GENERAL MEDICAL CONDITION/ SUBSTANCE USE]? 
 
IF “yes”, go to A1 and ask about that episode.    
 
If “no” go to A16 (Manic Episode) 
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A16  Have you ever had a period 
of time when you were feeling so 
good, high, excited, or hyper that 
other people thought you were 
not your normal self or you got 
into trouble?  (Did anyone say 
you were manic? Was that more 
than just feeling good?) 
 
What was that like? 
 
IF NO:  What about a period of 
time when you were so irritable 
that you found yourself shouting 
at people or starting fights or 
arguments? (Did you find 
yourself yelling at people you 
didn’t really know?) 
 
A. A distinct period of abnormally and persistently 
elevated, expansive, or irritable mood . . . 
 
       
A16 








A17  How long did that last? 
(As long as one week?)  
(Did you have to go into a 
hospital?) 
. . . lasting at least 1 week (or any duration if 












Have you had more than one time such as that? Which time were the most [high/irritable/OWN 
WORDS]? 
 
FOR ITEMS A18 – A27 FOCUS ON THE MOST EXTREME EPISODE. 
 




During (PERIOD OF WORST MANIC 
SYMPTOMS) … 
 
B. During the period of mood disturbance, three 
(or more) of the following symptoms have 
persisted (four if mood is only irritable) and have 
been present to a significant degree: 
 
If A16 is “-“ (i.e. never any periods of elevated or irritable mood) go to A45 (Dysthymic Disorder) 
If A17 is “-“ (i.e. duration is less than 1 week) go to A30 (Hypomanic Episode) 
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A18 . . .how did you feel about yourself? 
 
(More self-confident than usual?  Any 
special powers or abilities?) 
 
 
(1)  inflated self-esteem or grandiosity A18 
?  -  
+ 
A19 . . .did you need less sleep than usual 
 




(2)  decreased need for sleep (e.g. feels 
rested after only 3 hours of sleep) 





?  -  
+ 
A20 . . .were you much more talkative than 
usual?  
(Did people have trouble stopping you or 
understanding you?  Did people have 
trouble getting a word in edgewise?) 
 
 
(3)  more talkative than usual or pressure to 
keep talking 
A20 
?  -  
+ 




(4) flight of ideas or subjective experience 






?  -  
+ 
A22 . .  .were you so easily distracted by 
things around you that you had trouble 




(5) distractibility (i.e. attention too easily 
drawn to unimportant or irrelevant 
external stimuli) 
A22 
?  -  
+ 
A23. . .how did you spend your time?  
(Work, friends, hobbies? Were you so 
active that your friends or family were 
concerned about you?) 
    
IF NO INCREASED ACTIVITY: Were you 
physically restless?  (How bad was it?) 
 
(6) increase in goal- directed activity 
(socially, at work or school, or sexually) or 
psychomotor agitation 
A23 
?  -  
+ 
A24. . did you do anything that could have 
caused trouble for you or your family?  
(Buying things you didn’t need? Anything 






 (7) excessive involvement in pleasurable 
activities which have a high potential for 
painful consequences (e.g., engaging in 
unrestrained buying sprees,  
sexual indiscretions, or foolish business 
investments) 
A24 
?  -  
+ 
A25 
AT LEAST THREE OF B1 – B7 ARE “+” (OR FOUR IF MOOD IRRITABLE AND NOT 
ELEVATED) 
A25 















A26 IF NOT KNOWN: At that time, did you 
have serious problems at home or at 
work (school) because you were 
[SYMPTOMS] or did you have to go into a 
hospital? 
 
D.  The mood disturbance is sufficiently 
severe to cause marked impairment in 
occupational functioning or in usual social 
activities or relationships with others, or to 
necessitate hospitalization to prevent harm 

















A27 Just before this began, were you 
physically ill? 
  
Just before this began, were you 
taking any  
medications? 
 
IF YES: Any change in the amount you 
were taking? 
 
Just before this began, were you 













E. The symptoms are not due to the direct 
physiological effects of a substance (e.g a drug 
of abuse, medication) or to a general medical 
condition. 
 
Note: Manic-like episodes that are clearly 
caused by somatic antidepressant treatment 
(e.g. medication, electroconvulsive therapy, 
light therapy) should not count toward a 
diagnosis of Bipolar I Disorder but are 
considered Substance-Induced Mood Disorders. 
 
Etiological general medical conditions include 
degenerative neurological illnesses (e.g., 
Huntingdon’s disease, multiple sclerosis), 
cerebrovascular disease (e.g., stroke), 
metabolic conditions (e.g., Vitamin B-12 
deficiency, Wilson’s disease), endocrine 
conditions (e.g. hyperthyroidism), viral or other 
infections and certain cancers (e.g. cerebral 
neoplasms). 
 
Etiological substances include: alcohol, 
amphetamines, cocaine, hallucinogens, 
inhalants, opioids, phencyclidine, sedatives, 
hypnotics, anxiolytics.  Medications include 
psychotropic medications (e.g. 
A27 
?  -  + 
 
If A25 above is “-“ (i.e. fewer than three are “+”) ask the following: 
Have there been any other times since we last saw you, when you were [high/irritable/OWN WORDS] 
and had even more of the symptoms that we’ve just talked about? 
 
  IF “yes” go back to A16 and ask about that episode.   If “no” go to A45 (Dysthymic Disorder) 
 
If A26 above is “-“ (i.e. not sufficiently severe) ask the following: 
Have there been any other times since we last saw you when you were [high/irritable/OWN WORDS] 
and you got into trouble with people or were hospitalized? 
 
 IF “yes” go back to A16 and ask abo t that episode.   If “no” go t  A39 (Criterion C for Hypomanic 
Episode) 
If there is any indication that the mania may 
be secondary (i.e., a direct physiological 
consequence of a general medical condit on 
or substance), go to A61 and return here to 










How many separate times since we last saw you 
were you [HIGH/OWN WORDS] and had 
[ACKNOWLEDGED MANIC SYMPTOMS] for at least 
a week (or were hospitalized)? 
Total number of Manic Episodes, 
including current, (CODE 99 if too 
indistinct or too numerous to 











A30   IF UNKNOWN: When you were 
[HIGH / IRRITABLE / OWN WORDS], did it 
last for at least 4 days? 
 
Have you had more than one time like 
that? 
(Which time were you the most [high / 
irritable / OWN WORDS]?) 
A. A distinct period of persistently elevated, 
expansive, or irritable mood, lasting 
throughout at least 4 days, that is clearly 












During [PERIOD OF MOST EXTREME 
HYPOMANIC SYMPTOMS] … 
 
B. During the period of mood disturbance, three (or 
more) of the following symptoms have 
persisted(four if the mood is only irritable) and 
have been present to a significant degree: 
 
A31… how did you feel about yourself? 
 
(More self-confident than usual? Any 
special powers or abilities?) 
 
(1)  inflated self-esteem or grandiosity A31 
?  -  
+ 
antidepressants), corticosteroids, anabolic 
steroids, isoniazid, antiparkinson medication 
(e.g. levodopa), and sympathominimetics/ 
decongestants. 
 
A28   CRITERIA A, B, D AND E ARE “ +”                                                               MANIC EPISODE       
 
IF UNKNOWN: Have you had (SYMPTOMS RATED “+” ABOVE) in the past month? 
 
Check here   _______ if criteria have been met in the past month  





A32 . . did you need less sleep than usual? 
 
  IF YES:  Did you still feel rested? 
 
(2)  decreased need for sleep (e.g., feels 
rested after only 3 hours of sleep) 





?  -  
+ 
A33 . . were you much more talkative than 
usual? (Did people have trouble stopping 
you or understanding you?   
Did people have trouble getting a word in 
edgewise?) 
 
(3)  more talkative than usual or pressure to 
keep talking  
A33 
?  -  
+ 
 
A34. .  were your thoughts racing through 
your head? 
 
(4)  flight of ideas or subjective experience 





?  -  
+ 
A35 . . were you so easily distracted by 
things around you that you had trouble 




(5) distractibility (i.e. attention too easily 
drawn to unimportant or irrelevant 
external stimuli) 
A35 
?  -  
+ 
A36 . . how did you spend your time?  
(Work, friends, hobbies? Were you so 
active that your friends or family were 
concerned about you?) 
    
IF NO INCREASED ACTIVITY: Were you 
physically restless?   (How bad was it?) 
 
(6) increase in goal- directed activity (either 
socially, at work or school, or sexually) or 
psychomotor agitation 
A36 
?  -  
+ 
A37  . . did you do anything that could 
have caused trouble for you or your 
family?  (Buying things you didn’t need? 




 (7) excessive involvement in pleasurable 
activities which have a high potential for 
painful consequences (e.g., engaging in 
unrestrained buying sprees, sexual 
indiscretions, or foolish business 
investments) 
A37 
?  -  
+ 
 
AT LEAST THREE OF B1 – B7 ARE “+” (OR FOUR IF MOOD IS  IRRITABLE AND NOT 
ELEVATED) 
A38 













A39  IF UNKNOWN: Is this very different 
from the way you usually are?  (How 
C. The episode is associated with an 
unequivocal change in functioning that is 
A39 
?  -  
If A38 is “-“ (i.e. fewer than three are “+”) ask the following: 
Have there been any other times since we last saw you when you were [high/irritable/OWN 
WORDS] and had even more of the symptoms that we’ve just talked about? 
 
  IF “yes” go back to A30 and ask about that episode.   If “no” go to A45 (Dysthymic Disorder) 
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were you different?  At work?  With 
friends?) 

















A40 IF UNKNOWN: Did other people 
notice the change in you?  (What did they 
say?) 
D. The disturbance in mood and the change 
in functioning are observable by others. 
A40 














A41 IF UNKNOWN: At that time, did you 
have serious problems at home or at 
work (school) because you were 
[SYMPTOMS] or did you have to go into a 
hospital? 
E. The episode is not severe enough to 
cause marked impairment or to need 













If A39 is “-“ (i.e. characteristically “hypomanic”), ask the following: 
Have there been any other times since we last saw you when you were [high/irritable/OWN WORDS] 
and you were really different from the way you usually are? 
 
  IF “yes” go back to A30 and ask about that episode.   If “no” go to A45 (Dysthymic Disorder) 
 
If A40 is “-“ (i.e. not observable by others) ask the following: 
  
Have there been any other times since we last saw you when you were [high/irritable/OWN 
WORDS] and other people did notice the change in the way you were acting? 
 
  IF “yes” go back to A30 and ask about that episode.   If “no” go to A45 (Dysthymic Disorder) 
 
If A41 is “-“ (i.e. severe enough to cause marked impairment),  go back to A26, code “+” for that item, 











How many separate times since we last saw you  
were you (high/irritable/OWN WORDS) and had 
[ACKNOWLEDGED HYPOMANIC SYMPTOMS] for a 
period of time? 
 
 
Total number of Hypomanic 
Episodes, (CODE 99 if too indistinct 












A42 Just before this began, were you 
physically ill? 
  




IF YES: Any change in the amount you 
were taking? 
 
Just before this began, were you drinking 









F. The symptoms are not due to the direct 
physiological effects of a substance (e.g a 
drug of abuse, medication) or to a general 
medical condition. 
 
Note: Hypomanic-like symptoms that are 
clearly caused by somatic antidepressant 
treatment (e.g. medication, 
electroconvulsive therapy, light therapy) 
should not count toward a diagnosis of 
Bipolar II Disorder but are considered 
Substance-Induced Mood Episodes. 
 
Refer to list of possibly etiological general 
medical conditions and substances included 
with item A27. 
A42 
?  -  + 
 
A43     
        CRITERIA A, B, C, D, E AND F ARE “ +”                                              HYPOMANIC 
EPISODE        
 
IF UNKNOWN: Have you had (SYMPTOMS RATED “+” ABOVE) in the past month? 
 
Check here   _______ if criteria met in the past month               
 
A43               
+ 
If there is any indication that the hypomania may 
be secondary (i.e., a direct physiological 
consequence of a general medical condition or 
substance), go to A61and make a rating of “-” or 
“+” 
If A42 above is “-“(i.e. the hypomania is due to a substance or general medical condition), ask the 
following: 
 
Have there been any other times since we last saw you when you were [high/irritable/OWN WORDS] and 
you were not [physically ill/ taking medication/ using SUBSTANCE]? 
 
  IF “yes” go back to A30 and ask about that episode.   If “no” go to A45 (Dysthymic Disorder) 
 
YOU ARE FINISHED EVALUATING MOOD EPISODES. GO TO MODULE B (PSYCHOTIC AND ASSOCIATED 
SYMPTOMS), B1. 
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A45   For the past couple of years, have you 
been bothered by depressed mood most of 
the day, more days than not?    (More than 
half of the time?)    
 
IF YES:  What was that like? 
 
A.  Depressed mood for most of the day, 
for more days than not, as indicated 
either by subjective account or 
observation made by others, for at least 
two years.   
A45 









During these periods of (OWN WORDS FOR 
CHRONIC DEPRESSION) do you find that 
most of the time you… 
 
B.   Presence, while depressed, of two (or 
more) of the following: 
 
A46 . . . lose your appetite?  (What about 
overeating?) 
  (1) poor appetite or overeating A46 
?    -   
+ 
 
A47 . . . have trouble sleeping or sleep too 
much? 
   (2) insomnia or hypersomnia A47 
?    -   
+ 
 
A48 . . . have little energy to do things or 
feel tired a lot? 
   (3) low  energy or fatigue A48 
?    -   
+ 
 
A49 . . . feel down on yourself?  (Feel 
worthless, or a failure?) 
  (4) low self-esteem A49 
?    -   
+ 
 
A50 . . . have trouble concentrating or 
making decisions? 
  (5) poor concentration or difficulty 
making decisions 
A50 
?    -   
+ 
 
A51. . . feel hopeless?   (6) feelings of hopelessness A51 
?    -   
+ 
 
A52                                                                               AT LEAST TWO “B”   SYMPTOMS 
CODED “+” 
A52 







NOTE: For presentations in which there is a history of multiple recurrent Major Depressive 
Episodes, the clinician may wish to skip the evaluation of Dysthymic Disorder (i.e. go to B1). 
If A45 is “-“ (ie. No chronic depressed mood. ..) go to B1 (Psychotic and Associated Symptoms) 
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A53 What is the longest time, during this 
period of long-lasting depression, that you 
felt OK? (NO DYSTHYMIC SYMPTOMS) 
C.  During the 2-year period of the 
disturbance, the person has never been 
without the symptoms in criteria A and B 
for more than 2 months at a time. 
 
A53 








A54 How long have you been feeling this 
way?  (When did this begin?) 
 
Age at onset of current Dysthymic Disorder 





A55 IF UNKNOWN: Did it begin gradually 
or did it start with a bad period of 
depression? 
D. No Major Depressive Episode during the 
first 2 years of the disturbance i.e. not 
better accounted for by chronic Major 
Depressive Disorder or Major Depressive 
Disorder, In Partial Remission. 
 
Note:  There may have been a previous 
Major Depressive Episode provided there 
was a full remission (no significant signs or 
symptoms for 2 months)before 
development of the Dysthymic Disorder.  In 
addition, after the initial 2 years of 
Dysthymic Disorder, there may be 
superimposed episodes of Major 
Depressive Disorder, in which case both 
diagnoses may be given when criteria are 
met for a Major Depressive Episode. 
 
A55 










E. There has never been a Manic Episode, a 
Mixed Episode or a Hypomanic Episode, 












A57 THIS MAY NEED TO BE DEFERRED 
UNTIL AFTER PSYCHOTIC DISORDERS 
HAVE BEEN RULED OUT 
F.  The disturbance does not occur 
exclusively during the course of a chronic 
Psychotic Disorder, such as Schizophrenia 
or Delusional Disorder. 
 
A57 





If A53 is “-“ (ie. More than 2 months without symptoms) go to B1 (Psychotic and Associated 
Symptoms) 
If A55 is “-“(i.e. Major Depressive Episode during first 2 years) go to B1 (Psychotic and Associated Symptoms) 
If A56 is “-“ (i.e. past Manic, Mixed or Hypomanic Episode or criteria met for Cyclothymic Disorder) 





A58 Just before this began, were you 
physically ill? 
  




IF YES: Any change in the amount you 
were taking? 
 
Just before this began, were you drinking 










G.  The symptoms are not due to the direct 
physiological effects of a substance (e.g., a 
drug of abuse, a medication) or to a 
general medical condition. 
Etiological general medical conditions 
include: degenerative neurological 
illnesses (e.g., Parkinson’s disease), 
cerebrovascular disease (e.g., stroke), 
metabolic conditions (e.g., Vitamin B-12 
deficiency), endocrine conditions (e.g., 
hyper- and hypothyroidism, hyper- and 
hypoadrenocorticism); viral or other 
infections (e.g., hepatitis, mononucleosis, 
HIV), and certain cancers (e.g., carcinoma 
of the pancreas). 
 
Etiological substances include: alcohol, 
amphetamines, cocaine, hallucinogens, 
inhalants, opioids, phencyclidine, 
sedatives, hypnotics, anxiolytics.  
Medications include antihypertensives, 
oral contraceptives, corticosteroids, 
anabolic steroids, anticancer agents, 
analgesics, anticholinergics, and cardiac 
medications. 
A58 









A59 IF UNCLEAR: How much do 
[SYMPTOMS IN A AND B] interfere with 
your life? 
H.  The symptoms cause clinically 
significant distress or impairment in social, 
occupational, or other important areas of 
functioning 
A59 
?    -   
+ 







A60    












If there is any indication that the dysthymia may 
be secondary (i.e., a direct physiological 
consequence of a general medical condition or 
substance), go to A61 and return here to make a 
rating of “-” or “+” 
If A58 is “-“ (i.e. due to a chronic general medical condition or chronic substance use) go 
to B1 (Psychotic and Associated Symptoms) 
If A59 is “-“ (i.e. not clinically significant) go to B1 (Psychotic and Associated Symptoms) 
Go to B1 (Psychotic and Associated Symptoms) 
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MOOD DISORDER DUE TO GENERAL MEDICAL CONDITION  CRITERIA 
 
A61   CODE BASED ON INFORMATION 
ALREADY OBTAINED 
 
A.  A prominent and persistent disturbance 
in mood predominant in the clinical picture 
and by either (or both) of the following: 
 
 (1)  depressed mood or markedly 
diminished interest or pleasure in all, or 
almost all, activities 
 





?   -    
+ 
A62 Do you think your (MOOD 
SYMPTOMS) were in any way related to 
your (COMORBID GMC)?    
 
 IF YES:  Tell me how. 
 
(Did the [MOOD SYMPTOMS] start or get 
much worse only after [COMORBID GMC] 
began?) 
 
IF YES AND GMC HAS RESOLVED: Did the 
[MOOD SYMPTOMS] get better once the 
[COMORBID GMC] got better? 
B./C. There is evidence from the history, 
physical examination, or laboratory 
findings that the disturbance is the direct 
physiological consequence of a general 
medical condition and the disturbance is 
not better accounted for by another 
mental disorder (e.g. Adjustrment Disorder 
With Depressed Mood in response to the 


















A63  IF UNCLEAR:  How much did (MOOD 
SYMPTOMS) interfere with your life? 
E.  The symptoms cause clinically 
significant distress or impairment in social, 




?   -    
+ 
 
A64    CRITERIA A, B/C AND E ARE +                                            
                                 
293.83    MOOD DISORDER DUE TO A   GENERAL MEDICAL CONDITION                                                                                                       
 
IF UNKNOWN: Have you had (SYMPTOMS RATED “+” ABOVE) in the past month? 
 





If A62 is “-“ (GMC not etiological) go to A65 (Substance-induced Mood Disorder) 
 
If mood symptoms are not temporarily associated with a general medical condition, go to A65 










If mood symptoms are not temporarily associated with substance use, return to episode being 
evaluated: 
 
A12 for Major Depressive Episode          A27 for Manic Episode                        A42 for Hypomanic 
Episode 




SUBSTANCE-INDUCED MOOD DISORDER CRITERIA          
 
A65  CODE BASED ON INFORMATION 
ALREADY OBTAINED 
 
A.  A prominent and persistent disturbance 
in mood predominant in the clinical picture 
and by either (or both) of the following: 
 
 1)  depressed mood or markedly 
diminished interest or pleasure in all, or 
almost all, activities 
 
(2)  elevated, expansive or  irritable mood 
 
A65 
?   -    
+ 
A66  IF UNKNOWN:  When did the 
(MOOD SYMPTOMS) begin?  Were you 
already using (SUBSTANCE) or had you 
just stopped or cut down your use? 
B. There is evidence from the history, 
physical examination, or laboratory 
findings of either (1) or (2): 
 
 (1) the symptoms in criterion A developed 
during or, within a month of, Substance 
Intoxication or Withdrawal 
 
(2) medication use is etiologically related 















If A66 is “-“ (i.e. not etiologically related to a substance), then return to episode being 
evaluated: 
 
A12 for Major Depressive Episode          A27 for Manic Episode                        A42 for 
Hypomanic Episode 
A58 for Dysthymic Disorder                    D11 for Other Bipolar Disorders           D18 for 
Depressive Disorder NOS 
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A67  Do you think your (MOOD 
SYMPTOMS) are in any way related to 
your (SUBSTANCE USE)?         
 
IF YES:  Tell me how. 
 
ASK ANY OF THE FOLLOWING QUESTIONS 
AS NEEDED TO RULE OUT A NON 
SUBSTANCE- ETIOLOGY 
 
IF UNKNOWN:  Which came first, the 
SUBSTANCE USE) or the (MOOD 
SYMPTOMS)? 
 
IF UNKNOWN:  Have you had a period of 
time when you stopped using 
(SUBSTANCE)? 
 
 IF YES:  After you stopped using 
(SUBSTANCE) did the (MOOD SYMPTOMS) 
get better? 
 
IF UNKNOWN:  How much of 
(SUBSTANCE) were you using when you 
began to have (MOOD SYMPTOMS)? 
 
IF UNKNOWN:  Have you had any other 
episodes of (MOOD SYMPTOMS)? 
 
  IF YES:  How many?  Were you using 
(SUBSTANCES) at those times? 
 
C.  The disturbance is not better 
accounted for by a Mood Disorder that is 
not substance-induced.  Evidence that the 
symptoms are better accounted for by a 
Mood Disorder that is not substance 
induced might include: 
 
1) the mood symptoms precede the onset 
of the substance use  (or medication use) 
 
  
2)  the mood symptoms persist for a 
substantial period of time (e.g. about a 
month) after the cessation of acute 





3)  the mood symptoms are substantially 
in excess of what would be expected 
given the type or amount of the 
substance used or the duration of use  
 
 
 4)  there is other evidence that suggests  
the existence of an independent non-
substance-induced Mood Disorder (e.g. a 
history of recurrent non-substance-
related Major Depressive Episodes) 
 
A67 









A68 IF UNKNOWN:  How much did 
(MOOD SYMPTOMS) interfere 
with your life? 
E.  The symptoms cause clinically significant 
distress or impairment in social, occupational, or 
other important areas of functioning. 
 
A68 
?   -    
+ 
A69  CRITERIA A, B/C AND E ARE +                   SUBSTANCE-INDUCED MOOD DISORDER  
 
                                     Code 291.8 for Alcohol, 292.84 for all other substances.   
 
IF UNKNOWN: Have you had (SYMPTOMS RATED “+” ABOVE) in the past month? 
 







If A67 is “-“ (i.e. the disturbance is better accounted for by a non-substance-induced Mood 
Disorder) then return to episode being evaluated: 
 
A12 for Major Depressive Episode          A27 for Manic Episode                        A42 for Hypomanic 
Episode 













SCID-I DIAGNOSTIC SUMMARY 
 
MOOD DISORDERS 
Current    Lifetime    Bipolar I Disorder 
   296.40 Bipolar I Disorder, Most Recent Episode Hypomanic 
   296.0x Bipolar I Disorder, Single Manic Episode 
   296.4x Bipolar I Disorder, Most Recent Manic Episode 
   296.6x Bipolar I Disorder, Most Recent Episode Mixed 
   296.5x Bipolar I Disorder, Most Recent Episode Depressed 
       Check fifth digit specifier: 
__ 1 - Mild 
__ 2 - Moderate 
__ 3 - Severe, Without Psychotic Features 
__ 4 - Severe, With Psychotic Features 
__ 5 - In Partial Remission 
__ 6 – In Full Remission 
   __ 0 – Unspecified 
    296.7 Bipolar I Disorder, Most Recent Episode Unspecified 
Other Bipolar Disorders 
   296.89 Bipolar II Disorder (D9) 
 Check specifier: 
__ Hypomanic 
__ Depressed 
   301.13 Cyclothymic Disorder (D12) 
   296.80 Bipolar Disorder Not Otherwise Specified (D12) 
 
 
Major Depressive Disorder (D16) 
   296.2x Major Depressive Disorder, Single Episode 
   296.3x Major Depressive Disorder, Recurrent 
Check fifth digit specifier: 
__ 1 - Mild 
__ 2 - Moderate 
__ 3 - Severe, Without Psychotic Features 
__ 4 - Severe, With Psychotic Features 
__ 5 - In Partial Remission 
__ 6 – In Full Remission 
__ 0 – Unspecified 
 
Other Depressive Disorders 
   300.4 Dysthymic Disorder (A60) 
   311    Depressive Disorder Not Otherwise Specified (D19) 
 
Other Mood Disorders 
   293.83 Mood Disorders Due to General Medical Condition (A64) 
Return to episode being evaluated: 
 
A12 for Major Depressive Episode          A27 for Manic Episode                        A42 for Hypomanic 
Episode 




            Indicate GMC ___________________________________ 
Check specifier: 
__ Major Depressive-like Episode 
__ Other Depressive Symptoms 
__ Manic  
__ Mixed 





   292.84 Other Substance-Induced Mood Disorder (A69) 











1. DEPRESSED MOOD 
(Sadness, hopeless, helpless, worthless) 
0=Absent 
1=These feelings are indicated only on questioning 
2=These feelings are spontaneously reported verbally 
3=Communicates feelings non-verbally i.e., through facial expression, posture, voice, and 
tendency to weep  
4=Patient reports VIRTUALLY ONLY these feelings in his spontaneous verbal and non-verbal 
communication 
2. FEELINGS OF GUILT 
 0=Absent 
 1=Self reproach, feels he has let people down 
 2=Ideas of guilt or rumination over past errors or sinful deed 
 3=Present illness is a punishmnent. Delusions of guilt 
 4=Hears accusatory or denunciatory voices and/or experiences threatening visual hallucinations 
3. SUICIDE 
 0=Absent 
 1=Feels life is not worth living 
 2=Wishes he were dead or any thoughts of possible death to self 
 3=Suicide ideas or gesture 
 4=Attempts at suicide (any serious attempt rates) 
4. INSOMNIA EARLY 
 0=No difficulty falling asleep 
 1=Complains of occasional difficulty falling asleep - more than 1/2 hour 
 2=Complains of nightly difficulty falling asleep 
5. INSOMNIA MIDDLE 
 0=No difficulty 
 1=Patient complains of being restless and disturbed during the night 
 2=Waking during the night - any getting out of bed (except for purposes of voiding) 
6. INSOMNIA LATE  
 0=No difficulty 
 1=Waking in early hours of the morning but goes back to sleep 
 2=Unable to fall asleep again if he gets out of bed 
7. WORK AND ACTIVITIES  
 0=No difficulty 
 1=Thoughts and feelings of incapacity, fatigue or weakness related to activities (work or hobbies) 
 2=Loss of interest in activities (hobbies or work) - either directly reported by patient, or indirectly 
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in listlessness, indecision and vacillation (feels he has to push himself to work or do activities) 
3=Decrease in actual time spent in activities or decrease in productivity. In hospital, if patient 
does not spend at least three hours a day in activities (hospital job or hobbies) exclusive of ward 
chores 
4=Stopped working because of present illness. In hospital, if patient engages in no activities 
except ward chores, or if patient fails to perform ward chores unassisted 
8. RETARDATION: PSYCHOMOTOR 
(Slowness of thought and speech; impaired ability to concentrate; decreased motor activity) 
 0=Normal speech and thought 
 1=Slight retardation at interview 
 2=Obvious retardation at interview 
 3=Interview difficult 




 2=Playing with hands, hair,etc 
 3=Moving about, can't sit still 
 4=Hand wringing, nail biting, hair-pulling, biting of lips 
10. ANXIETY: PSYCHIC 
 0=No difficulty 
 1=Subjective tension and irritability 
 2=Worrying about minor matters 
 3=Apprehensive attitude apparent in face or speech 
 4=Fears expressed without questioning 
11. ANXIETY: SOMATIC 
(Physiological concomitants of anxiety, such as - Gastro-intestinal: dry mouth, wind, indigestion, 
diarrhea, cramps, belching. - Cardio-vascular : palpitations, headaches. - Respiratory: 






12. SOMATIC SYMPTOMS: GASTROINTESTINAL  
 0=None 
 1=Loss of appetite but eating without staff encouragement. Heavy feelings in abdomen 
 2=Difficulty eating without staff urging. Requests or requires laxatives or medication for bowels or  
medication for gastro-intestinal symptoms 
13. SOMATIC SYMPTOMS: GENERAL 
 0=None 
 1=Heaviness in limbs, back or head. Backaches, headache, muscle aches. Loss of energy and 
fatigability 
 2=Any clear-cut symptom 
14. GENITAL SYMPTOMS 






 0=Not present 
 1=Self-absorption (bodily) 
 2=Preoccupation with health 
 3=Frequent complaints, requests for help, etc. ... 
 4=Hypochondriacal delusions 
16. LOSS OF WEIGHT 
 0=No weight loss 
 1=Probable weight loss associated with present illness (>500g/week) 
 2=Definite weight loss(>1kg/week) 
17. INSIGHT 
 0=Not depressed (based on above items) OR Acknowledges being depressed and ill 
 1=Acknowledges illness but attributes cause to bad food, climate, overwork, virus, need for rest, 
etc. 
 2=Denies being ill at all 
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1.  WHO BROUGHT YOU UP BEFORE AGE 17 
 
Please write below the Parent Figures who brought you up in childhood.  List each family 
arrangement with different parent figures which lasted one year or longer. 
Consider natural parent, step-parent (including parent's live-in partner), aunt, friend of the 
family, adoptive parent, foster parent etc. 
 
Fill in the first family arrangement below.  For example, if this was with your natural parents, 
write in 'Mother' and 'Father' and age '0';  or if this was with just your mother write in 'Mother', 









1a 1b 1c 
 
If you have lived in more than just one family arrangement, such as with mother and stepfather, 
then list them below, together with the age you were when the arrangement began. 
Family 
arrangement 

















1m 1n 1o 
 
1p **Were you ever in a children's home or institution before age 17?   YES   NO 
     (please circle the appropriate answer) 
 
If 'YES' fill in the boxes below.  If 'NO' skip to question 2 overleaf 
TYPE OF INSTITUTION 













2.  PARENTAL LOSS 
 







2a. Did either parent die before you were aged 17?  
YES    NO 
 
YES   NO 











2d. Have you ever been separated from your parent 
      for one year or more before the age of 17? 
 
 
YES    NO 
 
YES   NO 
 
 







At what age were you first separated? 2e 2f 
How long was this separation, in years? 2g 2h 
Please circle the reason for the separation:   
Parent's illness (2i) YES    NO YES    NO 
Parent's work (2j) YES    NO YES    NO 
Parents' divorce or separation (2k) YES    NO YES    NO 
Abandoned by parent or never knew parent (2l) YES    NO YES    NO 
Other reason (2m) YES    NO YES    NO 
 







3.  Please circle the appropriate numbers to describe your Mother Figure, as you remember her 
in your first 17 years.   If you had more than one, choose the one you were with the longest, or 
the one you found most difficult to live with. 
 
3a.  Which mother figure are you describing below? 
 1. Natural mother  
 2. Step-mother/father's live-in partner        
 3. Other relative e.g aunty, grandmother 
 4. Other non-relative e.g. foster mother, godmother 
 5. Other (describe)……………………………… 
 Yes, 
definitely 
 Unsure  No, 
not at 
all 
3b She was very difficult  to please 1 2 3 4 5 
3c She was concerned about my worries 1 2 3 4 5 
3d She was interested in how I did at  
     school 
1 2 3 4 5 
3e She made me feel unwanted 1 2 3 4 5 
3f  She tried to make me feel better  
     when I was upset 
1 2 3 4 5 
3g She was very critical of me 1 2 3 4 5 
3h She would leave me unsupervised 
     before I was 10 years old 
1 2 3 4 5 
3i  She would usually have time to talk 
     to me 
1 2 3 4 5 
3j She would hit me 1 2 3 4 5 
3k At times she made me feel I was a 
     nuisance 
1 2 3 4 5 
3l  She often picked on me unfairly 1 2 3 4 5 
3m She was there if I needed her 1 2 3 4 5 
3n She was interested in who my 
      friends were 
1 2 3 4 5 
3o She was concerned about my 
     whereabouts 
1 2 3 4 5 
3p She cared for me when I was ill 1 2 3 4 5 
3q She neglected my basic needs (e.g. 
      food and clothes) 
1 2 3 4 5 
3r  She did not like me as much as my 
     brothers and sisters (leave blank if no 
     siblings) 
1 2 3 4 5 
 
3s. Do you want to add anything about your mother?………………………………….. 
     ………………………………………………………………………………………….. 
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4.  Please circle the appropriate numbers to describe your Father Figure, as you remember him 
in your first 17 years.   If you had more than one, choose the one you were with the longest, or 
the one you found most difficult to live with. 
 
4a.  Which father figure are you describing below? 
 1. Natural father  
 2. Step-father/mother's live-in partner        
 3. Other relative e.g uncle, grandfather 
 4. Other non-relative e.g. foster father, adoptive father 
 5. Other (describe)…………………………… 
 Yes, 
definitely 
 Unsure  No, 
not at 
all 
4b He was very difficult  to please 1 2 3 4 5 
4c He was concerned about my worries 1 2 3 4 5 
4d He was interested in how I did at  
     school 
1 2 3 4 5 
4e He made me feel unwanted 1 2 3 4 5 
4f  He tried to make me feel better  
     when I was upset 
1 2 3 4 5 
4g He was very critical of me 1 2 3 4 5 
4h He would leave me unsupervised 
     before I was 10 years old 
1 2 3 4 5 
4i  He would usually have time to talk 
     to me 
1 2 3 4 5 
4j  He would hit me 1 2 3 4 5 
4k At times he made me feel I was a 
     nuisance 
1 2 3 4 5 
4l  He often picked on me unfairly 1 2 3 4 5 
4m He was there if I needed him 1 2 3 4 5 
4n He was interested in who my 
      friends were 
1 2 3 4 5 
4o He was concerned about my 
     whereabouts 
1 2 3 4 5 
4p He cared for me when I was ill 1 2 3 4 5 
4q He neglected my basic needs (e.g. 
      food and clothes) 
1 2 3 4 5 
4r  He did not like me as much as my 
     brothers and sisters (leave blank if no 
     siblings) 
1 2 3 4 5 
 




5. CLOSE RELATIONSHIPS IN CHILDHOOD 
    (please circle as appropriate – if you circle NO to any question, SKIP the rest of 
     that section and go on to the next one) 
 
5a  When you were a child or teenager, were there any ADULTS you could go to with 
your problems or to discuss your feelings?           
        YES     NO 
 
5b  If YES: Who was that?  (circle more than one if relevant) 
      
 1.  mother / mother figure 
 2.  father / father figure 
 3.  other relative 
 4.  family friend 
 5.  teacher, vicar etc 
 6.  other (describe) ………………………………. 
 
5d  Do you want to note anything about the relationship(s)? ………………………… 
 
 
5e Were there other CHILDREN/TEENAGERS your age that you could discuss  
      your  problems and feelings with? 
 
             YES     NO 
 
5f  If YES: Who was that?        (circle more than one if relevant) 
 
 1.  sister 
 2.  brother 
 3.  other relative 
 4.  close friend 
 5. other less close friend(s) 
 6. other person (describe)……………………………….. 
 
5h  Do you want to note anything about the relationship(s)?……………………… 
 
 
5i Who would you describe as the TWO CLOSEST people to you as a  
    child/teenager?        (circle up to two) 
 
 1.  mother / mother figure 
 2.  father / father figure 
 3.  sister or brother 
 4.  other relative 
 5.  family friend (adult) 
 6.  friend your age 
 7. other (describe) …………………………………………. 
 
5k  Do you want to note anything about the relationship(s)?………………………… 
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6.  PHYSICAL PUNISHMENT BEFORE AGE 17 BY PARENT FIGURE OR 
     OTHER HOUSEHOLD MEMBER 
 
6a  When you were a child or teenager were you ever hit repeatedly with an implement 
(such as a belt or stick) or punched, kicked or burnt by someone in the household?  
          YES     NO 
 


















Did the hitting happen on more 




YES    NO 
 
 
YES    NO 
How were you hit? 6e 
1. belt or stick 
2. punched/kicked 




1. belt or stick 
2. punched/kicked 
3. hit with hand 
4. other 
 
Were you ever injured e.g. bruises, 








YES    NO 
Was this person so angry they 








YES    NO 
 






6j. Did you experience this from anyone else in the household?     YES      NO 
 






7.  UNWANTED SEXUAL EXPERIENCES BEFORE AGE 17 
      (please circle as appropriate) 
 
7a. When you were a child or teenager did you ever have     YES  NO  UNSURE 
      any unwanted sexual experiences? 
 
7b.  Did anyone force you or persuade you to have sexual     YES  NO  UNSURE 
       intercourse against your wishes before age 17? 
 
7c.  Can you remember any upsetting sexual  YES  NO UNSURE 
experiences before age 17 with a related adult or someone in authority e.g. a teacher? 
 
If NO to all these,FINISH 










Was the other person someone you knew? 
 
7e 
       YES     NO     
7m      
      YES    NO 
Was the other person a relative? 
 
7f 
       YES     NO      
7n 
      YES    NO 
Did the other person live in your household? 
 
7g 
       YES     NO      
7o  
      YES    NO 
Did this person do it to you on more than one 
occasion? 
7h 
       YES     NO      
7p 
       YES    NO 
Did it involve touching private parts of your body? 7i 
       YES     NO      
7q 
       YES    NO 
Did it involve touching private parts of the other 
person's body? 
7j 
       YES     NO      
7r 
       YES    NO 
Did it involve sexual intercourse? 
 
7k 
       YES     NO      
7s 
       YES    NO 
 
 







Appendix I: 11 and 16 years maltreatment interview 
 
 




Subject has been the victim of physical abuse by a member of the family. 
Has anyone in your family ever hit or hurt you badly? 
Or beaten you up really badly? What happened? Did they threaten you with a weapon? Why 
did they do it? 
 
Definitions and questions 
Coding rules 
VICTIM OF PHYSICAL ABUSE: EVER 
0 = Absent 
2 = Some physical injury (e.g., black eye, cuts), or force with potential for such. 
3 = Serious injury (e.g., broken limb, unconsciousness, hospitalization), or force with potential 
for such. 
PERSON USING FORCE: EVER 
2 = Parent in the home 
3 = Other parent not in the home 
4 = Sibling in the home 
5 = Sibling not in the home 
6 = Other adult family member. 
THREATENED WITH WEAPON: EVER 
0 = Absent 
2 = Weapon used to threaten but not to hurt victim. 
3 = Weapon used to threaten and injure victim. 
 
 
SEXUAL ABUSE OR RAPE 
Sexual abuse episode(s) in which a person, termed a perpetrator, involves a child or adolescent 
in activities for the purpose of the perpetrator's own sexual gratification. These activities can 
include kissing (that makes a person uncomfortable), genital fondling (over or under clothing), 
oral-genital or oral-anal contact, genital or anal intercourse, or use of instruments. Sexual abuse 
does not include medical exams or mutually desires sexual relations with a peer. 
Rape is a sudden unexpected (usually isolated) event involving non-consensual sexual 
intercourse. 
 
Has anyone ever touched you in places where they shouldn't? 
Has anyone ever touched you in ways that made you feel funny? 
Or seemed wrong to you? 
Has anyone ever made you touch them in ways that made you feel uncomfortable? 
What happened? Who was involved? How did you feel about it? Were you upset? When did it 
first happen? How many times has it happened? Has it happened in the last 3 months? 
 




SEXUAL ABUSE: EVER 
0 = Absent 
2 = Present 
NUMBER OF TIMES SEXUAL ABUSE: EVER 
ONSET SEXUAL ABUSE: 
RAPE: EVER 
2 = Perpetrator is a stranger 
3 = Perpetrator is known individual 
ONSET RAPE: EVER 






Appendix J: Protocol for the calculation of high sensitivity C-
reactive protein 
 
High sensitivity c reactive protein (hsCRP) 
 
 
EXPLANATION OF THE TEST 
 
CRP is a 125,000 Dalton tetrameric protein synthesized in the liver that circulates in the plasma 
at an average concentration of 2.5 mg/L. Its production is regulated by interleukin-6. CRP binds 
polysaccharides, phosphorylcholine, phosphatidylcholine, histories, and nucleic acids. Once it 





HsCRP reagents are supplied by P.Z. Cormay, ul. Rapackiego 19, 20-150 Lublin, Poland, P.O. Box 
122 20-954 Lublin 2. 
 
The Cormay hsCRP assay employs an anti-CRP antibody that has been sensitized to latex 
particles. The antibody coats the surface of latex particles forming a milky appearing sensitised 
latex. This antibody then reacts with CRP within the sample and results in visible agglutination. 
Latex particles are used to magnify the antigen-antibody complex. The degree of agglutination is 
detected as a decrease in the intensity of transmitted light at 572nm (turbidimetry), which is 
proportional to the amount of CRP within the sample. The concentration of CRP is determined 
by interpolation from a calibration curve prepared from calibrators of known concentration. The 







 Level 1 Level 2 Level 3 
N 21 21 21 
Mean (mg/dL) 0.046 0.228 0.981 
SD  0.003 0.005 0.011 




 Level 1 Level 2 Level 3 
N 21 21 21 
Mean (mg/dL) 0.047 0.218 0.976 
SD 0.003 0.007 0.012 






The specimen should be serum from a plain or gel separator vacutainer The usual precautions 
for venipuncture should be observed.  
 
Serum is aliquoted into a 2mL tube and placed in the fridge for up to 4 hours. For longer storage 
samples should be stored in the freezer at -20°C or below until assayed.  
 
Avoid repeat freeze-thaw cycles. Avoid using samples with gross haemolysis or lipaemia. 
 
To assay the sample in duplicate a minimum of 200 μL is required. However, the sample tube 










Low risk: less than 1.0 mg/L  
Average risk: 1.0 to 3.0 mg/L  
High risk: above 3.0 mg/L  
 
Women on hormone replacement therapy have been shown to have elevated hs-CRP levels, 













Cholesterol reagent supplied by Siemens Healthcare Diagnostics Ltd, Newton House, Sir William 
Siemens Square, Frimley, Camberley, Surrey, Gu16 8QD 
 
Serum cholesterol is determined using an enzymatic method. Cholesterol esterase completely 
hydrolyses cholesterol esters in serum to free cholesterol, which is in turn oxidised by 
cholesterol oxidase generating hydrogen peroxide. The hydrogen peroxide formed combines 
with 4-aminophenazone and a phenol to form a red quinone amine dye which is measured as an 
endpoint reaction at 505/694 nm. The increase in dye absorbance is directly proportional to the 
concentration of cholesterol in the sample, when compared to a previous calibration assay.  
 
 
Cholesterol esters + H2O 
 
 
Cholesterol  + fatty acid 
 
 
     H2O2   + Choleste-4-en-3-one  
+ phenol, 4-aminophenazone 
 







 Level 1) Level 2  Level 3  
N 20 20 20 
Mean (mmol/L) 3.91 5.15 5.67 
SD 0.026 0.034 0.031 




 Level 1  Level 2  Level 3  
N 20 20 20 
Mean (mmol/L) 3.91 5.15 5.67 
SD 0.044 0.080 0.057 










Serum or heparinised plasma may be used. Specimens may be refrigerated overnight or stored 
at room temperature in seroseparator tubes. The ADVIA 2400 uses 2 µl of sample in the test, 
although the minimum volume required in the specimen container is 50µl (micro sample cups) 















Quoting reference values for serum cholesterol in terms of population distribution is actively 
discouraged in favour of setting desirable targets. Current WHO recommendations suggest a 





The ADVIA cholesterol method is traceable to the CDC reference method, which uses reference 







Triglyceride concentrations are useful in the calculation of LDL cholesterol via the Friedwald 





Triglyceride reagents supplied by Siemens Healthcare Diagnostics Ltd, Newton House, Sir 
William Siemens Square, Frimley, Camberley, Surrey, Gu16 8QD 
 
The Siemens Advia method for the measurement of triglycerides is an enzymatic assay. 
Triglycerides are converted to glycerol and free fatty acids by lipase. The glycerol is then 
converted to glycerol-3-phosphate by glycerol kinase followed by its conversion by glycerol-3-
phosphate-oxidase to hydrogen peroxide. A coloured complex is formed from hydrogen 
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peroxide, 4-aminophenazone and 4-chlorophenol under the catalytic influence of peroxidase. 







 Level 1  Level 2  
Mean (mmol/L) 1.32 2.36 
N 20 20 
SD 0.007 0.011 
CV% 0.6 0.5 
Inter-assay precision 
 
 Level 1  Level 2  
Mean (mmol/L) 1.32 2.36 
N 20 20 
SD 0.033 0.035 






Serum or heparinised plasma may be used. Specimens may be refrigerated overnight or stored 
at room temperature in seroseparator tubes. The ADVIA 2400 uses 2 µL of sample in the test, 
although the minimum volume required in the specimen container is 50µL (micro sample cups) 















The ADVIA triglyceride method measures total glycerols and is traceable to a reference method, 
which uses reference materials from the National Institute of Standards and Technology (NIST), 
via patient sample correlation. Assigned values of Bayer Chemistry Calibrator and Bayer Assayed 










HIGH DENSITY LIPOPROTEIN CHOL 
 
HDL cholesterol measurements enable LDL cholesterol to be calculated (given the total 




HDL cholesterol reagents supplied by Siemens Healthcare Diagnostics Ltd, Newton House, Sir 
William Siemens Square, Frimley, Camberley, Surrey, Gu16 8QD. 
 
 
The Siemens Advia Direct HDL cholesterol method is a two step automated procedure. In the 
first step cholesterol esterase and cholesterol oxidase react to remove non-HDL cholesterol from 
the sample. The hydrogen peroxide produced is then removed by the enzyme catalase. The 
absence of detergent in this first reaction prevents HDL from reacting with the enzymes. In stage 
2 detergent is added to allow HDL to react with the enzyme system. Sodium azide inhibits the 
reaction of the hydrogen peroxide formed with catalase. The hydrogen peroxide acts with 4-







 Level 1  Level 2  Level 3  
Mean (mmol/L) 0.91 1.39 1.95 
N 20 20 20 
SD 0.010 0.019 0.029 
CV% 1.1 1.4 1.5 
Inter-assay precision 
 
 Level 1  Level 2  Level 3  
Mean (mmol/L) 0.91 1.39 1.95 
N 20 20 20 
SD 0.020 0.029 0.049 





Serum or heparinised plasma may be used. Specimens may be refrigerated overnight or stored 
at room temperature in seroseparator tubes. The ADVIA 2400 uses 2 µl of sample in the test, 
although the minimum volume required in the specimen container is 50µl (micro sample cups) 
















Quoting reference values for serum HDL cholesterol in terms of population distribution is 
actively discouraged in favour of setting desirable targets. Current WHO recommendations 
suggest a cholesterol concentration above 1.0 mmol/l as being desirable to avoid coronary 
artery disease. HDL cholesterol is also used in conjunction with total cholesterol and triglycerides 





The Advia HDL method is traceable to the NCEP Designated Comparison Method (reference 
method) via patient sample correlation. Assigned values of ADVIA Chemistry HDL/LDL 
Cholesterol Calibrator and ADVIA Chemistry Lipid Controls are traceable to this standardization. 
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Salivette with swab 
 
Inner tube 
 Outer tube 
 








3.  Tip the swab into the lid and use this to place the swab 
under the front of your tongue. Do not touch the swab 
with your fingers. 
 
 




5.  Take the swab out of your mouth with the help of the 
lid (so you are not touching the swab with your 
fingers). 
 
6.  Carefully tip the swab into the salivette tube without 




7.  Replace the lid firmly. 
 







Swab with saliva 
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South London Child Development Study 








PLEASE ENSURE YOU TAKE YOUR SAMPLES AT THE CORRECT TIMES 
 Time Complete  
Awakening  BOX 1 
Awakening +15 minutes  BOX 2 
Awakening +30 minutes  BOX 3 
Awakening +60 minutes  BOX 4 
12pm  BOX 5 




Wake up (before 10am) 
Immediately after waking up collect your saliva as on the instruction diagram. Place the swab 
under your tongue and leave it there for 1-2 minutes, then place it as shown in the tube marked 
awakening. 
Then close the tube firmly and store in the fridge in the bag supplied. 
 
Write here the EXACT TIME OF AWAKENING: ________________________ 
 
PLEASE NOW USE THE TIMER PROVIDED 
Try to sit down and relax in the next hour. YOU MUST NOT BRUSH YOUR TEETH AND MUST NOT 
HAVE ANYTHING TO EAT, DRINK OR SMOKE FOR THE NEXT HOUR. 
You may drink water if you need to, but only immediately AFTER you have taken a sample. 
 
BOX 2 
15 minutes after waking up, collect your saliva in the tube marked 15 mins. 
Then close the tube firmly and store in the fridge in the bag supplied. 
 What time is it now? 
__________________________________________________________________ 
 What were you doing before giving the sample? 
____________________________________________ 
________________________________________________________________________ 
 Did you accidentally have anything to eat or drink before taking the sample? If yes, please 
describe it here: 
___________________________________________________________________________ 
 Did you have any difficult or tense situation, unpleasant thoughts or any kind of pain before 





30 minutes after waking up, collect your saliva in the tube marked 30 mins. 
Date of collection dd/mm/yy ……/.….../…… ID     
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Then close the tube firmly and store in the fridge in the bag supplied. 
 What time is it now? 
__________________________________________________________________ 




 Did you accidentally have anything to eat or drink before taking the sample? If yes, please 
describe it here: 
___________________________________________________________________________
____ 
 Did you have any difficult or tense situation, unpleasant thoughts or any kind of pain before 






60 minutes after waking up, collect your saliva in the tube marked 60 mins. 
Then close the tube firmly and store in the fridge in the bag supplied. 
 What time is it now? 
__________________________________________________________________ 




 Did you accidentally have anything to eat or drink before taking the sample? If yes, please 
describe it here: 
___________________________________________________________________________
___ 
 Did you have any difficult or tense situation, unpleasant thoughts or any kind of pain before 





*****YOU CAN NOW HAVE BREAKFAST AND BRUSH YOUR TEETH! ***** 
*****YOU SHOULD NOT EAT OR DRINK ANYTHING, SMOKE OR BRUSH YOU TEETH 
 IN THE 30 MINUTES BEFORE NOON.***** 
 
BOX 5 
At 12 noon, before lunch, collect your saliva in the tube marked 12 pm. 
Then close the tube firmly and store in the fridge in the bag supplied. 
 What time is it now? 
__________________________________________________________________ 
 What were you doing before giving the sample? 
____________________________________________ 
 _______________________________________________________________________ 
 Did you accidentally have anything to eat or drink before taking the sample? If yes, please 
describe it here: 
___________________________________________________________________________ 
 Did you have any difficult or tense situation, unpleasant thoughts or any kind of pain before 





*****YOU SHOULD NOT EAT OR DRINK ANYTHING, SMOKE OR BRUSH YOUR TEETH 
IN THE 30 MINUTES BEFORE 8PM.***** 
 
BOX 6 
At 8pm collect your saliva in the tube marked 8 pm. 
Then close the tube firmly and store in the fridge in the bag supplied  
 What time is it now? 
_________________________________________________________________ 
 What were you doing before giving the sample? 
___________________________________________ 
 ________________________________________________________________________ 
 Did you accidentally have anything to eat or drink before taking the sample? If yes, please 
describe it here: 
___________________________________________________________________________
___ 
 Did you have any difficult or tense situation, unpleasant thoughts or any kind of pain before 
















Posting the samples: 
Please post your samples back to us AS SOON AS POSSIBLE, keeping your sample in the fridge 
prior to posting. 
 
Place all the samples in the plastic bag provided and seal it carefully. Place the bag and the 





Office use only: 
[Date of sample receipt: __ / __ / __     Date of sample storage: __ / __ / __  ] 
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Appendix M: Assay procedure for salivary cortisol  
Saliva was collected using Sarstdet swabs and tubes containing samples were stored at -20C. 
Immediately before analysis samples were thawed and collection tubes were subjected to 15 
min of centrifugation at 3000 rpm. Determination of cortisol levels was done using the High 
Sensitivity Salivary Cortisol ELISA KIT from Salimetrics, following the recommended procedure.  
 
Briefly, 25 ul of saliva and standards were assayed in duplicates, by incubation on a microtitre 
plate coated with monoclonal antibodies against cortisol. Cortisol linked to horseradish 
peroxidase was added to compete with cortisol in the standards and unknowns for the antibody 
binding sites. After 1h of incubation, unbound components were washed away. Bound cortisol 
peroxidase was measured by reaction of the peroxidase enzyme on the substrate 
tetramethylbenzidine. The amount of cortisol peroxidase detected, as measured by the intensity 
of colour developed, was inversely proportional to the amount of cortisol present. Optical 
density was read at 450 nm with correction at 620 nm, using a Beckman Coulter DTX 880 plate 
reader, with Multimode Detection Software 2.0.0.12. Values of cortisol were calculated using 
SoftMax Pro 4.8 software, following a 4-parameter fit. 
 
All samples from the same participant were analysed in the same plate. 
 
Sensitivity: we set it to 0.33 nmol/l, equivalent to 0.012ug/dl (more stringent than the suggested 
0.003 ug/dl)  
 
Inter assay: level 1 8%,  level 2 11% (our values) 
Intra assay: level 1 5.6% level 2  9.6% (our values) 
